4 - The emergence of social anxiety disorder as a major medical condition  pp. 40-49

The emergence of social anxiety disorder as a major medical condition

By Michael R. Liebowitz

Chapter Abstract

Social phobia turned out to be a severe clinical problem for patients whose fear of evaluation and scrutiny by others interfered with social functioning as well as performance. The study comparing phenelzine, atenolol, and placebo in social anxiety disorder became a model to be followed by subsequent trials. Social anxiety disorder appears to be a highly prevalent condition. While the most recent epidemiologic survey, the NESARC, has found a lifetime prevalence of 5% as opposed to the 13% found in the original National Comorbidity Survey (NCS) study, it would still appear that social anxiety disorder is one of the more common psychiatric conditions. Future studies should go a long way toward clarifying the pathophysiology of social anxiety disorder, which in turn should facilitate diagnosis as well as treatment. Positron emission tomography (PET) scans of patients giving speeches are beginning to delineate the brain circuits relevant to social phobic symptomatology.


Keywords:

epidemiologic survey; national comorbidity survey; atenolol; positron emission tomography; social anxiety disorder; social phobic symptomatology; social phobia; phenelzine; placebo;

4

Reference Title: References

Reference Type: bibliography

Antony M. M. , & Stein M. B. , eds. (2008). Oxford Handbook of Anxiety and Related Disorders. Oxford: Oxford University Press.
Barlow D. H. , ed. (2004). Anxiety and Its Disorders: the Nature and Treatment of Anxiety and Panic, 2nd edn. New York, NY: Guilford Press.
Greenberg P. E. , Sisitsky T. , Kessler R. C. , et al. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60, 427–435.
Kessler R. C. , Chiu W. T. , Demler O. , Merikangas K. R. , & Walters E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.
Stein D. J. , Hollander E. , & Rothbaum B.O. , eds. (2009). Textbook of Anxiety Disorders, 2nd edn. Arlington, VA: American Psychiatric Publishing.

Reference Title: References

Reference Type: bibliography

Adewuya A. O. , Ola B. A. , & Adewumi T. A. (2007). The 12-month prevalence of DSM-IV anxiety disorders among Nigerian secondary school adolescents aged 13–18 years. Journal of Adolescence, 30, 1071–1076.
Albano A. M. , & Hack S. (2004). Children and adolescents. In R. G. Heimberg , C. L. Turk , & D.S. Mennin , eds., Generalized Anxiety Disorder: Advances in Research and Practice. New York, NY: Guilford.
Albano A. M. , & Kendall P. C. (2002). Cognitive behavioural therapy for children and adolescents with anxiety disorders: Clinical research advances. International Review of Psychiatry, 14, 129–134.
Alyahri A. , & Goodman R. (2008). The prevalence of DSM-IV psychiatric disorders among 7–10 year old Yemini schoolchildren. Social Psychiatry and Psychiatric Epidemiology, 43, 224–230.
Andrews B. , Brewin C. R. , Phipott R. , & Stewart L. (2007). Delayed-onset posttraumatic stress disorder: a systematic review of the evidence. American Journal of Psychiatry, 164, 1319–1326.
Barlow D. H. , Allen L. B. , & Badsen S. L. (2007). Psychological treatments for panic disorders, phobias, and generalized anxiety disorder. In P. E. Nathan & J. M. Gorman , eds., A Guide to Treatments that Work, 3rd edn. New York, NY: Oxford University Press.
Beekman A. T. F. , Debeurs E. , van Balkom A. J. L. M. , et al. (2000). Anxiety and depression in later life: Co-occurrence and communality of risk factors. American Journal of Psychiatry, 157, 89–95.
Bogetto F. , Venturello S. , Albert U. , Maina G. , & Ravizza L. (1999). Gender-related clinical differences in obsessive–compulsive disorder. European Psychiatry, 14, 434–441.
Brady E. U. , & Kendall P. C. (1992). Comorbidity of anxiety and depression in children and adolescents. Psychological Bulletin, 111, 244–255.
Breslau J. , Kendler K. S. , Su M. , Gaxiola-Aguilar S. , & Kessler R. C. (2004). Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychological Medicine, 35, 317–327.
Breslau J. , Aguilar-Gaxiola S. , Borges G. , et al. (2007). Risk for psychiatric disorder among immigrants and their US-born descendants: Evidence from the National Comorbidity Survey Replication. Journal of Nervous and Mental Disease, 195, 189–195.
Canino G. J. , Bird H. R. , Shrout P. E. , et al. (1987). The prevalence of specific psychiatric disorders in Puerto Rico. Archives of General Psychiatry, 44, 727–735.
Carter R. M. , Wittchen H. U. , Pfister H. , & Kessler R. C. (2001). One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depression and Anxiety, 13, 78–88.
Chartier M. J. , Walker J. R. , & Stein M. B. (2003). Considering comorbidity in social phobia. Social Psychiatry and Psychiatric Epidemiology, 38, 728–734.
Cho M.J. , Kim J.-K. , Jeon H.J. , et al. (2007). Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults. Journal of Nervous and Mental Disease, 195, 203–210.
Comer J. S. , & Kendall P. C. (2004). A symptom-level examination of parent–child agreement in the diagnosis of anxious youths. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 878–886.
Comer J. C. , & Kendall P. C. (2007). Terrorism: the psychological impact on youth. Clinical Psychology, 14, 178–212.
Comer J. S. , Kendall P. C. , Franklin M. E. , Hudson J. L. , & Pimentel S. S. (2004). Obsessing/worrying about the overlap between obsessive–compulsive disorder and generalized anxiety disorder in youth. Clinical Psychology Review, 24, 663–683.
Comer J. S. , Blanco C. , Hasin D. S. , et al. (in press). Healthrelated quality of life and clinical correlates across the anxiety disorders. Journal of Clinical Psychiatry.
Comer J. S. , Fan B. , Duarte C. , et al. (in press). Attack-related life disruption and child psychopathology in New York City public schoolchildren 6-months post-9/11. Journal of Clinical Child and Adolescent Psychology.
Copeland W. E. , Keeler G. , Angold A. , & Costello E. J. (2007). Traumatic events and posttraumatic stress in childhood. Archives of General Psychiatry, 64, 577–584.
Costello E. J. , Mustillo S. , Erkanli A. , Keeler G. , & Angold A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60, 837–844.
Costello E. J. , Egger H. , & Angold A. (2005). 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 972–986.
Craske M. G. , Miller P. P. , Rotunda R. , & Barlow D. H. (1990). A descriptive report of features of initial unexpected panic attacks in minimal and extensive avoiders. Behaviour Research and Therapy, 28, 395–400.
Creamer M. , Burgess P. , & McFarlane A. C. (2001). Posttraumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-Being. Psychological Medicine, 31, 1237–1247.
De Los Reyes A. , & Kazdin A. E. (2005). Informant discrepancies in the assessment of childhood psychopathology: a critical review, theoretical framework, and recommendations for further study. Psychological Bulletin, 131, 483–509.
de Mathis M. A. , do Rosario M. C. , Diniz J. B. , et al. (2008). Obsessive–compulsive disorder: influence of age at onset on comorbidity patterns. European Psychiatry, 23, 187–194.
Dohrenwend B. P. , & Dohrenwend B. S. (1982). Perspectives on the past and future of psychiatric epidemiology: the 1981 Rema Lapouse lecture. American Journal of Public Health, 72, 1271–1279.
Egger H. L. , & Angold A. (2006). Common emotional and behavioral disorders in preschool children: presentation, nosology, and epidemiology. Journal of Child Psychology and Psychiatry, 47, 313–337.
Eng W. , Coles M. E. , Heimberg R. G. , & Safren S. A. (2005). Domains of life satisfaction in social anxiety disorder: Relation to symptoms and response to cognitive–behavioral therapy. Journal of Anxiety Disorders, 19, 143–156.
ESEMeD/MHEDEA 2000 Investigators (2004a). Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109 (Suppl. 420), 21–27.
ESEMeD/MHEDEA 2000 Investigators (2004b). 12-month comorbidity patterns and associated factors in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109 (Suppl. 420), 28–37.
ESEMeD/MHEDEA 2000 Investigators (2004c). Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand, 109 (Suppl. 420), 47–54.
Galea S. , Brewin C. R. , Gruber M. , et al. (2007). Exposure to hurricane-related stressors and mental illness after Hurricane Katrina. Archives of General Psychiatry, 64, 1427–1434.
Gellar D. , Biederman J. , Jones J. , et al. (1998). Is juvenile obsessive–compulsive disorder a developmental subtype of the disorder? A review of pediatric literature. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 420–427.
Goodwin R. D. , Faravelli C. , Rosi S. , et al. (2005). The epidemiology of panic disorder and agoraphobia in Europe. European Neuropsychopharmacology, 15, 435–443.
Grant B. F. , Stinson F. S. , Dawson D. A. , et al. (2004a). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807–816.
Grant B. F. , Stinson F. S. , Hasin D. S. , et al. (2004b). Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Archives of General Psychiatry, 61, 1226–1233.
Grant B. F. , Hasin D. S. , Blanco C. , et al. (2005a). The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66, 1351–1361.
Grant B. F. , Hasin D. S. , Stinson F. S. , et al. (2005b). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the U.S.: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research, 39, 1–9.
Grant B. F. , Hasin D. S. , Stinson F. S. , et al. (2005c). Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine, 35, 1747–1759.
Greenberg P. E. , Sisitsky T. , Kessler R. C. , et al. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60, 427–435.
Gross R. , Olfson M. , Gameroff M. J. , et al. (2005). Social anxiety disorder in primary care. General Hospital Psychiatry, 27, 161–168.
Gureje O. , Lasebikan V. O. , Kola L. , & Makanjuola V. A. (2006). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. British Journal of Psychiatry, 188, 465–471.
Hambrick J. P. , Turk C. L. , Heimberg R. G. , Schneier F. R. , & Liebowitz M. R. (2003). The experience of disability and quality of life in social anxiety disorder. Depression and Anxiety, 18, 46–50.
Hanna G. L. (1995). Demographic and clinic features of obsessive compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 19–27.
Heimberg R. G. , Liebowitz M. R. , Hope D. A. , et al. (1998). Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Archives of General Psychiatry, 55, 1133–1141.
Helzer J. E. , Kraemer H. C. , Krueger R. F. , et al. (2008). Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-IV. Washington, DC: American Psychiatric Association.
Henning E. R. , Turk C. L. , Mennin D. S. , Fresco D. M. , & Heimberg R. G. (2007). Impairment and quality of life in individuals with generalized anxiety disorder. Depression and Anxiety, 24, 342–349.
Holaway R. M. , Rodebaugh T. L. , & Heimberg R. G. (2006). The epidemiology of worry and generalized anxiety disorder. In G. C. L. Davey and A. Wells , eds., Worry and Its Psychological Disorders: Theory, Assessment, and Treatment. Hoboken, NJ: Wiley.
Horwath E. , & Weissman M. M. (2000). The epidemiology and cross-national presentation of obsessive–compulsive disorder. Psychiatric Clinics of North America, 23, 493–507.
Hoven C. W. , Duarte C. S. , Lucas C. P. et al. (2005). Psychopathology among New York City public school children 6 months after September 11. Archives of General Psychiatry, 62, 545–552.
Hunt C. , Issakidis C. , & Andrews G. (2002). DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine, 32, 649–659.
International Federation of Red Cross and Red Crescent Societies (1998). World Disasters Report. New York, NY: Oxford University Press.
International Federation of Red Cross and Red Crescent Societies (2004). World Disasters Report. New York, NY: Oxford University Press.
Jacobi F. , Wittchen H. U. , Holting C. , et al. (2004). Prevalence, comorbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine, 34, 597–611.
Kendall P. C. , Hudson J. L. , Gosch E. , Flannery-Schroeder E. , & Suveg C. (2008). Cognitive–behavioral therapy for anxiety disordered youth: a randomized clinical trial evaluating child and family modalities. Journal of Consulting and Clinical Psychology, 76, 282–297.
Kessler R. C. , & Frank R. G. (1997). The impact of psychiatric disorders on work loss days. Psychological Medicine, 27, 861–873.
Kessler R. C. , & Greenberg P. E. (2002). The economic burden of anxiety and stress disorders. In K. Davis , ed., Neuropsychopharmacology: the Fifth Generation of Progress. Baltimore, MD: American College of Neuropsychopharmacology and Lippincott Williams & Wilkins.
Kessler R. C. , & Ustun T. B. (2008). The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. New York, NY: Cambridge University Press.
Kessler R. C. , McGonagle K. A. , Zhao S. , et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
Kessler R. C. , Foster C. L. , Saunders W. B. , & Stang P. E. (1995a). Social consequences of psychiatric disorders, I: Educational attainment. American Journal of Psychiatry, 152, 1026–1032.
Kessler R. , Sonnega A. , Bromet E. , Hughes M. , & Nelson C. (1995b). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048–1060.
Kessler R. C. , Walters E. E. , & Forthofer M. S. (1998). The social consequences of psychiatric disorders, III: Probability of marital stability. American Journal of Psychiatry, 155, 1092–1096.
Kessler R. C. , Borges G. , & Walters E. E. (1999). Prevalence and risk factors of lifetime suicide attempts in the National Comorbidity Survey. Archives of General Psychiatry, 56, 617–626.
Kessler R. , Walters E. , & Wittchen H. U. (2004). Epidemiology. In R. Heimberg , C. Turk , & D. Mennin (Eds.), Generalized anxiety disorder: Advances in Research and Practice. New York, NY: Guilford Press, pp. 29–50.
Kessler R. C. , Berglund P. , Demler O. , et al. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593–602.
Kessler R. C. , Chiu W. T. , Demler O. , Merikangas K. R. , & Walters E. E. (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.
Kessler R. C. , Demler O. , Frank R. G. , et al. (2005c). Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine, 352, 2515–2523.
Kessler R. C. , Chiu W. T. , Jin R. , et al. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415–424.
Koran L. M. (2000). Quality of life in obsessive–compulsive disorder. Psychiatric Clinics of North America, 23, 509–517.
Koran L. M. , Thienemann M. L. , & Davenport R. (1996). Quality of life for patients with obsessive–compulsive disorder. American Journal of Psychiatry, 153, 783–788.
Kroenke K. , Spitzer R. L. , Williams J. B. W. , Monahan P. O. , & Lowe B. (2007). Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine, 146, 317–325.
Kuehn B. M. (2008). Scientists examine primary care based screening and treatments for anxiety. JAMA, 16, 1886–1887.
Kulka R. A. , Fairbank W. E. , Hough R. I. , et al. (1990). Trauma and the Vietnam War Generation: Report of findings from the National Vietnam Veterans Readjustment Study. New York, NY: Brunner/Mazel.
Lampe L. , Slade T. , Issakidis C. , & Andrews G. (2003). Social phobia in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine, 33, 637–646.
Lensi P. , Cassano G. B. , Correddu G. , Ravagli J. L. , & Akiskal H. S. (1996). Obsessive–compulsive disorder: familial-developmental history, symptomatology, comorbidty and course with special reference to gender-related differences. British Journal of Psychiatry, 169, 101–107.
Lieb R. , Becker E. , & Altamura C. (2005). The epidemiology of generalized anxiety disorder in Europe. European Neuropsychopharmacology, 15, 445–452.
McFarlane A. (2004). The contribution of epidemiology to the study of traumatic stress. Social Psychiatry and Psychiatric Epidemiology, 39, 874–882.
Medina-Mora M. E. , Borges G. , Lara C. , et al. (2005). Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychological Medicine, 35, 1773–1783.
Mendlowicz M. V. , & Stein M. B. (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry, 157, 669–682.
Merikangas K. R. , Avenevoli S. , Acharyya S. , Zhang H. , & Angst J. (2002). The spectrum of social phobia in the Zurich Cohort Study of Young Adults. Biological Psychiatry, 51, 81–91.
Merikangas K. R. , Ames M. , Cui L. , et al. (2007). The impact of comorbidity of mental and physical conditions on role disability in the U.S. adult population. Archives of General Psychiatry, 64, 1180–1188.
Milliken C. S. , Auchterlonie J. L. , & Hoge C. W. (2008). Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq War. JAMA, 298, 2141–2148.
Neria Y. , & Koenen K. C. (2003). Do combat stress reaction and posttraumatic stress disorder relate to physical health and adverse health practices? An 18-year follow-up of Israeli war veterans. Anxiety, Stress, & Coping, 16, 227–239.
Neria Y. , Gross R. , Olfson M. , et al. (2006). Posttraumatic stress disorder in primary care one year after the 9/11 attacks. General Hospital Psychiatry, 28, 213–222.
Neria Y. , Gross R. , Litz B. , et al. (2007). Prevalence and psychological correlates of complicated grief among bereaved adults 2.5–3.5 years after September 11th attacks. Journal of Traumatic Stress, 20, 251–262.
Neria Y. , Olfson M. , Gameroff M. J. , et al. (2008). The mental health consequences of disaster-related loss: Findings from primary care one year after the 9/11 terrorist attacks. Psychiatry: Interpersonal and Biological Processes, 71, 339–348.
Olfson M. , & Gameroff M. J. (2007). Generalized anxiety disorder, somatic pain and health care costs. General Hospital Psychiatry, 29, 310–316.
Olfson M. , Fireman B. , Weissman M. M. , et al. (1997). Mental disorders and disability among patients in a primary care group practice. American Journal of Psychiatry, 154, 1734–1740.
Perkonigg A. , Pfister H. , Stein M. B. , et al. (2005). Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adults. American Journal of Psychiatry, 162, 1320–1327.
Pilowsky D. J. , Olfson M. , Gameroff M. J. , et al. (2006). Panic disorder and suicidal ideation in primary care. Depression and Anxiety, 23, 11–16.
Pirkola S. P. , Isometsa E. , Suvisaari J. , et al. (2005). DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population: results from the Health 2000 Study. Social Psychiatry and Psychiatric Epidemiology, 40, 1–10.
Puliafico A. C. , Comer J. S. , & Kendall P. C. (2007). Social phobia in youth: The diagnostic utility of feared social situations. Psychological Assessment, 19, 152–158.
Rice D. P. , & Miller L. S. (1998). Health economics and cost implications of anxiety and other mental disorders in the United States. British Journal of Psychiatry Supplement, (34), 4–9.
Riddle M. (1998). Obsessive–compulsive disorder in children and adolescents. British Journal of Psychiatry, 173, 91–96.
Robin J. A. , Puliafico A. C. , Creed T. A. , et al. (2005). Generalized anxiety disorder. In R.T. Ammerman , ed., Comprehensive Handbook of Personality and Psychopathology, Volume 3: Child Psychopathology. Hoboken, NJ: Wiley.
Robins L. N. , & Regier D. A. (1991). Psychiatric Disorders in America: the Epidemiologic Catchment Area Study. New York, NY: Free Press.
Rodriguez B. F. , Weisberg R. B. , Pagano M. E. , et al. (2004). Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Comprehensive Psychiatry, 45, 129–137.
Roy-Byrne P. P. , & Cowley D. S. (2007). Pharmacological treatments for panic disorder, generalized anxiety disorder, specific phobia, and social anxiety disorder. In P. E. Nathan & J. M. Gorman , eds., A Guide to Treatments that Work, 3rd edn. New York, NY: Oxford University Press.
Ruscio A. M. , Lane M. , Roy-Byrne P. , et al. (2005). Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the U.S. National Comorbidity Survey Replication. Psychological Medicine, 35, 1761–1772.
Ruscio A. M. , Brown T. A. , Chiu W. T. , et al. (2008). Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychological Medicine, 38, 15–28.
Rutter M. (1994). Comorbidity: meaning and mechanisms. Clinical Psychology: Science and Practice, 1, 100–103.
Rutter M. (1997). Comorbidity: concepts, claims and choices. Criminal Behaviour and Mental Health, 7, 265–285.
Schlenger W. E. , Caddell J. M. , Ebert L. , et al. (2002). Psychological reactions to terrorist attacks: findings from the National Study of Americans' Reactions to September 11. JAMA, 288, 581–588.
Schneier F. R. , Johnson J. , Hornig C. D. , Liebowitz M. R. , & Weissman M. W. (1992). Social phobia: Comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry, 49, 282–288.
Schneier F. R. , Heckelman L. , Garfinkel R. , et al. (1994). Functional impairment in social phobia. Journal of Clinical Psychiatry, 55, 322–331.
Seal K. H. , Bertenthal D. , Miner C. R. , Sen S. , & Marmar C. (2007). Bringing the war back home: mental health disorders among 103,788 U.S. veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Archives of Internal Medicine, 167, 476–482.
Shear K. , Jin R. , Ruscio A. M. , Walters E. E. , & Kessler R. C. (2006). Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 1074–1083.
Shulman I. D. , Cox B. J. , Aqinaon R. P. , Kuch K. , & Reichman J. T. (1994). Precipitating events, locations and reactions associated with initial unexpected panic attacks. Behaviour Research and Therapy, 32, 17–20.
Smith S. M. , Stinson F. S. , Dawson D. A. , et al. (2006). Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine, 36, 987–998.
Solomon Z. (1989). Characteristic psychiatric symptomatology in PTSD veterans: a three year follow-up. Psychological Medicine, 19, 927–936.
Stein D. J. , Seedat S. , Herman A. , et al. (2008). Lifetime prevalence of psychiatric disorders in South Africa. British Journal of Psychiatry, 192, 112–117.
Stein M. , & Heimberg R G. (2004). Well-being and life satisfaction in generalized anxiety disorder: Comparison to major depressive disorder in a community sample. Journal of Affective Disorders, 79, 161–166.
Stein M. , & Kean Y. (2000). Disability and quality of life in social phobia: epidemiologic findings. American Journal of Psychiatry, 157, 1606–1613.
Stein M. , Walker J. , Hazen A. , & Forde D. (1997). Full and partial posttraumatic stress disorder: findings from a community survey. American Journal of Psychiatry, 154, 1114–1119.
Stein M. B. , Torgrud L. J. , & Walker J. R. (2000). Social phobia symptoms, subtypes, and severity: findings from a community survey. Archives of General Psychiatry, 57, 1046–1052.
Stinson F. S. , Dawson D. A. , Chou S. P. , et al. (2007). The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Disorders. Psychological Medicine, 37, 1047–1059.
Strine T. W. , Mokdad A. H. , Dube S. R. , et al. (2008). The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling U.S. adults. General Hospital Psychiatry, 30, 127–137.
Torres A. R. , Prince M. J. , Bebbington P. E. , et al. (2006). Obsessive–compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry, 163, 1978–1985.
Vega W. A. , Kolody B. , Aguilar-Gaxiola S. , et al. (1998). Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California. Archives of General Psychiatry, 55, 771–778.
Wang P. S. , Berglund P. , Olfson M. , et al. (2005). Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 603–613.
Wang P. S. , Aguilar-Gaxiola S. , Alonso J. , et al. (2007). Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet, 370, 841–850.
Weissman M. M. , Bland R. C. , Canino G. J. , et al. (1994). The cross national epidemiology of obsessive compulsive disorder: The Cross National Collaborative Group. Journal of Clinical Psychiatry, 55 (Suppl. 3), 5–10.
Wittchen H. U. (1988). Natural course and spontaneous remissions of untreated anxiety disorder: results of the Munich Follow-up Study (MFS). In I. Hand & H. U. Wittchen , eds., Panic and Phobias. Berlin: Springer.
Wittchen H. U. (2002). Generalized anxiety disorder: prevalence, burden, and cost to society. Depression and Anxiety, 16, 162–171.
Wittchen H. U. , Zhao Z. , Kessler R. C , & Eaton W. W. (1994). DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Archives of General Psychiatry, 51, 355–364.
Wittchen H. U. , Neslon C. B. , & Lachner G. (1998). Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychological Medicine, 28, 109–126.
Wittchen H. , Fuetsch M. , Sonntag, Muller N. , & Liebowitz M. R. (1999). Disability and quality of life in pure and comorbid social phobia: findings from a controlled study. European Psychiatry, 14, 118–131.
Zlotnick C. , Johnson J. , Kohn R. , et al. (2006). Epidemiology of trauma, post-traumatic stress disorder (PTSD) and co-morbid disorders in Chile. Psychological Medicine, 36, 1523–1533.

Reference Title: References

Reference Type: bibliography

American Medical Association (1952). Standard Nomenclature of Diseases and Operations, 4th edn. Philadelphia, PA: Blakistone.
American Psychiatric Association (1952). Diagnostic and Statistical Manual of Mental Disorders (DSM-I). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders, 2nd edn (DSM-II). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised (DSM-III-R). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Andrews G. , Brugha T. , Thase M. E. , et al. (2008). Dimensionality and the category of major depressive episode. In J. E. Helzer , H. C. Kraemer , R. F. Krueger , et al., eds., Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-5. Arlington, VA: American Psychiatric Press, pp. 35–51.
Angst J. (2007). The bipolar spectrum. British Journal of Psychiatry, 190, 189–191.
Berrios G. (1996). The History of Mental Symptoms: Descriptive Psychopathology Since the Nineteenth Century. Cambridge: Cambridge University Press.
Breslau N. , & Kessler R. (2001). The stressor criterion in DSM-IV posttraumatic stress disorder: an empirical investigation. Biological Psychiatry, 50, 699–704.
Brown T. A. , & Barlow D. H. (2005). Dimensional versus categorical classification of mental disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and beyond: comment on the special section. Journal of Abnormal Psychology, 114, 551–556.
Feighner J. P. , Robins E. , Guze S. B. , et al. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.
Foa E. , Kozak M. , Goodman W. , et al. (1998). DSM-IV field trial: obsessive–compulsive disorder. In T. Widiger , A. Frances , H. Pincus , et al., eds., DSM-IV Sourcebook, Volume 4. Washington, DC: American Psychiatric Association, pp. 761–778.
Frances A. , Widiger T. , & Pincus H. A. (1989). The development of DSM-IV. Archives of General Psychiatry, 46, 373–375.
Frances A. , Pincus H. , Manning D. , & Widiger T. (1990). Classification of anxiety states in DSM-III and perspectives for its classification in DSM-IV. In S. Sartorius , V. Andreoli , G. Cassano , et al., eds., Anxiety: Psychobiological and Clinical Perspectives. New York, NY: Hemisphere, pp. 139–146.
Fyer A. , Katon W. , Hollifield M. , et al. (1998). DSM-IV panic disorder field trial: panic attack frequency and functional disability. In T. Widiger , A. Frances , H. Pincus , et al., DSM-IV Sourcebook, Volume 4. Washington, DC: American Psychiatric Association, pp. 779–802.
Haggard P. , Furman A. , Levy S. T. , et al. (2008). Psychoanalytic theories. In A. Tasman , J. Kay , J. Lieberman , M. First & M. Maj , eds., Psychiatry, 3rd edn. Chichester: Wiley, pp. 464–485.
Helzer J. E. , Bucholz K. K. , Gossop M. (2008a). A dimensional option for the diagnosis of substance dependence in DSM-5. In J. E. Helzer , H. C. Kraemer , R. F. Krueger , et al., eds., Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-5. Arlington, VA: American Psychiatric Press, pp. 19–34.
Helzer J. E. , Kraemer H. C. , Krueger R. F. , et al., eds. (2008b). Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-5. Arlington, VA: American Psychiatric Press.
Helzer J. E. , Wittchen H. U. , Krueger R. F. , & Kraemer H. C. (2008c). Dimensional options for DSM-5: the way forward. In J. E. Helzer , H. C. Kraemer , R. F. Krueger , et al., eds., Dimensional Approaches in Diagnostic Classification: Refining the Research Agenda for DSM-5. Arlington, VA: American Psychiatric Press, pp. 115–127.
Hinton D. , Ba P. , Peou S. , & Um K. (2000). Panic disorder among Cambodian refugees attending a psychiatric clinic: Prevalence and subtypes. General Hospital Psychiatry, 22, 437–444.
Kawakami N. , Takeshima T. , Ono Y. , et al. (2005). Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary findings from the World Mental Health Japan Survey 2002–2003. Psychiatry and Clinical Neurosciences, 59, 441–452.
Kay J. , & Kay R. (2008). Individual psychoanalytic psychotherapy. In A. Tasman , J. Kay , J. Lieberman , M. First & M. Maj , eds., Psychiatry, 3rd edn. Chichester: Wiley, pp. 1851–1874.
Kilpatrick D. G. , Resnick H. S. , Freedy J.R. , et al. (1998). The posttraumatic stress disorder field trial: evaluation of the PTSD construct – criteria A through E. In T. Widiger , A. Frances , H. Pincus , et al., DSM-IV Sourcebook, Volume 4. Washington, DC: American Psychiatric Association, pp. 803–846.
Klein D. (1964). Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia, 5, 397–408.
Kupfer D. , First M. , & Regier D. (2002). Introduction. In D. Kupfer , M. First , & D. Regier , eds., A Research Agenda for DSM-5. Washington, DC: American Psychiatric Association, pp. xv–xxiii.
Leckman J. , Merikangas K. , Pauls D. L. , Prusoff B. A. , & Weismann M. M. (1983). Anxiety disorders and depression: contradictions between family study data and DSM-III conventions. Archives of General Psychiatry, 140, 880–882.
Lehman A. F. , Alexopolous G. S. , Goldman H. , Jeste D. , & Ustun B. (2002). Mental disorders and disability: time to reevaluate the relationship? In D. J. Kupfer , M. B. First , & D. A. Regier , eds., A Research Agenda for DSM-5. Washington, DC: American Psychiatric Association, pp. 201–218.
Lewis-Fernández R. , & Díaz N. (2002). The cultural formulation: a method for assessing cultural factors affecting the clinical encounter. Psychiatric Quarterly, 73, 271–295.
Pine D. S. , Alegría M. , Cook E. H. , et al. (2002). Advances in developmental science and DSM-5. In D. J. Kupfer , M. B. First , & D. A. Regier , eds., A Research Agenda for DSM-5. Washington, DC: American Psychiatric Association, pp. 85–122.
Regier D. A. , Boyd J. H. , Burke J. D. , et al. (1988). Onemonth prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Archives of General Psychiatry, 45, 977–986.
Roth S. , Newman E. , Pelcovitz D. , van der Kolk B. , & Mandel F. S. (1997). Complex PTSD in victims exposed to sexual and physical abuse: results from the DSM-IV Field Trial for Posttraumatic Stress Disorder. Journal of Trauma and Stress, 10, 539–555.
Samuels J. F. , Bienvenu O. J. , Pinto A. , et al. (2007). Hoarding in obsessive–compulsive disorder: results from the OCD collaborative genetics study. Behaviour Research and Therapy, 45, 673–686.
Schneier F. R. , Liebowitz M. R. , Beidel D. C. , et al. (1996). Social phobia. In T. A. Widiger , A. J. Frances , H. A. Pincus , et al., eds., DSM–IV Sourcebook, Vol. 2. Washington DC: American Psychiatric Association, pp. 507–548.
Spitzer R. , & Williams J. (1985). Proposed revisions in the DSM-III classification of anxiety disorders based on research and clinical experience. In A. Tuma & J. Maser , eds., Anxiety and the Anxiety Disorders. Hillsdale: Lawrence Erlbaum Associates, pp. 759–773.
Spitzer R. , First M. , Williams J. B. , et al. (1992). Now is the time to retire the term “organic mental disorders”. American Journal of Psychiatry, 149, 240–244.
Zitrin C. , Klein D. , & Woerner M. G. (1978). Behavior therapy, supportive psychotherapy, imipramine, and phobias. Archives of General Psychiatry, 35, 307–316.

Reference Title: References

Reference Type: bibliography

American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised (DSM-III-R). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington DC: American Psychiatric Association.
Barlow D. H. , Gorman J. M. , Shear M. K. , & Woods S. W. (2000). Cognitive–behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA, 283, 2529–2536.
Birbaumer N. , Grodd W. , Diedrich O. , Klose W. , & Erb M. (1998). fMRI reveals amygdala activation to human faces in social phobia. NeuroReport, 9, 1223–1226.
Blanco C. , Heimberg R. G. , Schneier F. R. , Fresco D. M. , Chen H. , Turk C. L. , Vermes D. , Erwin B. A. , Schmidt A. B. , Juster H. R. , Campeas R. , & Liebowitz M. R. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy and their combination for social anxiety disorder. Archives of General Psychiatry, 2010, 67(3), 286–295.
Davidson J. R. T. , Foa E. B. , Huppert J. D. , et al. (2004). Fkuoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry, 61, 1005–1013.
Falloon I. R. , Lloyd G. G. , & Harpin R.E. (1981). The treatment of social phobia: real-life rehearsal with nonprofessional therapists. Journal of Nervous and Mental Disorders, 169, 180–184.
Foa E. B. , Liebowitz M. R. , Kozak M. J. , et al. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine and their combination in the treatment of obsessive–compulsive disorder. American Journal of Psychiatry, 162, 151–161.
Gelernter C. S. , Uhde T. W. , Cimbolic P. , et al. (1991). Cognitive–behavioral and pharmacological treatments of social phobia: a controlled study. Archives of General Psychiatry, 48, 938–945.
Gorman J. M. , Liebowitz M. R. , Fyer A. J. , Campeas R. , & Klein D. F. (1985). Treatment of social phobia with atenolol. Journal of Clinical Psychopharmacology, 5, 298–301.
Grant B. F. , Hasin D. S. , Blanco C. , et al. (2005). The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66, 1351–1361.
Hariri A. R. , Mattay V. S. , Tessitore A. , et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297, 400–403.
Heimberg R. G. , Liebowitz M. R. , Hope D. A. , et al. (1998). Cognitive–behavioral group therapy versus phenelzine in social phobia: 12-week outcome. Archives of General Psychiatry, 55, 1133–1141.
Heimberg R. H. , Horner K. J. , Juster H. R. , et al. (1999). Psychometric properties of the Liebowitz social anxiety scale. Psychological Medicine, 29, 199–212.
Hoffman S. G. , Meuret A. E. , Smits J. A. J. , et al. (2006). Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298–304.
Kessler R. C. , McGonagle K. A. , Zhao S. , et al. (1994). Lifetime and 12-month prevalence of DSM III psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
Lane C. (2007). Shyness: How Normal Behavior Became a Sickness. New Haven, NJ: Yale University Press.
Levin A. P. , Saoud J. , Strauman T. , et al. (1993). Responses of “generalized” and “discrete” social phobics during public speaking. Journal of Anxiety Disorders, 7, 207–221.
Liebowitz M. R. (1987). Social phobia. In D. F. Klein , J. M. Gorman , A. F. Fyer , & M. R. Liebowitz , eds., Modern Problems of Pharmacopsychiatry: Anxiety. Basel: Karger.
Liebowitz M. R. , Gorman J. G. , Fyer A. J. , & Klein D. F. (1985). Social phobia: review of a neglected anxiety disorder. Archives of General Psychiatry, 42, 729–736.
Liebowitz M. R. , Fyer A. J. , Gorman J. M. , Campeas R. , & Levin A. (1986). Phenelzine in social phobia. Journal of Clinical Psychopharmacology, 6, 93–98.
Liebowitz M. R. , Quitkin F. M. , Stewart J. W. , et al. (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry, 45, 129–137.
Liebowitz M. R. , Schneier F. R. , Campeas R. , et al. (1992). Phenelzine vs. atenolol in social phobia: a placebo controlled comparison. Archives of General Psychiatry, 49, 290–300.
Liebowitz M. R. , Heimberg R. G. , Schneier F. R. , et al. (1999). Cognitive–behavioral group therapy versus phenelzine in social phobia: Long term outcome. Depression and Anxiety, 10, 89–98.
Liebowitz M. R. , DeMartinis N. A. , Weihs K. , et al. (2003). Efficacy of sertraline in severe generalized social anxiety disorder: Results of a double-blind placebo-controlled study. Journal of Clinical Psychiatry, 64(7), 785–792.
Liebowitz M. R. , Gelenberg A. J. , & Munjack D. (2005). Venlafaxine extended-release vs. placebo and paroxetine in social anxiety disorder. Archives of General Psychiatry, 62, 190–198.
Mannuzza S. , Schneier F. R. , Chapman T. F. , Liebowitz M. R. , Klein D. F. , & Fyer A. J. (1995). Generalized social phobia: reliability and validity. Archives of General Psychiatry 52, 230–237.
Marks I. M. , & Gelder M. G. (1966). Different age of onset in varieties of phobias. American Journal of Psychiatry, 123, 218–221.
Masia-Warner C. , Storch E. A. , Pincus D. B. , et al. (2003). Liebowitz Social Anxiety Scale for children and adolescents: an initial psychometric investigation. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1076–1084.
Millon T. , Meagher S. , & Millon C. (2004) Personality Disorders in Modern Life. Hoboken, NJ: Wiley.
Pande A. C. , Davidson J. R. T. , Jefferson J. W. , et al. (1999). Treatment of social phobia with gabapentin: a placebocontrolled study. Journal of Clinical Psychopharmacology, 19, 341–348.
Regier D. A. , Myers J. K. , Kramer M. , et al. (1984). The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Archives of General Psychiatry, 41, 934–941.
Schneier F. R. , Saoud J. B. , Campeas R. , et al. (1993). Buspirone in social phobia. Journal of Clinical Psychopharmacology, 13(4), 251–56.
Schneier F. R. , Heckelman L. R. , Garfinkel R. , et al. (1994). Functional impairment in social phobia. Journal of Clinical Psychiatry, 55, 322–331.
Schneier F. R. , Liebowitz M. R. , Abi-Dargham A. , et al. (2000). Low dopamine D2 receptor binding potential in social phobia. American Journal of Psychiatry, 157, 457–459.
Simpson H. B. , Schneier F. R. , Campeas R. , et al. (1998a). Imipramine in the treatment of social phobia. Journal of Clinical Psychopharmacology, 18, 132–135.
Simpson H. B. , Schneier F. R. , Marshall R. D. , et al. (1998b). Low dose selegiline (L-Deprenyl) in social phobia. Depression and Anxiety, 7, 126–129.
Stein M. B. , Liebowitz M. R. , Lydiard R. B. , et al. (1998a). Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized, double-blind, placebo-controlled study. JAMA, 280, 708–713.
Stein M. B. , Chartier M. J. , Hazen A. L. , et al. (1998b). A direct interview family study of generalized social phobia. American Journal of Psychiatry, 155, 90–97.
Stein M. B. , Fyer A. J. , Davidson J. R. T. , Pollack M. H. , & Wiita B. (1999). Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. American Journal of Psychiatry, 156, 756–760.
Tillfors M. , Furmark T. , Marteinsdottir I. , et al. (2001). Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. American Journal of Psychiatry, 158, 1220–1226.
Versiani M. , Nardi E. , & Liebowitz M. R. (1992). Phenelzine vs moclobemide in social phobia: a placebo controlled trial. British Journal of Psychiatry, 161, 353–360.

Reference Title: References

Reference Type: bibliography

Brown G. W. , Harris T. O. , & Bifulco A. (1986). Longterm effects of early loss of parent. In M. Rutter , C. E. Izard , & P. B. Read, eds., Depression in Young People: Developmental and Clinical Perspectives. New York, NY: Guilford Publications.
Caligor E. , Stern B. L. , Hamilton M. , et al. (2009). Why we recommend analytic treatment for some patients and not for others. Journal of the American Psychoanalytic Association, 57, 677–694.
Caspi A. , Sugden K. , Moffitt T. E. , et al. (2003). Influence of stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389.
Coplan J.D. , Smith E.L.P. , Altemus M. , et al. (2001). Variable for aging demand rearing: sustained elevations in C1 sternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates. Biological Psychiatry, 50, 200–204.
Davis M. , & Whalen P. J. (2001) The amygdala: vigilance and emotion. Molecular Psychiatry, 6, 13–34.
Dawson G. , Ashman S. B. , & Carver L. J. (2000). The role of early experience in shaping behavioral and brain development and its implications for social policy. Developmental Psychopathology, 12, 695–712.
Drevets W. C. , Price J. L. , Simpson J. R. , et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824–827.
Etkin A. , Pittenger C. , Polan H.J. , & Kandel E.R. (2005). Toward a neurobiology of psychotherapy: basic science and clinical applications. Journal of Neuropsychiatry and Clinical Neuroscience, 17, 145–158.
Freud A. (1936). The Ego and the Mechanisms of Defence. London: Hogarth Press.
Freud S. (1894). The Neuro-Psychoses of Defence. The Standard Edition of the Complete Psychological Works of Sigmund Freud, Volume III (1893–1899). London: Hogarth Press.
Freud S. (1896). Further Remarks on the Neuro-Psychoses of Defence. The Standard Edition of the Complete Psychological Works of Sigmund Freud, Volume III (1893–1899). London: Hogarth Press.
Freud S. (1923). The Ego and the Id. The Standard Edition of the Complete Psychological Works of Sigmund Freud, Volume IXX, 1–66. London: Hogarth Press.
Freud S. (1926). Inhibitions, Symptoms, and Anxiety. The Standard Edition of the Complete Psychological Works of Sigmund Freud, Volume XX. London: Hogarth Press.
Garfinkle S. , Hamilton M. , Wininger L. , Garfinkle M. , & Roose S. (2009). Diagnosis and medication of mood disorders vs anxiety disorders by psychoanalytic candidates. New Research, Meeting of the American Psychoanalytic Association of New York.
Gutman D. , & Nemeroff C. B. (2002). Neurobiology of early life stress: rodent studies. Seminars in Clinical Neuropsychiatry, 7, 89–95.
Hartmann H. (1939). Ego Psychology and the Problem of Adaptation. New York, NY: International Universities Press.
Heim C. , Newport D. J. , Heit S. , et al. (2000). Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA, 284, 592–597.
Heim C. , Newport D. J. , Bonsall R. , Miller A. H. , & Nemeroff C. B. (2001). Altered pituitary-adrenal responses to provocative challenge tests in adult survivors of childhood abuse. American Journal of Psychiatry, 158, 575–581.
Hofer M. A. (1975). Studies on how early maternal separation produces behavioral change in young rats. Psychosomatic Medicine, 37, 245–64.
Hofer M. A. (1996). Multiple regulators of ultrasonic vocalization in the infant rat. Psychoneuroendocrinology, 21, 203–217.
Kagan J. , Reznick J. , & Snidman N. (1987). The physiology and psychology of behavioral inhibition in children. Child Development, 58, 1459–1473.
Kagan J. , Reznick J. , & Snidman N. (1988). Biological bases of childhood shyness. Science, 240, 167–171.
Kandel E. (1983). From metapsychology to molecular biology: explorations into the nature of anxiety. American Journal of Psychiatry, 40, 1277–1293. Reprinted in Psychiatry, Psychoanalysis, and the New Biology of Mind. Washington, DC: American Psychiatric Publishing, 2005.
Kernberg O. (1976). Object Relations Theory and Clinical Psychoanalysis. New York, NY: Jason Aronson.
Kim S. Y. , & Holloway R. G. (2003) Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis. American Journal of Psychiatry, 160, 1272–1276.
Klein M. (1964). Contributions to Psychoanalysis, 1921–1945. New York, NY: McGraw-Hill.
Klein M. (1975) Envy and Gratitude and Other Works: 1946–1963. New York, NY: Delacorte.
Kohut H. (1971). The Analysis of Self. New York, NY: International Universities Press
Kohut H. (1977). The Restoration of the Self. New York, NY: International Universities Press
Kuhn C. M. , & Schanberg S. M. (1991). Stimulation in infancy and brain development. In B. J. Carroll , ed., Psychopathology and the Brain. New York, NY: Raven Press.
Mirescu C. , Peters J. D. , & Gould E. (2004). Early life experience alters response of adult neurogenesis to stress. Nature Neuroscience, 7, 841–846.
Rutherford B. , Sneed J. , & Roose S. P. (2009). Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychotherapy and Psychosomatics, 78, 172–181.
Sneed J. R. , Rutherford B. R. , Rindskopf D. , et al. (2008). Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late life depression. American Journal of Geriatric Psychiatry, 16, 65–73.
Sullivan G. , Debiec J. , Bush D. , Lyons D. , & LeDoux J. (2009). The neurobiology of fear and anxiety. In D. Charney , & E. Nestler , eds., Neurobiology of Mental Illness. New York, NY: Oxford University Press.
Winnicott D. W. (1965). The Maturational Process and the Facilitating Environment. London: Hogarth Press.

Reference Title: References

Reference Type: bibliography

Alcock J. (2001). The Triumph of Sociobiology. New York, NY: Oxford University Press.
Brunelli S. A. , & Hofer M. A. (2007). Selective breeding for infant rat separation-induced ultrasonic vocalizations: developmental precursors of passive and active coping styles. Behavioural Brain Research, 182, 193–207.
Brunelli S. A. , Vinocur D. D. , Soo-Hoo D. , & Hofer M. A. (1997). Five generations of selective breeding for ultrasonic vocalization (USV) responses in N:NIH strain rats. Developmental Psychobiology, 31(4), 255–265.
Cameron N. , Parent C. , Champagne F. , Fish E. , Kuroda K. , & Meaney M. (2005). The programming of individual differences in defensive responses and reproductive strategies in the rat through variations in maternal care. Neuroscience and Biobehavioral Review, 29, 843–865.
Campos J. J. , Mumme D. L. , Kermoian R. , & Campos R. G. (1994). A functionalist perspective on the nature of emotion. Monogaphs of the Society for Research in Child Development, 59, 284–303.
Carroll S. (2005). Endless Forms Most Beautiful: the New Science of Evo-Devo. New York, NY: Norton.
Champagne F. A. , & Meaney M. J. (2006). Stress during gestation alters postpartum maternal care and the development of the offspring in a rodent model. Biological Psychiatry, 59, 1227–1235.
Champagne F. A. , Weaver I. C. , Diorio J. , et al. (2006). Maternal care associated with methylation of the estrogen receptor-alpha 1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology, 147(6), 2909–2915.
Darwin C. (1859). On the Origin of Species by Means of Natural Selection. London: John Murray. Reprinted New York, NY: Penguin, 1985.
Darwin C. (1868). The Variation of Animals and Plants Under Domestication. London: John Murray. Reprinted Baltimore, MD: Johns Hopkins University Press, 1998.
Darwin C. (1872). The Expression of the Emotions in Man and Animals. London: John Murray. Reprinted Chicago, IL: University of Chicago Press, 1965.
De Fries J. C. , Hyde J. S. , Lynch C. , Peterson D. , & Roberts R. C. (1981). The design of selection experiments. In G. E. McClearn , R. A. Dietrich , & V. G. Erwin , eds., National Institute on Alcohol Abuse & Alcoholism Research Monograph, 6: Development of Animal Models as Pharmacogenetic Tools. Bethesda, MD: Alcohol, Drug Abuse & Mental Health Administration.
Diorio J. , & Meaney M. J. (2007). Maternal programming of defensive responses through sustained effects on gene expression. Journal of Psychiatry and Neuroscience, 32, 275–284.
Ehret G. (1992). Preadaptations in the auditory system for mammals for phoneme perception. In M. E. H. Schouten , ed., The Auditory Processing of Speech: From Sounds to Words. Berlin: Mouton de Gruyter, pp. 99–112.
Gottlieb G. (1987). The developmental basis of evolutionary change. Journal of Comparative Psychology, 101, 262–271.
Grant P. R. (1986). Ecology and Evolution of Darwin's Finches. Princeton, NJ: Princeton University Press.
Haldane J. B. S. (1932). The Causes of Evolution. Princeton, NJ: Princeton University Press.
Hamilton W. D. (1964). The genetical theory of social behaviour: I & II. Journal of Theoretical Biology, 7, 1–52.
Hofer M. A. (1996). Multiple regulators of ultrasonic vocalization in the infant rat. Psychoneuroendocrinology, 21, 203–217.
Hofer M. A. (2003). The emerging neurobiology of attachment and separation: how parents shape their infant's brain and behavior. In S. W. Coates , J. L. Rosenthal , & D. S. Schechter , eds., September 11: Trauma and Human Bonds. Hillsdale, NJ: Analytic Press.
Hofer M. A. (2009). Evolutionary concepts of anxiety. In D. J. Stein , E. Hollander , & B. O. Rothbaum , eds., Textbook of Anxiety Disorders, 2nd edn. Arlington, VA: American Psychiatric Publishing.
Hofer M. A. , & Shair H. (1978). Ultrasonic vocalization during social interaction and isolation in 2-weeek-old rats. Developmental Psychobiology, 11, 495–504.
Hofer M. A. , & Shair H. (1980). Sensory processes in the control of isolation-induced ultrasonic vocalization by 2-week-old rats. Journal of Computational Physiology and Psychology, 94, 271–279.
Hofer M. A. , & Shair H. N. (1991). Trigeminal and olfactory pathways mediating isolation distress and companion comfort responses in rat pups. Behavioral Neuroscience, 105, 699–706.
Hofer M. A. , & Shair H. N. (1992). Ultrasonic vocalization by rat pups during recovery from deep hypothermia. Developmental Psychobiology, 25, 511–528.
Hofer M. A. , Shair H. N. , Masmela J. R. , & Brunelli S. A. (2001). Developmental effects of selective breeding for an infantile trait: the rat pup ultrasonic isolation call. Developmental Psychobiology, 39, 231–246.
Izard C. (1977). Human Emotions. New York, NY: Plenum.
Kenny J. T. , & Blass E. M. (1977). Suckling as incentive to instrumental learning in preweanling rats. Science, 196, 898–899.
Kirschner M. W. , & Gerhart J. C. (2005). The Plausibility of Life: Resolving Darwin's Dilemma: New Haven, CT: Yale University Press.
Klein D. F. (1993). False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Archives of General Psychiatry, 50, 306–317.
Lazarus R. S. (1991). Emotion and Adaptation. New York, NY: Oxford University Press.
Lewis M. , & Brooks-Gunn J. (1979). Social Cognition and the Acquisition of Self. New York, NY: Plenum.
MacLean P. D. (1985). Brain evolution relating to family, play, and the separation call. Archives of General Psychiatry, 42, 405–417.
Marks I. M. , & Nesse R. M. (1994). Fear and fitness: an evolutionary analysis of anxiety disorders. Ethology and Sociobiology, 15, 247–261.
McGowan P. O. , Sasaki A. , Huang T. C. , et al. (2008). Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE, 3(5), e2085.
McGuire M. , & Troisi A. (1998). Darwinian Psychiatry. New York, NY: Oxford University Press.
Meaney M. J. (2007). Environmental programming of phenotypic diversity in female reproductive strategies. Advances in Genetics, 59, 173–215.
Miczek K. A. , Tornatsky W. , & Vivian J. (1991). Ethology and neuropharmacology: rodent ultrasounds. In B. Oliver , J. Mos & J. L. Slanger , eds., Animal Models in Psychopharmacology. Basel: Birkhauser.
Nesse R. M. , & Williams C. G. (1996). Why We Get Sick: the New Science of Darwinian Medicine. New York, NY: Vintage Books.
Smith G. J. , Kucharski D. , & Spear N. E. (1985). Conditioning of an odor aversion in preweanlings with isolation from home nest as the unconditioned stimulus. Developmental Psychobiology, 18, 421–434.
Smoller J. W. , & Faraone S. V. (2008). Genetics of anxiety disorders: complexities and opportunities. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 85–88.
Spear N. E. , Kucharski D. , & Hoffmann H. (1985). Contextual influences on conditioned taste aversions in the developing rat. Annals of the New York Academy of Sciences, 443, 42–53.
Stein D. J. , & Bouwer C. (1997). A neuro-evolutionary approach to the anxiety disorders. Journal of Anxiety Disorders, 11, 409–429.
Takahashi L. K. (1992). Ontogeny of behavioral inhibition induced by unfamiliar adult male conspecifics in preweanling rats. Physiology and Behavior, 52, 493–498.
Trivers R. L. (1974). Parent–offspring conflict. American Zoologist, 14, 249–264.
Tsankova N. , Renthal W. , Kumar A. , & Nestler E. J. (2007). Epigenetic regulation in psychiatric disorders. Nature Reviews Neuroscience, 8, 355–367.
Weaver I. C. , Cervoni N. , Champagne F. A. , et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7, 847–854.
West-Eberhard M. J. (2003). Developmental Plasticity and Evolution. Oxford: Oxford University Press.
Wilson E. O. (1975). Sociobiology: the New Synthesis. Cambridge, MA: Harvard University Press.

Reference Title: References

Reference Type: bibliography

Abramowitz J. S. , Deacon B. J. , Olatunji B. O. , Wheaton M. G. , Berman N. C. , Losardo D. , Timpano K. R. , McGrath P. B. , Riemann B. C. , Adams T. , Bjorgvinsson T. , Storch E. A. & Hale L. R. (2010). Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychological Assessment, 22, 180–198.
Albert U. , Picco C. , Maina G. , et al. (2002). [Phenomenology of patients with early and adult onset obsessive–compulsive disorder]. Epidemiologiae Psichiatria Sociale, 11(2), 116–126.
Albert U. , Maina G. , Forner F. , & Bogetto F. (2004). DSM-IV obsessive–compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects. Comprehensive Psychiatry, 45, 325–332.
Alonso P. , Menchon J. M. , Pifarre J. , et al. (2001). Longterm follow-up and predictors of clinical outcome in obsessive–compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. Journal of Clinical Psychiatry, 62, 535–540.
Alsobrook J. P. , Leckman J. F. , Goodman W. K. , Rasmussen S. A. , & Pauls D. L. (1999). Segregation analysis of obsessive–compulsive disorder using symptom-based factor scores. American Journal of Medical Genetics, 88, 669–675.
Baer L. (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. Journal of Clinical Psychiatry, 55 (Suppl), 18–23.
Bloch M. H. , Landeros-Weisenberger A. , Rosario M. C. , Pittenger C. , & Leckman J. F. (2008). Meta-analysis of the symptom structure of obsessive–compulsive disorder. American Journal of Psychiatry, 165, 1532–1542.
Boucher L. , Palmeri T. J. , Logan G. D. , & Schall J. D. (2007). Inhibitory control in mind and brain: An interactive race model of countermanding saccades. Psychological Review, 114, 376–397.
Braun A. R. , Randolph C. , Stoetter B. , et al. (1995). The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology, 13, 151–168.
Butler R. W. , Braff D. L. , Rausch J. L. , et al. (1990). Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. American Journal of Psychiatry, 147, 1308–1312.
Calvo R. , Lazaro L. , Castro-Fornieles J. , et al. (2008). Obsessive–compulsive personality disorder traits and personality dimensions in parents of children with obsessive–compulsive disorder. European Psychiatry, 24, 201–206.
Cavedini P. , Erzegovesi S. , Ronchi P. , & Bellodi L. (1997). Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. European Neuropsychopharmacology, 7, 45–49.
Chamberlain S. R. , Blackwell A. D. , Fineberg N. A. , Robbins T. W. , & Sahakian B. J. (2005). The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neuroscience and Biobehavioral Reviews, 29, 399–419.
Chamberlain S. R. , Fineberg N. A. , Blackwell A. D. , Robbins T. W. , & Sahakian B. J. (2006). Motor inhibition and cognitive flexibility in obsessive–compulsive disorder and trichotillomania. American Journal of Psychiatry, 163, 1282–1284.
Chamberlain S. R. , Fineberg N. A. , Menzies L. A. , et al. (2007). Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive–compulsive disorder. American Journal of Psychiatry, 164, 335–338.
Chamberlain S. R. , Menzies L. , Hampshire A. , et al. (2008). Orbitofrontal dysfunction in patients with obsessive–compulsive disorder and their unaffected relatives. Science, 321, 421–422.
Coles M. E. , Pinto A. , Mancebo M. C. , Rasmussen S. A. , & Eisen J. L. (2008). OCD with comorbid OCPD: a subtype of OCD? Journal of Psychiatric Research, 42, 289–296.
Cooper J. (1970). The Leyton Obsessional Inventory. Psychological Medicine, 1, 48–64.
Crino R. D. , & Andrews G. (1996). Personality disorder in obsessive compulsive disorder: a controlled study. Journal of Psychiatric Research, 30, 29–38.
Crosbie J. , Perusse D. , Barr C. L. , & Schachar R. J. (2008). Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 32, 40–55.
Cullen B. , Brown C. H. , Riddle M. A. , et al. (2007). Factor analysis of the Yale–Brown Obsessive Compulsive Scale in a family study of obsessive–compulsive disorder. Depression and Anxiety, 24, 130–138.
Delamater A. R. (2007). The role of the orbitofrontal cortex in sensory-specific encoding of associations in Pavlovian and instrumental conditioning. Annals of the New York Academy of Sciences, 1121, 152–173.
Delorme R. , Golmard J. L. , Chabane N. , et al. (2005). Admixture analysis of age at onset in obsessive–compulsive disorder. Psychological Medicine, 35, 237–243.
Delorme R. , Gousse V. , Roy I. , et al. (2007). Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive–compulsive disorder. European Psychiatry, 22, 32–38.
Diaferia G. , Bianchi I. , Bianchi M. L. , et al. (1997). Relationship between obsessive–compulsive personality disorder and obsessive–compulsive disorder. Comprehensive Psychiatry, 38, 38–42.
Diniz J. B. , Rosario-Campos M. C. , Shavitt R. G. , et al. (2004). Impact of age at onset and duration of illness on the expression of comorbidities in obsessive–compulsive disorder. Journal of Clinical Psychiatry, 65, 22–27.
Eisen J. L. , Coles M. E. , Shea M. T. , et al. (2006). Clarifying the convergence between obsessive compulsive personality disorder criteria and obsessive compulsive disorder. Journal of Personality Disorders, 20, 294–305.
Fontenelle L. F. , Mendlowicz M. V. , Marques C. , & Versiani M. (2003). Early- and late-onset obsessive–compulsive disorder in adult patients: an exploratory clinical and therapeutic study. Journal of Psychiatric Research, 37, 127–133.
Geyer M. A. , Krebs-Thomson K. , Braff D. L. , & Swerdlow N. R. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology, 156, 117–154.
Gottesman, II , & Gould T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–645.
Grados M. A. , Riddle M. A. , Samuels J. F. , et al. (2001). The familial phenotype of obsessive–compulsive disorder in relation to tic disorders: the Hopkins OCD Family Study. Biological Psychiatry, 50, 559–565.
Graham F. K. (1975). Presidential address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology, 12, 238–248.
Grant J. E. , Mancebo M. C. , Pinto A. , et al. (2007). Late-onset obsessive compulsive disorder: Clinical characteristics and psychiatric comorbidity. Psychiatry Research, 152, 21–27.
Hajcak G. , McDonald N. , & Simons R. F. (2003). Anxiety and error-related brain activity. Biological Psychology, 64, 77–90.
Hajcak G. , Franklin M. E. , Foa E. B. , & Simons R. F. (2008). Increased error-related brain activity in pediatric obsessive–compulsive disorder before and after treatment. American Journal of Psychiatry, 165, 116–123.
Hasler G. , Pinto A. , Greenberg B. D. , et al. (2007). Familiality of factor analysis-derived YBOCS dimensions in OCD affected sibling pairs from the OCD Collaborative Genetics Study. Biological Psychiatry, 61, 617–625.
Hoenig K. , Hochrein A. , Quednow B. B. , Maier W. , & Wagner M. (2005). Impaired prepulse inhibition of acoustic startle in obsessive–compulsive disorder. Biological Psychiatry, 57, 1153–1158.
Hoffman H. S. , & Ison J. R. (1980). Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychological Review, 87, 175–189.
Kessler R. C. , Berglund P. , Demler O. , et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593–602.
Koran L. M. (2000). Quality of life in obsessive–compulsive disorder. Psychiatric Clinics of North America, 23, 509–517.
Lawrence N. S. , Wooderson S. , Mataix-Cols D. , et al. (2006). Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive–compulsive disorder. Neuropsychology, 20, 409–419.
Leckman J. F. , Grice D. E. , Boardman J. , et al. (1997). Symptoms of obsessive–compulsive disorder. American Journal of Psychiatry, 154, 911–917.
Leckman J. F. , Pauls D. L. , Zhang H. , et al. (2003). Obsessive–compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 116B, 60–68.
Lenane M. , Swedo S. E. , Leonard H. L. , et al. (1990). Psychiatric disorders in first degree relatives of children and adolescents with obsessive–compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 407–412.
Leonard H. L. , Lenane M. C. , Swedo S. E. , et al. (1992). Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive–compulsive children. American Journal of Psychiatry, 149, 1244–1251.
Maina G. , Albert U. , Salvi V. , Pessina E. , & Bogetto F. (2008). Early-onset obsessive–compulsive disorder and personality disorders in adulthood. Psychiatry Research, 158, 217–225.
Mataix-Cols D. , Rauch S. L. , Manzo P. A. , Jenike M. A. , & Baer L. (1999). Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive–compulsive disorder. American Journal of Psychiatry, 156, 1409–1416.
Mataix-Cols D. , Rauch S. L. , Baer L. , et al. (2002a). Symptom stability in adult obsessive–compulsive disorder: data from a naturalistic two-year follow-up study. American Journal of Psychiatry, 159, 263–268.
Mataix-Cols D. , Marks I. M. , Greist J. H. , Kobak K. A. , & Baer L. (2002b). Obsessive–compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychotherapy and Psychosomatics, 71, 255–262.
Mataix-Cols D. , Wooderson S. , Lawrence N. , et al. (2004). Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive–compulsive disorder. Archives of General Psychiatry, 61, 564–576.
Mataix-Cols D. , Rosario-Campos M. C. , & Leckman J. F. (2005). A multidimensional model of obsessive–compulsive disorder. American Journal of Psychiatry, 162, 228–238.
Menzies L. , Achard S. , Chamberlain S. R. , et al. (2007). Neurocognitive endophenotypes of obsessive–compulsive disorder. Brain, 130, 3223–3236.
Menzies L. , Williams G. B. , Chamberlain S. R. , et al. (2008). White matter abnormalities in patients with obsessive–compulsive disorder and their first-degree relatives. American Journal of Psychiatry, 165, 1308–1315.
Miguel E. C. , Rauch S. L. & Jenike M. A. (1997). Phenomenology of intentional repetitive behaviors in obsessive–compulsive disorder and Tourette's disorder. Journal of Clinical Psychiatry, 56, 246–255.
Miguel E. C. , Leckman J. F. , Rauch S. , et al. (2005). Obsessive–compulsive disorder phenotypes: implications for genetic studies. Molecular Psychiatry, 10, 258–275.
Millet B. , Kochman F. , Gallarda T. , et al. (2004). Phenomenological and comorbid features associated in obsessive–compulsive disorder: influence of age of onset. Journal of Affective Disorders, 79, 241–246.
Murray C. , & Lopez A. (1996). The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press.
Nestadt G. , Samuels J. , Riddle M. , et al. (2000). A family study of obsessive–compulsive disorder. Archives of General Psychiatry, 57, 358–363.
Nestadt G. , Samuels J. , Riddle M. A. , et al. (2001). The relationship between obsessive–compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychological Medicine, 31, 481–487.
Olvet D. M. , & Hajcak G. (2008). The error-related negativity (ERN) and psychopathology: toward an endophenotype. Clinical Psychology Review, 28, 1343–1354.
Pauls D. L. , Towbin K. E. , Leckman J. F. , Zahner G. E. , & Cohen D. J. (1986). Gilles de la Tourette's syndrome and obsessive–compulsive disorder: evidence supporting a genetic relationship. Archives of General Psychiatry, 43, 1180–1182.
Pauls D. L. , Alsobrook J. P. , Goodman W. , Rasmussen S. , & Leckman J. F. (1995). A family study of obsessive–compulsive disorder. American Journal of Psychiatry, 152, 76–84.
Pigott T. A. , L'Heureux F. , Dubbert B. , Bernstein S. , & Murphy D. L. (1994). Obsessive compulsive disorder: comorbid conditions. Journal of Clinical Psychiatry, 55 (Suppl), 15–27; discussion 28–32.
Pinto A. (2009). Understanding obsessive compulsive personality disorder and its impact on obsessive compulsive disorder. Paper presented at Obsessive Compulsive Foundation Conference, Minneapolis, MN.
Pinto A. , Mancebo M. C. , Eisen J. L. , Pagano M. E. , & Rasmussen S. A. (2006). The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. Journal of Clinical Psychiatry, 67, 703–711.
Pinto A. , Eisen J. L. , Mancebo M. C. , et al. (2007). Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive compulsive disorder symptoms. Psychiatry Research, 151, 255–258.
Pinto A. , Eisen J. L. , Mancebo M. C. , & Rasmussen S. A. (2008a). Obsessive compulsive personality disorder. In J. S. Abramowitz , D. McKay , & S. Taylor , eds., Obsessive–compulsive Disorder: Subtypes and Spectrum Conditions. New York, NY: Elsevier.
Pinto A. , Greenberg B. D. , Grados M. A. , et al. (2008b). Further development of YBOCS dimensions in the OCD Collaborative Genetics Study: symptoms vs. categories. Psychiatry Research, 160, 83–93.
Pinto A. , Liebowitz M. R. , Foa E. B. , & Simpson H. B. (2009). OCPD severity as a predictor of CBT outcome for OCD. Paper presented at the Congress of the International Society for the Study of Personality Disorders, New York, NY.
Pitman R. K. (1987). Pierre Janet on obsessive–compulsive disorder (1903): review and commentary. Archives of General Psychiatry, 44, 226–232.
Preston G. A. , & Weinberger D. R. (2005). Intermediate phenotypes in schizophrenia: a selective review. Dialogues in Clinical Neuroscience, 7, 165–179.
Radomsky A. S. , & Taylor S. (2005). Subtyping OCD: prospects and problems. Behavior Therapy, 36, 371–379.
Rasmussen S. A. , & Eisen J. L. (1988). Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacoology Bulletin, 24, 466–470.
Rauch S. L. , Dougherty D. D. , Shin L. M. , et al. (1998). Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectrums, 3, 37–43.
Robbins T. W. (2007). Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philosophical Transactions of the Royal Society B, 362, 917–932.
Robins E. , & Guze S. B. (1970). Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. American Journal of Psychiatry, 126, 983–987.
Rosario-Campos M. C. , Leckman J. F. , Mercadante M. T. , et al. (2001). Adults with early-onset obsessive–compulsive disorder. American Journal of Psychiatry, 158, 1899–1903.
Rosario-Campos M. C. , Miguel E. C. , Quatrano S. , et al. (2006). The Dimensional Yale–Brown Obsessive–Compulsive Scale (DY-BOCS): an instrument for assessing obsessive–compulsive symptom dimensions. Molecular Psychiatry, 11, 495–504.
Rufer M. , Grothusen A. , Mass R. , Peter H. , & Hand I. (2005). Temporal stability of symptom dimensions in adult patients with obsessive–compulsive disorder. Journal of Affective Disorders, 88, 99–102.
Samuels J. , Nestadt G. , Bienvenu O. J. , et al. (2000). Personality disorders and normal personality dimensions in obsessive–compulsive disorder. British Journal of Psychiatry, 177, 457–462.
Samuels J. , Eaton W. W. , Bienvenu O. J. , et al. (2002). Prevalence and correlates of personality disorders in a community sample. British Journal of Psychiatry, 180, 536–542.
Saxena S. , Maidment K. M. , Vapnik T. , et al. (2002). Obsessive–compulsive hoarding: symptom severity and response to multimodal treatment. Journal of Clinical Psychiatry, 63, 21–27.
Saxena S. , Brody A. L. , Maidment K. M. , & Baxter L. R. (2007). Paroxetine treatment of compulsive hoarding. Journal of Psychiatric Research, 41, 481–487.
Schooler C. , Revell A. J. , Timpano K. R. , Wheaton M. , & Murphy D. L. (2008). Predicting genetic loading from symptom patterns in obsessive–compulsive disorder: a latent variable analysis. Depression and Anxiety, 25, 680–688.
Simpson H. B. , Rosen W. , Huppert J. D. , et al. (2006). Are there reliable neuropsychological deficits in obsessive–compulsive disorder? Journal of Psychiatric Research, 40, 247–257.
Skodol A. E. , Oldham J. M. , Hyler S. E. , et al. (1995). Patterns of anxiety and personality disorder comorbidity. Journal of Psychiatric Research, 5, 361–374.
Skoog G. , & Skoog I. (1999). A 40-year follow-up of patients with obsessive–compulsive disorder. Archives of General Psychiatry, 56, 121–127.
Sobin C. , Blundell M. L. , & Karayiorgou M. (2000). Phenotypic differences in early- and late-onset obsessive–compulsive disorder. Comprehensive Psychiatry, 41, 373–379.
Stein D. J. , Andersen E. W. , & Overo K. F. (2007). Response of symptom dimensions in obsessive–compulsive disorder to treatment with citalopram or placebo. Revista Brasileira de Psiquiatria, 29, 303–307.
Stern E. , Silbersweig D. A. , Chee K. Y. , et al. (2000). A functional neuroanatomy of tics in Tourette syndrome. Archives of General Psychiatry, 57, 741–748.
Swedo S. E. , Rapoport J. L. , Leonard H. L. , Lenane M. C. , & Cheslow D. (1989). Obsessive compulsive disorder in children and adolescents: Clinical and phenomenology of 70 consecutive cases. Archives of General Psychiatry, 46, 335–341.
Swerdlow N. R. , Benbow C. H. , Zisook S. , Geyer M. A. , & Braff D. L. (1993). A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biological Psychiatry, 33, 298–301.
Torgersen S. , Kringlen E. , & Cramer V. (2001). The prevalence of personality disorders in a community sample. Archives of General Psychiatry, 58, 590–596.
van den Heuvel O. A. , Remijnse P. L. , Mataix-Cols D. , et al. (2009). The major symptom dimensions of obsessive–compulsive disorder are mediated by partially distinct neural systems. Brain, 132, 853–868.
Watkins L. H. , Sahakian B. J. , Robertson M. M. , et al. (2005). Executive function in Tourette's syndrome and obsessive–compulsive disorder. Psychological Medicine, 35, 571–582.
Wellen D. , Samuels J. , Bienvenu O. J. , et al. (2007). Utility of the Leyton Obsessional Inventory to distinguish OCD and OCPD. Depression and Anxiety, 24, 301–306.

Reference Title: References

Reference Type: bibliography

Alnaes S. , & Torgersen S. (1988). The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatrica Scandinavica, 78, 485–492.
Alpert J. E. , Uebelacker L. A. , McLean N. E. , et al. (1997). Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychological Medicine, 27, 627–633.
Altamura C. , Paluello M. M. , Mundo E. , Medda S. , & Mannu P. (2001). Clinical and subclinical body dysmorphic disorder. European Archives of Psychiatry and Clinical Neuroscience, 251, 105–108.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Argyropoulos S. V. , Bell C. J. , & Nutt D. J. (2001). Brain function in social anxiety disorder. Psychiatric Clinics of North America, 24, 707–772.
Battaglia M. , Ogliari A. , Zanoni A. , et al. (2005). Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions. Archives of General Psychiatry, 62, 85–94.
Beesdo K. , Bittner A. , Pine D. S. , et al. (2007). Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Archives of General Psychiatry, 64, 903–912.
Berger P. , Sachs G. , Amering M. , et al. (2004). Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. Journal of Affective Disorders, 80, 75–78.
Biederman J. , Hirshfeld-Becker D. R. , Rosenbaum J. F. , et al. (2001). Further evidence of association between behavioral inhibition and social anxiety in children. American Journal of Psychiatry, 158, 1673–1679.
Birchwood M. , Trower P. , Brunet K. , et al. (2006). Social anxiety and the shame of psychosis: a study in first episode psychosis. Behaviour Research and Therapy, 45, 1025–1027.
Black B. , & Uhde T. (1995). Psychiatric characteristics of children with selective mutism: a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 847–856.
Book S. W. , Thomas S. E. , Randall P. K. , & Randall C. L. (2008). Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Journal of Anxiety Disorders, 22, 310–318.
Broberg A. , Lamb M. , & Hwang P. (1990). Inhibition: its stability and correlates in sixteen- to forty-month-old children. Child Development, 61, 1153–1163.
Cath D. C. , Ran N. , Smit J. H. , van Balkom A. J. , & Comijs H. C. (2008). Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive–compulsive disorder in adults: a preliminary case-controlled study. Psychopathology, 41, 101–110.
Chambless D. L. , Fydrich T. , & Rodebaugh T. L. (2008). Generalized social phobia and avoidant personality disorder: meaningful distinction or useless duplication? Depression and Anxiety, 25, 8–19.
Chavira D. A. , Shipon-Blum E. , Hitchcock C. , Cohan S. , & Stein M. B. (2007). Selective mutism and social anxiety disorder: all in the family? Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1464–1472.
Coles M. E. , Phillips K. A. , Menard W. , et al. (2006). Body dysmorphic disorder and social phobia: cross-sectional and prospective data. Depression and Anxiety, 23, 26–33.
Connor K. M. , Davidson J. R. , Chung H. , Yang R. , & Clary C. M. (2006a). Multidimensional effects of sertraline in social anxiety disorder. Depression and Anxiety, 23, 6–10.
Connor K. M. , Cook J. L. , & Davidson J. R. (2006b). Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial. Journal of Clinical Psychiatry, 67, 30–36.
Cooper P. J. , & Eke M. (1999). Childhood shyness and maternal social phobia: a community study. British Journal of Psychiatry, 174, 439–443.
Cornwell B. R. , Johnson L. , Berardi L. , & Grillon C. (2006). Anticipation of public speaking in virtual reality reveals a relationship between trait social anxiety and startle reactivity. Biological Psychiatry, 59, 664–666.
Dalrymple K. L. , & Zimmerman M. (2007). Does comorbid social anxiety disorder impact the clinical presentation of principal major depression disorder? Journal of Affective Disorders, 100, 241–247.
Davidson R. T. , Hughes D. C. , George L. K. , & Blazer D. G. (1994). The boundary of social phobia: exploring the threshold. Archives of General Psychiatry, 51, 975–983.
Dummit E. S. , Klein R. G. , Tancer N. K. , et al. (1997). Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 653–660.
Erickson K. , Gabry K. E. , Schulkin J. , et al. (2005). Social withdrawal behaviors in nonhuman primates and changes in neuroendocrine and monoamine concentrations during a separation paradigm. Developmental Psychobiology, 46, 331–339.
Fairbanks L. A. , Jorgensen M. J. , Huff A. , et al. (2004a). Adolescent impulsivity predicts adult dominance attainment in male vervet monkeys. American Journal of Primatology, 64, 1–17.
Fairbanks L. A. , Newman T. K. , Bailey J. N. , et al. (2004b). Genetic contributions to social impulsivity and aggressiveness in vervet monkeys. Biological Psychiatry, 55, 642–647.
Fehm L. , Beesdo K. , Jacobi F. , & Fiedler A. (2008). Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Social Psychiatry and Psychiatric Epidemiology, 43, 257–265.
Fox N. A. , Nichols K. E. , Henderson H. A. , et al. (2005). Evidence for a gene–environment interaction in predicting behavioral inhibition in middle childhood. Psychological Science, 16, 921–926.
Gilbert N. , & Meyer C. (2003). Social anxiety and social comparison: differential links with restrictive and bulimic attitudes among nonclinical women. Eating Behavior, 4, 257–264.
Gilbert P. (2001). Evolution and social anxiety: the role of attraction, social competition, and social hierarchies. Psychiatric Clinics of North America, 24, 723–752.
Godart N. T. , Flament M. F. , Lecrubier Y. , & Jeammet P. (2000). Anxiety disorders in anorexia nervosa and bulimia nervosa: Comorbidity and chronology of appearance. European Psychiatry, 15, 38–45.
Golwyn D. H. , & Sevlie C. P. (1999). Phenelzine treatment of selective mutism in four prepubertal children. Journal of Child and Adolescent Psychopharmacology, 9, 109–113.
Gundel H. , Wolf A. , Xidarra V. , Busch R. , & Ceballos-Baumann A. O. (2001). Social phobia in spasmodic torticollis. Journal of Neurology, Neurosurgery, and Psychiatry, 71, 499–504.
Hayward C. , Killen J. , Kraemer K. , & Taylor C. (1998). Linking self-reported childhood behavioral inhibition to adolescent social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1308–1316.
Himmelhoch J. M. (1998). Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. Journal of Affective Disorders, 50, 203–213.
Hinde R. A. (1985). Expression and negotiation. In G. Zivin , ed., The Development of Expressive Behavior. San Diego, CA: Academic Press.
Hirshfeld-Becker D. R. , Biederman J. , Henin A. , et al. (2007). Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up. Journal of Developmental and Behavioral Pediatrics, 28, 225–233.
Hirshfeld-Becker D. R. , Micco J. , Henin A. , et al. (2008). Behavioral inhibition. Depression and Anxiety, 25, 357–367.
Holma K. M. , Holma I. A. , Melartin T. K. , Rytsälä H. J. , & Isometsä E. T. (2008). Long-term outcome of major depressive disorder in psychiatric patients is variable. Journal of Clinical Psychiatry, 69, 196–205.
Hummelen B. , Wilberg T. , Pedersen G. , & Karterud S. (2007). The relationship between avoidant personality disorder and social phobia. Comprehensive Psychiatry, 48, 348–356.
Huppert J. D. , Strunk D. R. , Ledley D. R. , Davidson J. R. , & Foa E. B. (2008). Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. Depression and Anxiety, 25, 441–448.
Kagan J. , Reznick J. S. , & Snidman N. (1988). Biological bases of childhood shyness. Science, 240, 167–171.
Kessler R. C. , Stang P. , Wittchen H. U. , Stein M. , & Walters E. E. (1999). Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychological Medicine, 29, 555–567.
Kinoshita Y. , Chen J. , Rapee R. M. , et al. (2008). Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya–Osaka diagnostic criteria for social anxiety disorder. Journal of Nervous and Mental Disease, 196, 307–313.
Kummer A. , Cardoso F. , & Teixeira A. L. (2008). Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease. Movement Disorders, 23, 1739–1743.
Lissek S. , Levenson J. , Biggs A. L. , et al. (2008). Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. American Journal of Psychiatry, 165, 124–32.
Low N. C. , Cui L. , & Merikangas K. R. (2008). Specificity of familial transmission of anxiety and comorbid disorders. Journal of Psychiatric Research, 42, 596–604.
Manassis K. , Fung D. , Tannock R. , et al. (2003). Characterizing selective mutism: is it more than social anxiety? Depression and Anxiety, 218, 153–161.
Mannuzza S. , Schneier F. R. , Chapman T. F. , et al. (1995). Generalized social phobia. Reliability and validity. Archives of General Psychiatry, 52, 230–237.
Manuck S. B. , Kaplan J. R. , Rymeski B. A. , Fairbanks L. A. , & Wilson M. E. (2003). Approach to a social stranger is associated with low central nervous system serotonergic responsivity in female cynomolgus monkeys (Macaca fascicularis). American Journal of Primatology, 61, 187–194.
Massion A. O. , Dyck I. R. , Shea T. , et al. (2002). Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Archives of General Psychiatry, 59, 434–440.
McClintock J. M. , & Evans I. M. (2001). The underlying psychopathology of eating disorders and social phobia: a structural equation analysis. Eating Behavior, 2, 247–261.
Millon T. , ed. (1969). Modern Psychopathology: a Biosocial Approach to Maladaptive Learning and Functioning. Philadelphia, PA: Saunders.
Morris E. P. , Stewart S. H. , & Ham L. S. (2005). The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clinical Psychology Review, 25, 734–760.
Moscovitch D. A. , Hofmann S. G. , Suvak M. K. , & In-Albon T. (2005). Mediation of changes in anxiety and depression during treatment of social phobia. Journal of Clinical and Consulting Psychology, 73, 945–952.
Nelson E. C. , Grant J. D. , Bucholz K. K. , et al. (2000). Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychological Medicine, 30, 797–804.
Newell R. , & Marks I. (2000). Phobic nature of social difficulty in facially disfigured people. British Journal of Psychiatry, 176, 177–181.
Öhman A. (1986). Face the beast and fear the face: animal and social fears as prototypes for evolutionary analyses of emotion. Psychophysiology, 23, 123–145.
Pallanti S. , Quercioli L. , & Pazagli A. (2000). Social anxiety and premorbid personality disorders in paranoid schizophrenic patients treated with clozapine. CNS Spectrums, 5(9), 29–43.
Pallanti S. , Quercioli L. , & Hollander E. (2004). Social anxiety in outpatients with schizophrenia: a relevant cause of disability. American Journal of Psychiatry, 161, 53–58.
Parker G. , Wilhelm K. , Mitchell P. , et al. (1999). The influence of anxiety as a risk to early onset major depression. Journal of Affective Disorders, 52, 11–17.
Perez-Edgar K. , Roberson-Nay R. , Hardin M. G. , et al. (2007). Attention alters neural responses to evocative faces in behaviorally inhibited adolescents. Neuroimage, 35, 1538–1546.
Perugi G. , Akiskal H. S. , Toni C. , Simonini E. , & Gemignani A. (2001). The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive–compulsive patients with comorbid bipolar disorder. Journal of Affective Disorders, 67, 199–206.
Perugi G. , Frare F. , Madaro D. , Maremmani I. , & Akiskal H. S. (2002). Alcohol abuse in social phobic patients: is there a bipolar connection? Journal of Affective Disorders, 68, 33–39.
Phillips K. A. , & Stout R. L. (2006). Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive–compulsive disorder and social phobia. Psychiatry Research, 40, 360–369.
Piven J. , & Palmer P. (1999) Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families. American Journal of Psychiatry, 156, 557–563.
Randall C. L. , Thomas S. , & Thevos A. K. (2001). Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcoholism, Clinical and Experimental Research, 25, 210–220.
Reichborn-Kjennerud T. , Czajkowski N. , Torgersen S. , et al. (2007). The relationship between avoidant personality disorder and social phobia: a population-based twin study. American Journal of Psychiatry, 164, 1631–1633.
Schmidt L. A. , Fox N. A. , Rubin K. H. , et al. (1997). Behavioral and neuroendocrine responses in shy children. Developmental Psychobiology, 30, 127–140.
Schneier F. R. , Johnson J. , Hornig C. D. , Liebowitz M. R. , & Weissman M. M. (1992). Social phobia. Comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry, 49, 282–288.
Schneier F. R. , Liebowitz M. R. , Abi-Dargham A. , et al. (2000). Low dopamine D2 receptor binding potential in social phobia. American Journal of Psychiatry, 157, 457–459.
Schneier F. R. , Barnes L. F. , Albert S. M. , & Louis E. D. (2001). Characteristics of social phobia among persons with essential tremor. Journal of Clinical Psychiatry, 62, 367–372.
Schneier F. R. , Martinez D. , Abi-Dargham A. , et al. (2008). Striatal dopamine D2 receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depression and Anxiety, 25, 1–7.
Schneier F.R. , Foose T.E. , Hasin D.S. , et al. (2010). Social anxiety disorder and alcohol use disorder comorbidity in the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine, 40(6), 977–988.
Schultz L. T. , & Heimberg R. G. (2008). Attentional focus in social anxiety disorder: Potential for interactive processes. Clinical Psychology Review, 8, 1206–1221.
Schwartz C. , Snidman N. , & Kagan J. (1999). Adolescent social anxiety as an outcome of inhibited temperament in childhood. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1008–1015.
Schwartz C.E. , Wright C.I. , Shin L.M. , Kagan J. , & Rauch S.L. (2003). Inhibited and uninhibited infants “grown up”: adult amygdalar response to novelty. Science, 300, 1952–1953.
Simonoff E. , Pickles A. , Charman T. , et al. (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 921–929.
Stein M. B. , Walker J. R. , & Forde D. R. (1994). Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety. American Journal of Psychiatry, 151, 408–412.
Stein M. B. , Baird A. , & Walker J. R. (1996). Social phobia in adults with stuttering. American Journal of Psychiatry, 153, 278–280.
Stein M. B. , Chartier M. J. , Hazen A. L. , et al. (1998). A direct-interview family study of generalized social phobia. American Journal of Psychiatry, 155, 90–97.
Stein M. B. , Chavira D. A. , & Jang K. L. (2001a). Bringing up bashful baby: developmental pathways to social phobia. Psychiatric Clinics of North America, 24, 661–675.
Stein M. B. , Fuetsch M. , Müller N. , et al. (2001b). Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Archives of General Psychiatry, 58, 251–256.
Stein M. B. , Goldin P. R. , Sareen J. , Zorrilla L. T. , & Brown G. G. (2002). Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Archives of General Psychiatry, 59, 1027–1034.
Stemberger R. T. , Turner S. M. , Beidel D. C. , & Calhoun K. S. (1995). Social phobia: an analysis of possible developmental factors. Journal of Abnormal Psychology, 104, 526–531.
Tamam L. , & Ozpoyraz N. (2002). Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology, 35, 203–209.
Thomas S. E. , Randall P. K. , Book S. W. , & Randall C. L. (2008). A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcoholism, Clinical and Experimental Research, 32, 77–84.
Tien A. Y. , & Eaton W. W. (1992). Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Archives of General Psychiatry, 49, 37–46.
Turner S. M. , Beidel D. C. , & Townsley R. M. (1990). Social phobia: relationship to shyness. Behaviour Research and Therapy, 28, 497–505.
Turner S. M. , Beidel D. C. , & Townsley R. M. (1992). Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. Journal of Abnormal Psychology, 101, 326–331.
Williamson D. E. , Coleman K. , Bacanu S. A. , Devlin B. J. , Rogers J. , Ryan N. D. , & Cameron J. L. (2003). Heritability of fearful-anxious endophenotypes in infant rhesus macaques: a preliminary report. Biological Psychiatry, 53, 284–291.
Yoon K. L. , Fitzgerald D. A. , Angstadt M. , McCarron R. A. , & Phan K. L. (2007). Amygdala reactivity to emotional faces at high and low intensity in generalized social phobia: A 4-Tesla functional MRI study. Psychiatry Research: Neuroimaging, 154, 93–98.
Zimbardo P. G. (1977). Shyness: What It is, What to Do About It. Reading, MA: Addison-Wesley.

Reference Title: References

Reference Type: bibliography

Akiskal H. S. , Lemmi H. , Dickson H. , et al. (1984). Chronic depressions: Part 2. Sleep EEG differentiation of primary dysthymic disorders from anxious depressions. Journal of Affective Disorders, 6, 287–295.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington DC: American Psychiatric Association.
Barkow K. , Heun R. , Wittchen H. U. , et al. (2004). Mixed anxiety–depression in a 1 year follow-up study: shift to other diagnoses or remission? Journal of Affective Disorders, 79, 235–239.
Breslau N. , & Davis G. C. (1985). Further evidence on the doubtful validity of generalized anxiety disorder. Psychiatry Research, 16, 177–179.
Calabrese J. R. , Keck P. E. , Macfadden W. , et al. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry, 162, 1351–1360.
Clayton P. J. , Grove W. M. , Coryell W. , et al. (1991). Follow-up and family study of anxious depression. American Journal of Psychiatry, 148, 1512–1517.
Cleary P. , & Guy W. (1977). Factor analysis of the Hamilton depression scale. Drugs Under Experimental and Clinical Research, 1, 115–120.
Davidson J. R. (2007). A history of the concept of atypical depression. Journal of Clinical Psychiatry, 68 (Suppl 3), 10–15.
Davidson J. R. , Meoni P. , Haudiquet V. , Cantillon M. , & Hackett D. (2002). Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depression and Anxiety, 16, 4–13.
Enoch M. A. , White K. V. , Waheed J. , & Goldman D. (2008). Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depression and Anxiety, 25, 383–392.
Fava M. , Uebelacker L. A. , Alpert J. E. , et al. (1997). Major depressive subtypes and treatment response. Biological Psychiatry, 42, 568–576.
Fava M. , Rush A. J. , Alpert J. E. , et al. (2006). What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Canadian Journal of Psychiatry, 51, 823–835.
Fava M. , Rush A. J. , Alpert J. E. , et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry, 165, 342–351.
Fawcett J. , Scheftner W. A. , Fogg L. , et al. (1990). Time-related predictors of suicide in major affective disorder. American Journal of Psychiatry, 147, 1189–1194.
Flint A. J. , & Rifat S. L. (1997). Anxious depression in elderly patients: response to antidepressant treatment. American Journal of Geriatric Psychiatry, 5, 107–115.
Gao K. , Muzina D. , Gajwani P. , & Calabrese J. R. (2006). Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. Journal of Clinical Psychiatry, 67, 1327–1340.
Goodnick P. J. , Puig A. , DeVane C. L. , & Freund B. V. (1999). Mirtazapine in major depression with comorbid generalized anxiety disorder. Journal of Clinical Psychiatry, 60, 446–448.
Jiang X. , Xu K. , Hoberman J. , et al. (2005). BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology, 30, 1353–1361.
Kendler K. S. (1996). Major depression and generalised anxiety disorder: same genes, (partly) different environments – revisited. British Journal of Psychiatry Supplement, (30), 68–75.
Kendler K. S. (1997). The diagnostic validity of melancholic major depression in a population-based sample of female twins. Archives of General Psychiatry, 54, 299–304.
Kendler K. S. , Gardner C. O. , Gatz M. , & Pedersen N. L. (2007). The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychology and Medicine, 37, 453–462.
Kendler K. S. , Neale M. C. , Kessler R. C. , Heath A. C. , & Eaves L. J. (1992). Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Archives of General Psychiatry, 49, 716–722.
Kessler R. C. , Nelson C. B. , McGonagle K. A. , et al. (1996). Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. British Journal of Psychiatry Supplement, (30), 17–30.
Kessler R. C. , DuPont R. L. , Berglund P. , & Wittchen H. U. (1999). Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. American Journal of Psychiatry, 156, 1915–1923.
Kessler R. C. , Chiu W. T. , Jin R. , et al. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415–424.
Kessler R. C. , Gruber M. , Hettema J. M. , et al. (2008). Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychology and Medicine, 38, 365–374.
Londborg P. D. , Smith W. T. , Glaudin V. , & Painter J. R. (2000). Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. Journal of Affective Disorders, 61, 73–79.
MacMillan S. , Szeszko P. R. , Moore G. J. , et al. (2003). Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression. Journal of Child and Adolescent Psychopharmacology, 13, 65–73.
McGrath P. J. , Stewart J. W. , Janal M. N. , Petkova E. , Quitkin F. M. , & Klein D. F. (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. American Journal of Psychiatry, 157, 344–350.
McGrath P. J. , Khan A. , Trivedi M. H. , et al. (2008). Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. Journal of Clinical Psychiatry, 69, 1847–1855.
Means-Christensen A. J. , Sherbourne C. D. , Roy-Byrne P. P. , et al. (2006). In search of mixed anxiety-depressive disorder: a primary care study. Depression and Anxiety, 23, 183–189.
Montgomery S. A. , Tobias K. , Zornberg G. L. , Kasper S. , & Pande A. C. (2006). Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. Journal of Clinical Psychiatry, 67, 771–782.
Moras K. , Clar L. A. , Katon W. , et al. (1996). Mixed anxiety–depression. In T. A. Widiger , A. J. Frances , H. A. Pincus , et al., eds., DSM-IV Sourcebook. Washington, DC: American Psychiatric Association.
Nash J. R. , Sargent P. A. , Rabiner E. A. , et al. (2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. British Journal of Psychiatry, 193, 229–234.
Nutt D. , Demyttenaere K. , Janka Z. , et al. (2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology, 21, 461–471.
Otto M. W. , Simon N. M. , Wisniewski S. R. , et al. (2006). Prospective 12-month course of bipolar disorder in outpatients with and without comorbid anxiety disorders. British Journal of Psychiatry, 189, 20–25.
Pande A. C. , Feltner D. E. , Jefferson J. W. , et al. (2004). Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24, 141–149.
Papakostas G. I. , Stahl S. M. , Krishen A. , et al. (2008). Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. Journal of Clinical Psychiatry, 69, 1287–1292.
Quitkin F.M. (2002). Depression with atypical features: diagnostic validity, prevalence, and treatment. Primary Care Companion Journal of Clinical Psychiatry, 4, 94–99.
Quitkin F. M. , McGrath P. J. , Stewart J. W. , et al. (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Archives of General Psychiatry, 47, 935–941.
Reimold M. , Batra A. , Knobel A. , et al. (2008). Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Molecular Psychiatry, 13, 606–613, 557.
Rickels K. , Amsterdam J. D. , Clary C. , Puzzuoli G. , & Schweizer E. (1991). Buspirone in major depression: a controlled study. Journal of Clinical Psychiatry, 52, 34–38.
Roy M. A. , Neale M. C. , Pedersen N. L. , Mathe A. A. , & Kendler K. S. (1995). A twin study of generalized anxiety disorder and major depression. Psychology and Medicine, 25, 1037–1049.
Roy-Byrne P. (2008). Comorbid MDD and GAD: revisiting the concept of “anxious depression”. Psychiatric Times (Suppl.), August (1), 25–30.
Ruscio A. M. , Brown T. A. , Chiu W. T. , et al. (2008). Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychology and Medicine, 38, 15–28.
Ruscio A. M. , Stein D. J. , Chiu W. T. , & Kessler R. C. (2010). The epidemiology of obsessive–compulsive disorder in the National Comorbidity Survey Replication. Molecular Psychiatry, 15, 53–63.
Rush A. J. , Wisniewski S. R. , Warden D. , et al. (2008) Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment. Archives of General Psychiatry, 65, 870–880.
Russell J. M. , Koran L. M. , Rush J. , et al. (2001). Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and Anxiety, 13, 18–27.
Saxena S. , Brody A. L. , Ho M. L. , et al. (2001). Cerebral metabolism in major depression and obsessive–compulsive disorder occurring separately and concurrently. Biological Psychiatry, 50, 159–170.
Simon N. M. , Zalta A. K. , Otto M. W. , et al. (2007). The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. Journal of Psychiatric Research, 41, 255–264.
Smith W. T. , Londborg P. D. , Glaudin V. , & Painter J. R. (1998). Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. American Journal of Psychiatry, 155, 1339–1345.
Smith W. T. , Londborg P. D. , Glaudin V. , & Painter J. R. (2002). Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? Journal of Affective Disorders, 70, 251–259.
Smolka M. N. , Schumann G. , Wrase J. , et al. (2005). Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience, 25, 836–842.
Stahl S. M. , Zhang L. , Damatarca C. , & Grady M. (2003). Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry, 64 (Suppl 14), 6–17.
Stahl S. M. , Pradko J. F. , Haight B. R. , et al. (2004). A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion Journal of Clinical Psychiatry, 6, 159–166.
Stahl S. M. , & Wise D. D. (2008). The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders. CNS Spectrums, 13, 467–483.
Stein D. J. , Baldwin D. S. , Baldinetti F. , & Mandel F. (2008). Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. European Neuropsychopharmacology, 18, 422–430.
Sullivan G. M. , Oquendo M. A. , Simpson N. , et al. (2005). Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety. Biologial Psychiatry, 58, 947–954.
Tohen M. , Vieta E. , Calabrese J. , et al. (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry, 60, 1079–1088.
Tollefson G. D. , Holman S. L. , Sayler M. E. , & Potvin J. H. (1994). Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry, 55, 50–59.
Trivedi M. H. , Thase M. E. , Fava M. , et al. (2008). Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. Journal of Clinical Psychiatry, 69, 1928–1936.
Usall J. , & Marquez M. (1999). [Mixed anxiety and depression disorder: a naturalistic study]. Actas Españolas de Psiquiatría, 27, 81–86.
Weisberg R. B. , Maki K. M. , Culpepper L. , & Keller M. B. (2005). Is anyone really M.A.D.? The occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. Journal of Nervous and Mental Diseases, 193, 223–230.
Weissman M. M. , Wickramaratne P. , Nomura Y. , et al. (2005). Families at high and low risk for depression: a 3-generation study. Archives of General Psychiatry, 62, 29–36.
Wickramaratne P. J. , & Weissman M. M. (1998). Onset of psychopathology in offspring by developmental phase and parental depression. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 933–942.
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Zinbarg R. E. , Barlow D. H. , Liebowitz M. , et al. (1994). The DSM-IV field trial for mixed anxiety-depression. American Journal of Psychiatry, 151, 1153–1162.

Reference Title: References

Reference Type: bibliography

Abramowitz J. S. , & Moore E. L. (2007). An experimental analysis of hypochondriasis. Behaviour Research and Therapy, 45, 413–424.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Aronson K. R. , Feldman Barrett L. , & Quigley K. S. (2001). Feeling your body or feeling badly. Evidence for the limited validity of the Somatosensory Amplification Scale as an index of somatic sensitivity. Journal of Psychosomatic Research, 51, 387–394.
Asmundson G. J. G. , Taylor S. , Sevgur S. , & Cox B. J. (2001). Health anxiety: classification and clinical features. In G. J. G. Asmundson , S. Taylor , & B. J. Cox , eds., Health Anxiety: Clinical and Research Perspectives on Hypochondriasis and Related Conditions. Chichester: Wiley.
Aw D. C. , Thong J. Y. , & Chan H. L. (2005). Delusional parasitosis: case series of 8 patients and review of the literature. Annals of the Academy of Medicine, 34(1), 141–142.
Barsky A. J. , & Ahern D. K. (2004). Cognitive behavior therapy for hypochondriasis. JAMA, 291, 1464–1470.
Barsky A. J. , & Deans E. C. (2006). Stop Being Your Symptoms and Start Being Yourself: a Six Week Mind–Body Program to Ease Your Chronic Symptoms. New York, NY: HarperCollins.
Barsky A. J. , Wyshak G. , & Klerman G. L. (1986). Hypochondriasis: an evaluation of the DSM-III-R criteria in medical outpatients. Archives of General Psychiatry, 43, 493–500.
Barsky A. J. , Wyshak G. , & Klerman G. L. (1990). The somatosensory amplification scale and its relationship to hypochondriasis. Journal of Psychiatric Research, 24, 323–334.
Barsky A. J. , Cleary P. D. , Wyshak G. , et al. (1992). A structured diagnostic interview for hypochondriasis: a proposed criterion standard. Journal of Nervous & Mental Disease, 180, 20–27.
Barsky A. J. , Wool C. , Barnett M. C. , & Cleary P. D. (1994). Histories of childhood trauma in adult hypochondriacal patients. American Journal of Psychiatry, 151, 397–401.
Barsky A. , Ettner S. L. , Horsky J. , & Bates D. W. (2001). Resource utilization of patients with hypochondriacal health anxiety and somatization. Medical Care, 39, 705–715.
Bienvenu O. J. , Samuels J. F. , Riddle M. A. , et al. (2000). The relationship of obsessive–compulsive disorder to possible spectrum disorders: from a family study. Biological Psychiatry, 48, 287–293.
Bleichardt G. , & Hiller W. (2007). Hypochondriasis and health anxiety in the German population. British Journal of Health Psychology, 12, 511–523.
Bouman T. K. , & Vervaeke G. (2006). [Training in Attention Manipulation (TAM) as a treatment for hypochondriasis: case illustrations.] (Dutch). Gedragstherapie, 39, 293–305.
Butcher J. N. , Dahlstrom W. G. , Graham J. R. , Tellegen A. , & Kaemmer B. (1989). MMPI-2 (Minnesota Multiphasic Personality Inventory-2): Manual for administration and scoring. Minneapolis, MN: University of Minnesota Press.
Buwalda F. M. , Bouman T. K. , & van Duijnb M. A. J. (2006). Psychoeducation for hypochondriasis: a comparison of a cognitive–behavioral approach and a problem-solving approach. Behaviour Research and Therapy, 45, 887–899.
Coghill R. C. , McHaffie J. G. , & Yen Y. F. (2003). Neural correlates of interindividual differences in the subjective experience of pain. Proceedings of the National Academy of Sciences of the USA, 100, 8538–8542.
Creed F. , & Barsky A. J. (2004). A systematic review of the epidemiology of somatization disorder and hypochondriasis. Journal of Psychosomatic Research, 56, 391–408.
de Gelder B. , Snyder J. , Greve D. , Gerard G. , & Hadjikhani N. (2004). Fear fosters flight: a mechanism for fear contagion when perceiving emotion expressed by a whole body. Proceedings of the National Academy of Sciences of the USA, 101, 16701–16706.
Dimsdale J. E. , & Dantzer R. (2007). A biological substrate for somatoform disorders: importance of pathophysiology. Psychosomatic Medicine, 69, 850–854.
Druss R. G. (1995). The Psychology of Illness: in Sickness and in Health. Washington DC: American Psychiatric Press.
Fallon B. A. (2001). Pharmacologic strategies for hypochondriasis. In V. Starcevic & D. R. Lipsett . eds., Hypochondriasis: Modern Perspectives on an Ancient Malady. New York, NY: Oxford Univerity Press.
Fallon B. A. , Qureshi A. I. , Schneier F. R. , et al. (2003). An open trial of fluvoxamine for hypochondriasis. Psychosomatics, 44, 298–303.
Fallon B. A. , Petkova E. , Skritskaya N. , et al. (2008). A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology, 28(6), 638–645.
Fava G. A. , Grandi S. , Belluardo P. , et al. (1994). Benzodiazepines and anxiety sensitivity in panic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 18, 1163–1168.
Feldman M. D. (2000). Munchausen by Internet: detecting factitious illness and crisis on the Internet. Southern Journal of Medicine, 93, 669–672.
Fink P. , Ørnbol E. , Toft T. , et al. (2004). A new, empirically established hypochondriasis diagnosis. American Journal of Psychiatry, 161(9), 1680–1691.
Fox S. (2006). Online health search. Last modified October 29, 2006. www.pewinternet.org/Reports/2006/Online-Health-Search-2006.aspx (accessed February 25, 2010).
Freudenmann R. W. , Lepping P. (2008) Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy. Journal of Clinical Psychopharmacology, 28, 500–508.
Greeven A. , van Balkom A. J. L. M. , Visser S. , et al. (2007). Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. American Journal of Psychiatry, 164, 91–99.
Gureje O. , Ustun T. B. , & Simon G. E. (1997). The syndrome of hypochondriasis: a cross-national study in primary care. Psychological Medicine, 27, 1001–1010.
Hamann K. , & Avnstorp C. (1982) Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Dermato-Venereologica, 62, 55–58.
Harris Poll (2006). Number of “cyberchondriacs” – adults who have ever gone online for health information – increases to an estimated 136 million nationwide. #59 August 1, 2006. www.harrisinteractive.com/harris_poll/index.asp?PID=686 (accessed February 25, 2010).
Hiller W. , & Fichter M. (2004). High utilizer of medical care: a crucial subgroup among somatizing patients. Journal of Psychosomatic Research, 56, 437–443.
Hirschfeld R. M. , Mallinckrodt C. , Lee T. C. , & Detke M. J. (2005). Time course of depression symptom improvement during treatment with duloxetine. Depression and Anxiety, 21, 170–177.
Kellner R. (1987). Abridged manual of the illness attitude scales (mimeographed). Albuquerque, NM: University of New Mexico Department of Psychiatry.
Kouyanou K. , Pither C. E. , & Wessely S. (1997). Iatrogenic factors and chronic pain. Psychosomatic Medicine, 59, 597–604.
Kroenke K. (2007). Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine, 69, 881–888.
Kroenke K. , Sharpe M. , & Sykes R. (2007). Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics, 48, 277–285.
Lamm C. , Nusbaum H. C. , Meltzoff A. N. , & Decety J. (2007). What are you feeling? Using functional magnetic resonance imaging to assess the modulation of sensory and affective responses during empathy for pain. PLoS ONE, 2(12), e1292.
Lieb R. , Zimmermann P. , Friis R. H. , Höfler M. , Tholen S. , & Wittchen H. U. (2002). The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective–longitudinal community study. European Psychiatry, 17, 321–331.
Looper K. J. , & Kirmayer L. J. (2001). Hypochondriacal concerns in a community population. Psychological Medicine, 31, 577–584.
Martin A. , & Jacobi F. (2006). Features of hypochondriasis and illness worry in the general population in Germany. Psychosomatic Medicine, 68, 770–777.
McKay D. , & Bouman T. K. (2008). Enhancing cognitive–behavioral therapy for monosymptomatic hypochondriasis with motivational interviewing: three case illustrations. Journal of Cognitive Psychotherapy, 22, 154–166.
Morgan O. W. , Page L. , Forrester S. , & Maguire H. (2008). Polonium-210 poisoning in London: hypochondriasis and public health. Prehospital and Disaster Medicine, 23, 96–97.
Nemery B. , Fischler B. , Boogaerts M. , & Lison D. (1999). Dioxins, Coca-Cola, and mass sociogenic illness in Belgium. Lancet, 354, 77.
Nemery B. , Fischler B. , Boogaerts M. , Lison D. , & Willems J. (2002). The Coca-Cola incident in Belgium, June 1999. Food and Chemical Toxicology, 40, 1657–1667.
Nezu A. M. , Nezu C. M. , Jain D. , et al. (2007). Social problem solving and noncardiac chest pain. Psychosomatic Medicine, 69, 944–951.
Noyes R. , Reich J. , Clancy J. , & O'Gorman T. W. (1986). Reduction in hypochondriasis with treatment of panic disorder. British Journal of Psychiatry, 149, 631–635.
Noyes R. , Holt C. S. , Happel R. L. , Kathol R. G. , & Yagla S. J. (1997). A family study of hypochondriasis. Journal of Nervous and Mental Disorders, 185, 223–232.
Noyes R. , Stuart S. , Langbehn D. R. , et al. (2002). Childhood antecedents of hypochondriasis. Psychosomatics, 43, 282–289.
Noyes R. , Stuart S. P. , Langbehn D. R. , et al. (2003). Test of an interpersonal model of hypochondriasis. Psychosomatic Medicine, 65, 292–300.
Noyes R. , Carney C. P. , Hillis S. L. , Jones L. E. , & Langbehn D. R. (2005). Prevalence and correlates of illness worry in the general population. Psychosomatics, 46, 529–539.
Oosterbaan D. B. , van Balkom A. J. , van Boeijen C. A. , de Meij T. G. J. , & van Dyck R. (2001). An open study of paroxetine in hypochondriasis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 1023–1033.
Papageorgiou C. , & Wells A. (1998). Effects of attention training on hypochondriasis: a brief case series. Psychological Medicine, 28, 193–200.
Pavlovsky F. , Peskin V. , Di Noto L. , & Stagnaro J. C. (2008). [Delusion of parasitosis: report of twelve cases]. Vertex, 19(79), 99–111.
Philen R. M. , Kilbourne E. M. , McKinley T. W. , & Parrish R. G. (1989). Mass sociogenic illness by proxy: parentally reported epidemic in an elementary school. Lancet, 334, 1372–1376.
Pilowsky I. (1967). Dimensions of hypochondriasis. British Journal of Psychiatry, 113, 89–93.
Politi P. (2007). Successful treatment of refractory hypochondriasis with duloxetine. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 1145–1146.
Raij T. T. , Numminen J. , Narvanen S. , Hiltunen J. , & Hari R. (2005). Brain correlates of subjective reality of physically and psychologically induced pain. Proceedings of the National Academy of Sciences of the USA, 102, 2147–2151.
Rief W. , Hessel A. , & Braehler E. (2001). Somatization symptoms and hypochondriacal features in the general population. Psychosomatic Medicine, 63, 595–602.
Rincon P. (2006). Sophistication behind spy's poisoning. Last modified November 28, 2006. http://news.bbc.co.uk/1/hi/sci/tech/6190144.stm. Accessed March 26, 2009.
Robbins J. M. , & Kirmayer L. J. (1996). Transient and persistent hypochondriacal worry in primary care. Psychological Medicine, 26, 575–589.
Saxena S. , Brody A. L. , Schwartz J. M. , & Baxter L. R. (1998). Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder. British Journal of Psychiatry Supplement, (35), 26–37.
Schmidt S. , Strauss B. , & Braehler E. (2002). Subjective physical complaints and hypochondriacal features from an attachment theoretical perspective. Psychology and Psychotherapy, 75, 313–332.
Simon GE , Gureje O , Fullerton C. (2001). Course of hypochondriasis in an international primary care study, General Hospital Psychiatry, 23, 51–55.
Simpson H. B. , Zuckoff A. , Page J. R. , Franklin M. E. , & Foa E. B. (2008). Adding motivational interviewing to exposure and ritual prevention for obsessive–compulsive disorder: An open pilot trial. Cognitive Behaviour Therapy, 37, 38–49.
Sirri L. , Grandi S. , & Fava G. A. (2008). The Illness Attitude Scales: a clinimetric index for assessing hypochondriacal fears and beliefs. Psychotherapy and Psychosomatics, 77, 337–350.
Speckens A. E. M. , Van Hemert A. M. , Spinhoven P. , & Bolk J. H. (1996). The diagnostic and prognostic significance of the Whiteley Index, the Illness Attitude Scales and the Somatosensory Amplification Scale. Psychological Medicine, 26, 1085–1090.
Thomson A. , & Page L. (2007). Psychotherapies for hypochondriasis. Cochrane Database of Systematic Reviews, (4), CD006520.
Trabert W. (1995). 100 years of delusional parasitosis. Psychopathology, 28, 238–246.
Ungvári G , & Vladár K. (1986) Pimozide treatment for delusion of infestation. Act Nerv Super (Praha), 28(2), 103–107.
van den Heuvel O. A. , Veltman D. J. , Groenewegen H. J. , et al. (2005). Disorder-specific neuroanatomical correlates of attentional bias in OCD, PD and Hypochondriasis. Archives of General Psychiatry, 62, 922–933.
Visser S. , & Bouman T. K. (2001). The treatment of hypochondriasis: exposure plus response prevention vs. cognitive therapy. Behavior Research and Therapy, 39, 423–442.
Wearden A. , Perryman K. , & Ward V. (2006). Adult attachment, reassurance seeking and hypochondriacal concerns in college students. Journal of Health Psychology, 11, 877–886.

Reference Title: References

Reference Type: bibliography

Alnaes S. , & Torgersen S. (1988). The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatrica Scandinavica, 78, 485–492.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
Bollinger A. , Riggs D. , Blake D. , & Ruzek J. (2000). Prevalence of personality disorders among combat veterans with posttraumatic stress disorder. Journal of Traumatic Stress, 13, 255–270.
Chambless D. , Renneberg B. , Goldstein A. , & Gracely E. D. (1992). MCMI diagnosed personality disorders among agoraphobic outpatients: Prevalence and relationship to severity of treatment outcome. Journal of Anxiety Disorders, 6, 193–211.
Coles M. E. , Pinto A. , Mancebo M. C. , Rasmussen S.A. , & Eisen J. L. (2008). OCD with comorbid OCPD: a subtype of OCD? Journal of Psychiatric Research, 42, 289–296.
Crawford T. N. , Cohen P. , First M. B. , et al. (2008). Comorbid Axis I and Axis II disorders in early adolescence. Archives of General Psychiatry, 65, 641–648.
Denys D. , Tenney N. , van Megen H. J. , de Geus F. , & Westenberg H. G. (2004). Axis I and II comorbidity in a large sample of patients with obsessive–compulsive disorder. Journal of Affective Disorders, 80, 155–162.
Dreessen L. , & Arntz A. (1998). The impact of personality disorders on treatment outcome in anxiety disorders: best evidence synthesis. Behaviour Research and Therapy, 36, 483–504.
Dreessen L. , & Arntz A. (1999). Personality disorders have no excessively negative impact on therapist-rated therapy process in the cognitive and behavioural treatment of Axis I anxiety disorders. Clinical Psychology and Psychotherapy, 6, 384–399.
Dunn N. , Yanasak E. , & Schillaci J. (2004). Personality disorders in veterans with posttraumatic stress disorder and depression. Journal of Trauma Stress, 17, 75–82.
Dyck I. R. , Phillips K. A. , Warshaw M. G. , et al. (2001). Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia. Journal of Personality Disorders, 15, 60–71.
Eisen J. L. , Coles M. E. , Shea M. T. , et al. (2006). Clarifying the convergence between obsessive compulsive personality disorder criteria and obsessive compulsive disorder. Journal of Personality Disorders, 20, 294–305.
Engel G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 196, 129–136.
Faustman W. , & White P. (1989). Diagnostic and psychopharmacological treatment characteristics of 536 inpatients with posttraumatic stress disorder. Journal of Nervous & Mental Disease, 177, 154–159.
Feske U. , Perry K. J. , Chambless D. L. , Renneberg B. , & Goldstein A. (1996). Avoidant personality disorder as a predictor for treatment outcome among generalized social phobics. Journal of Personality Disorders, 10, 174–184.
Frances A. (1980). The DSM-III personality disorders section: a commentary. American Journal of Psychiatry, 137, 1050–1054.
Frances A. , & Cooper A. M. (1981). Descriptive and dynamic psychiatry: a perspective on DSM-III. American Journal of Psychiatry, 138, 1198–1202.
Golier J. A. , Yehuda R. , Bierer L. M. , et al. (2003). The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. American Journal of Psychiatry, 160, 2018–2024.
Grant B. F. , Hasin D. S. , Stinson F. S. , et al. (2005). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research, 39, 1–9.
Grilo C. M. , Sanislow C. A. , Gunderson J.G. , et al. (2004). Two-year stability and change in schizotypal, borderline, avoidant and obsessive–compulsive personality disorders. Journal of Consulting and Clinical Psychology, 72, 767–775.
Gunderson J. , & Sabo A. (1993). The phenomenological and conceptual interface between borderline personality disorder and PTSD. American Journal of Psychiatry, 150, 19–27.
Hansen B. , Vogel P. A. , Stiles T. C. , & Gotestam K. G. (2007). Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive–compulsive disorder. Cognitive Behaviour Therapy. 36, 145–155.
Herman J. L. , Perry J. C. , & van der Kolk B. A. (1989). Childhood trauma in borderline personality disorder. American Journal of Psychiatry, 146, 490–495.
Hummelen B. , Wilberg T. , Pedersen G. , & Karterud S. (2007). The relationship between avoidant personality disorder and social phobia. Comprehensive Psychiatry, 48, 348–356.
Johnson J. G. , Cohen P. , Kasen S. , & Brook J. S. (2006). Personality disorders evident by early adulthood and risk for anxiety disorders during middle adulthood. Anxiety Disorders, 20, 408–426.
Lenzenweger M. F. , Lane M. , & Loranger A. W. (2007). DSM-IV personality disorders in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry, 62, 553–564.
Maina G. , Albert U. , Salvi V. , Pessina E. , & Bogetto F. (2008). Early-onset obsessive–compulsive disorder and personality disorders in adulthood. Psychiatry Research, 158, 217–225.
Matsunaga H. , Kiriike N. , Miyata A. , et al. (1998). Personality disorders in patients with obsessive–compulsive disorder in Japan. Acta Psychiatria Scandinavia, 98, 128–134.
Milrod B. , Leon A. C. , Barber J. P. , Markowitz J. C. , & Graf E. (2007). Do comorbid personality disorders moderate psychotherapy response in panic disorder? A preliminary empirical evaluation of the APA Practice Guideline. Journal of Clinical Psychiatry, 68, 885–891.
Ozkan M. , & Altindag A. (2005). Comorbid personality disorders in subjects with panic disorder: do personality disorders increase clinical severity? Comprehensive Psychiatry, 46, 20–26.
Reich J. (2003). The effect of Axis II disorders on the outcome of treatment of anxiety and unipolar depressive disorders: a review. Journal of Personality Disorders, 17, 387–405.
Reich J. , & Braginsky Y. (1994). Paranoid personality traits in a panic disorder population: a pilot study. Comprehensive Psychiatry, 35, 260–264.
Reichborn-Kjennerud T. , Czajkowski N. , Torgersen S. , et al. (2007). The relationship between avoidant personality disorder and social phobia: a population-based twin study. American Journal of Psychiatry, 164, 1722–1728.
Samuels J. , Nestadt G. , Bienvenu O. J. , et al. (2000). Personality disorders and normal personality dimensions in obsessive–compulsive disorder. British Journal of Psychiatry, 177, 457–462.
Sanderson W. C , Wetzler S. , Beck A. T. , & Betz F. (1993). Prevalence of personality disorders among patients with anxiety disorders. Psychiatry Research, 51, 167–174.
Schneier F. R. , Spitzer R. L. , Gibbon M. , Fyer A. J. , & Liebowitz M. R. (1991). The relationship of social phobia subtypes and avoidant personality disorder. Comprehensive Psychiatry, 32, 496–502.
Shea M. T. , & Yen S. (2003). Stability as a distinction between Axis I and Axis II disorders. Journal of Personality Disorders, 17, 373–386.
Shea M. T. , Stout R. , Gunderson J. G. , et al. (2002). Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive–compulsive personality disorders. American Journal of Psychiatry, 159, 2036–2041.
Skodol A. , Oldham J. M. , Hyler S. E. , et al. (1995). Patterns of anxiety and personality disorder comorbidity. Journal of Psychiatric Research, 29, 361–374.
Southwick S. , Yehuda R. , & Giller E. (1993). Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. American Journal of Psychiatry, 150, 1020–1023.
Spitzer R. L. (2001). Values and assumptions in the development of DSM-III and DSM-III-R: an insider's perspective and a belated response to Sadler, Hulgus, and Agich's “On values in recent American psychiatric classification”. Journal of Nervous and Mental Disease, 189, 351–358.
Torres A. R. , Prince M. J. , Bebbington P. E. , et al. (2006). Obsessive–compulsive disorder: prevalence, comorbidity, impact and help-seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry, 163, 1978–1985.
Weertman A. , Arntz A. , Schouten E. , & Dreessen L. (2005). Influences of beliefs and personality disorders on treatment outcome in anxiety patients. Journal of Consulting and Clinical Psychology, 73, 936–944.
Yen S. R. S. , Shea T. M. , Battlle L. C. , et al. (2002). Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant and obsessive–compulsive personality disorders: findings from the Collaborative Longitudinal Personality Disorders Study. Journal of Nervous and Mental Diseases, 190, 510–518.
Zanarini M. C. , Frankenburg F. R. , Hennen J. , Reich D. B. , & Silk K. R. (2006). Prediction of the 10-year course of borderline personality disorder. American Journal of Psychiatry, 163, 827–832.

Reference Title: References

Reference Type: bibliography

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Clark D. M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24, 461–470.
Good B. J. (1977). The heart of what's the matter: the semantics of illness in Iran. Culture, Medicine, and Psychiatry, 1, 25–58.
Good B. J. (1994). Medicine, Rationality, and Experience: an Anthropological Perspective. Cambridge: Cambridge University Press.
Guarnaccia P. J. , Canino G. , Rubio-Stipec M. , & Bravo M. (1993). The prevalence of ataques de nervios in the Puerto Rico disaster study. Journal of Nervous and Mental Disease, 181, 157–165.
Guarnaccia P. J. , Lewis-Fernández R. , & Rivera Marano M. (2003). Toward a Puerto Rican popular nosology: nervios and ataque de nervios. Culture, Medicine, and Psychiatry, 27, 339–366.
Guarnaccia P. J. , Martínez I. , Ramírez R. , & Canino G. (2005). Are ataques de nervios in Puerto Rican children associated with psychiatric disorder? Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1184–1192.
Guarnaccia P. J. , Lewis-Fernández R. , Martínez Pincay I. , et al. (2010). Ataque de nervios as a marker of social and psychiatric vulnerability: results from the NLAAS. International Journal of Social Psychiatry, 56(3), 298–309.
Hinton D. E. (2008). Key idioms of psychological distress among Cambodian refugees. International Society for Traumatic Stress Studies (ISTSS), 24th Annual Meeting: Terror and its Aftermath. Chicago, IL, November 13–15.
Hinton D. E. , Um K. , & Ba P. (2001a). Kyol goeu (“wind overload”) part I: a cultural syndrome of orthostatic panic among Khmer refugees. Transcultural Psychiatry, 38, 403–432.
Hinton D. E. , Um K. , & Ba P. (2001b). Kyol goeu (“wind overload”) part II: prevalence, characteristics and mechanisms of kyol goeu and near-kyol goeu episodes of Khmer patients attending a psychiatric clinic. Transcultural Psychiatry, 38, 433–460.
Hinton D. E. , Hinton S. , Um K. , Chea A. , & Sak S. (2002). The Khmer “weak heart” syndrome: Fear of death from palpitations. Transcultural Psychiatry, 39, 323–344.
Hinton D. E. , Chhean D. , Pich V. , et al. (2006a). Neck-focused panic attacks among Cambodian refugees: A logistic and linear regression analysis. Journal of Anxiety Disorders, 20, 119–138.
Hinton D. E. , Pich V. , Safren S. A. , et al. (2006b). Anxiety sensitivity among Cambodian refugees with panic disorder: a factor analytic investigation. Journal of Anxiety Disorders, 20, 281–295.
Hinton D. E. , Chhean D. , Fama J. M. , Pollack M. H. , & McNally R. J. (2007a). Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Journal of Anxiety Disorders, 21, 42–58.
Hinton D. E. , Sinclair J. , Chung R. C. , & Pollack M. H. (2007b). The SF-36 among Cambodian and Vietnamese refugees: an examination of psychometric properties. Journal of Psychopathology and Behavioral Assessment, 29, 38–45.
Hinton D. E. , Hofmann S. G. , Pitman R. K. , Pollack M. H. , & Barlow D. H. (2008a). The panic attack–PTSD model: applicability to orthostatic panic among Cambodian refugee. Cognitive Behaviour Therapy, 27, 101–116.
Hinton D. E. , Chong R. , Pollack M. H. , Barlow D. H. , & McNally R. J. (2008b). Ataque de nervios: Relationship to anxiety sensitivity and dissociation predisposition. Depression and Anxiety, 25, 489–495.
Hinton D. E. , Lewis-Fernández R. , Pollack M. H. (2009). A model of the generation of ataque de nervios: The role of fear of negative affect and fear of arousal symptoms. CNS Neuroscience & Therapeutics, 15, 264–275.
Kinoshita Y. , Chen J. , Rapee R. M. , et al. (2008). Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya–Osaka diagnostic criteria for social anxiety disorder. Journal of Nervous & Mental Disease, 196, 307–313.
Kirmayer L. J. , & Sartorius M. (2007). Cultural models and somatic models. Psychosomatic Medicine, 69, 832–840.
Kleinknecht R. A. , Dinnel D. L. , Kleinknecht E. E. , Hiruma N. , & Harada N. (1997). Cultural factors in social anxiety: A comparison of social phobia symptoms. Journal of Anxiety Disorders, 11, 157–177.
Lewis-Fernández R. , & Díaz N. (2002). The cultural formulation: a method for assessing cultural factors affecting the clinical encounter. Psychiatric Quarterly, 73, 271–295.
Lewis-Fernández R. , Garrido-Castillo P. , Bennasar M. C. , et al. (2002a). Dissociation, childhood trauma, and ataque de nervios among Puerto Rican psychiatric outpatients. American Journal of Psychiatry, 159, 1603–1605.
Lewis-Fernández R. , Guarnaccia P. J. , Martínez I. E. , et al. (2002b). Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder. Culture, Medicine, and Psychiatry, 26, 199–223.
Lewis-Fernández R. , Guarnaccia P. J. , Patel S. , Lizardi D. , & Díaz N. (2005). Ataque de nervios: anthropological, epidemiological, and clinical dimensions of a cultural syndrome. In A. M. Georgiopoulos & J. F. Rosenbaum , eds., Perspectives in Cross-Cultural Psychiatry. Philadelphia, PA: Lippincott Williams & Wilkins, pp. 63–85.
Lewis-Fernández R. , Guarnaccia P.J. , & Ruiz P. (2009a). Culture-bound syndromes. In B.J. Sadock , V.A. Sadock , & P. Ruiz , eds., Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 9th edn, Vol. 2. Philadelphia, PA: Lippincott Williams & Wilkins, pp. 2519–2538.
Lewis-Fernández R. , Horvitz-Lennon M. , Blanco C. , Alegría M. , & Guarnaccia P. J. (2009b). Significance of endorsement of psychotic symptoms by U.S. Latinos. Journal of Nervous and Mental Disease, 197, 337–347.
Markowitz J. C. , Patel S.R. , Balán I. , et al. (2009). Toward an adaptation of interpersonal psychotherapy for depressed Hispanic patients. Journal of Clinical Psychiatry, 70, 214–222.
Nichter M. (1981). Idioms of distress: alternatives in the expression of psychosocial distress. A case from South India. Culture, Medicine, and Psychiatry, 5, 379–408.
Schechter D. S. , Marshall R. , Salmán E. , et al. (2000). Ataque de nervios and history of childhood trauma. Journal of Traumatic Stress, 13, 529–534.
Wells A. (2000). Emotional Disorder and Metacognitions: Innovative Cognitive Therapy. Chichester: Wiley.

Reference Title: References

Reference Type: bibliography

Alsobrook J. P. , Zohar A. H. , Leboyer M. , et al. (2001). Association between the COMT locus and obsessive–compulsive disorder in females but not in males. American Journal of Medical Genetics, 114, 116–120.
Arbelle S. , Benjamin J. , Golin M. , et al. (2003). Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. American Journal of Psychiatry, 160, 671–676.
Arnold P. , Sicard T. , Burroughs E. , Richter M. , & Kennedy J. (2006). Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Archives of General Psychiatry, 63, 769–776.
Azzam A. , & Mathews C. (2003). Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 123B, 64–69.
Baca-Garcia E. , Vaquero-Lorenzo C. , Diaz-Hernandez M. , et al. (2007). Association between obsessive–compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 416–420.
Battaglia M. , Bajo S , Strambi LF , et al. (1997). Physiological and behavioral responses to minor stressors in off spring of patients with panic disorder. Journal of Psychiatric Research, 31, 365–376.
Bellodi L. , Scuito G. , Guiseppina D. , & Ronchi P. (1992). Psychiatric disroders in the families of patients with obsessive–compulsive disorder. Psychiatry Research, 42, 111–120.
Bellodi L. , Perna G. , Caldirola D. , et al. (1998). CO2-induced panic attacks: a twin study. American Journal of Psychiatry, 155, 1184–1188.
Bengel D. , Greenberg B. D. , Cora-Locatelli G. , et al. (1999). Association of the serotonin transporter promoter regulatory region polymorphism and obsessive–compulsive disorder. Molecular Psychiatry, 4, 463–466.
Biederman J. , Hirshfeld-Becker D. R. , Rosenbaum J. F. , et al. (2001). Further evidence of association between behavioral inhibition and social anxiety in children. American Journal of Psychiatry, 158, 1673–1679.
Billett E. A. , Richter M. A. , King N. , et al. (1997). Obsessive compulsive disorder, response to serotonin reuptake inhibiters and the serotonin transporter gene. Molecular Psychiatry, 2, 403–406.
Billett E. A. , Richter M. , Sam F. , et al. (1998). Investigation of dopamine system genes in obsessive–compulsive disorder. Psychiatric Genetics, 8, 163–169.
Bolton D. , Eley T. C. , O'Connor T. G. , et al. (2006). Prevalence and genetic and environmental influences on anxiety disorders in 6-year-old twins. Psychological Medicine, 36, 335–344.
Camarena B. , Rinetti G. , Cruz C. , et al. (2001a). Association study of the serotonin transporter gene polymorphism in obsessive–compulsive disorder. International Journal of Neuropsychopharmacology, 4, 269–272.
Camarena B. , Rinetti G. , Cruz C. , et al. (2001b). Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive–compulsive disorder. American Journal of Medical Genetics, 105, 279–282.
Camarena B. , Loyzaga C. , Aguilar A. , Weissbecker K. & Nicolini H. (2007). Association study between the dopamine D4 gene and obsessive–compulsive disorder. European Neuropsychopharmacology, 17, 406–409.
Cavallini M. , Di Bella D. , Siliprandi F. , Malchiodi F. , & Bellodi L. (2002). Exploratory factor analysis of obsessive–compulsive patients and association with 5-HTTLPR polymorphism. American Journal of Medical Genetics, 114, 347–353.
Chabane N. , Millet B. , Delorme R. , et al. (2004). Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive–compulsive disorder by case control and family association study in humans. Neuroscience Letters, 363, 154–156.
Chacon P. , Rosario-Campos M. C. , Pauls D. L. , et al. (2007). Obsessive–compulsive symptoms in sibling pairs concordant for obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 551–555.
Chantarujikapong S. I. , Scherrer J. F. , Xian H. , et al. (2001). A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Research, 103, 133–145.
Comings D. E. , Comings B. G. , Muhleman D. , et al. (1991). The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA, 266, 1793–1800.
Comings D. E. , Muhleman D. , & Gysin R. (1996). Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication. Biological Psychiatry, 40, 368–372.
Craddock N. , O'Donovan M. C. , & Owen M. J. (2008). Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Molecular Psychiatry, 13, 649–653.
Crowe R. R. , Goedken R. , Samuelson S. , et al. (2001). Genomewide survey of panic disorder. American Journal of Medical Genetics, 105, 105–109.
Deckert J. , Catalano M. , & Heils A. (1997). Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatric Genetics, 7, 45–47.
Deckert J. , Catalano M. , Syagailo Y. , et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics, 8, 621–624.
Denys D. , Van Nieuwerburgh F. , Deforce D. , & Westenberg H. (2006). Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in males. European Neuropsychopharmacology, 16, 446–450.
Di Bella D. , Cavallini M. C. , & Bellodi L. (2002). No association between obsessive–compulsive disorder and the 5-HT1Dβ receptor gene. American Journal of Psychiatry, 159, 1783–1785.
Dickel D. E. , Veenstra-VanderWeele J. , Cox N. J. , et al. (2006). Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Archives of General Psychiatry, 63, 778–785.
DiLalla L. , Kagan J. , & Reznick J. (1994). Genetic etiology of behavioral inhibition among 2-year-old children. Infant Behavior Development, 17, 405–412.
Distel M. A. , Vink J. M. , & Willemsen G. (2008). Heritability of self-reported phobic fear. Behavior Genetics, 38, 24–33.
do Rosario-Campos M. , Leckman J. , Curi M. , et al. (2005). A family study of early onset obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 136B, 92–97.
Domschke K. , Deckert J. , O'Donovan M. C. , & Glatt S. J. (2007). Meta-analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 667–673.
Eley T. C. , Bolton D. , O'Connor T. G. , et al. (2003). A twin study of anxiey-related behaviors in pre-school children. Journal of Child Psychology and Psychiatry, 44, 945–960.
Enoch M. A. , Xu K. , Ferro E. , Harris C. R. , & Goldman D. (2003). Genetic origins of anxiety in women: a role for a functional COMT polymorphism. Psychiatric Genetics, 13, 33–41.
Erdal M. , Tot S. , Yazici K. , et al. (2003). Lack of association of catechol-o-methyltransferase gene polymorphism in obsessive–compulsive disorder. Depression and Anxiety, 18, 41–45.
Fehr C. , Schleicher A. , Szegedi A. , et al. (2001). Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders, and narcolepsy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 965–982.
Freitag C. M. , Domschke K. , Rothe C. , et al. (2006). Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatric Genetics, 16, 59–65.
Frisch A. , Michaelovsky E. , Rockah R. , et al. (2000). Association between obsessive–compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. European Neuropsychopharmacology, 10, 205–209.
Furmark T. , Tillfors M. , Garpenstrand H. , et al. (2004). Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neuroscience Letters, 362, 189–192.
Fyer A. , Mannuzza S. , Gallops M. , et al. (1990). Familial transmission of simple phobias and fears. A preliminary report. Archives of General Psychiatry, 47, 252–256.
Fyer A. , Mannuzza S. , Chapman T. , Liebowitz M. , & Klein D. (1993). A direct interview family study of social phobia. Archives of General Psychiatry, 50, 286–293.
Fyer A. , Mannuzza S. , Chapman T. , et al. (1996). Panic disorder and social phobia: effects of comorbidity on familial transmission. Anxiety, 2, 173–178.
Fyer A. , Lipsitz J. , Mannuzza S. , Aronowitz B. , & Chapman T. (2005). A direct interview family study of obsessive–compulsive disorder. I. Psychological Medicine, 35, 1611–1621.
Fyer A. , Hamilton S. , Durner M. , et al. (2006). A thirdpass genome scan in panic disorder: evidence for multiple susceptability loci. Biological Psychiatry, 60, 388–401.
Gelernter J. , Southwick S. , Goodson S. , et al. (1999). No association between D2 dopamine receptor (DRD2) ‘A’ system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biological Psychiatry, 45, 620–625.
Gelernter J. , Bonvicini K. , Page G. , et al. (2001). Linkage genome scan for loci predisposing to panic disorder or agoraphobia. American Journal of Medical Genetics, 105, 548–557.
Gelernter J. , Page G. P. , Bonvicini K. , et al. (2003). A chromosome 14 risk locus for simple phobia: Results from a genomewide linkage scan. Molecular Psychiatry, 8, 71–82.
Gelernter J. , Page G. , Stein M. , & Woods S. (2004). Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. American Journal of Psychiatry, 161, 59–66.
Gerstein M. , Bruce C. , Rozowsky J. , et al. (2007) What is a gene, post-ENCODE? History and updated definition. Genome Research, 17, 669–681.
Goldsmith H. , & Lemery K. (2000). Linking temperamental anxiety symptoms: a behavior-genetic perspective. Biological Psychiatry, 48, 1199–1209.
Goldstein R. , Wickramante P. , Horwath E. , & Weissman M. (1997). Familial aggregation and pheonmenology of “early”-onset (at or before age 20 years) panic disorder. Archives of General Psychiatry, 54, 271–278.
Gordon J. A. , & Hen R. (2004). The serotonergic system and anxiety. Neuro Molecular Medicine, 5, 27–40.
Gregory A. , Lau J. Y. F. , & Eley T. C. (2008). Finding gene–environment interactions for generalised anxiety disorder. European Archives of Psychiatry and Clinical Neuroscience, 258, 69–75.
Hamilton S. , Haghighi F. , Heiman G. , et al. (2000). Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. American Journal of Medical Genetics, 96, 324–330.
Hamilton S. , Fyer A. , Durner M. , et al. (2003). Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proceedings from the National Academy of Sciences of the USA, 100, 2550–2555.
Hamilton S. , Slager S. L. , Mayo D. , et al. (2004a). Investigation of polymorphisms in the CREM gene in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 126B, 111–115.
Hamilton S. P. , Slager S. L. , de Leon A. B. , et al. (2004b). Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology, 29, 558–565.
Hanna G. L. , Veenstra-VanderWeele J. , Cox N. J. , et al. (2002). Genome-wide linkage analysis of families with obsessive–compulsive disorder ascertained through pediatric probands. American Journal of Medical Genetics, 114, 541–552.
Hemmings S. , & Stein D. (2006). The current status of association studies in obsessive–compulsive disorder. Psychiatric Clinics of North America, 29, 411–444.
Hemmings S. , Kinnear C. , Niehaus D. , et al. (2003). Investigating the role of dopaminergic and serotonergic candidate genes in obsessive–compulsive disorder. European Neuropsychopharmacology, 13, 93–98.
Hemmings S. , Kinnear C. , Lochner C. , et al. (2004). Early- versus late-onset obsessive–compulsive disorder: investigating genetic and clinical correlates. Psychiatric Annals, 128, 175–182.
Hetherington E. , Reiss D. , & Plomin R. (1993) Separate Social Worlds of Siblings: the Impact of Nonshared Envionment on Development. Hillsdale, NJ: Lawrence Erlbaum Associates.
Hettema J. M. , Neale M. C. , & Kendler K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry, 158, 1568–1578.
Hettema J. M. , Prescott C. A. , & Kendler K. S. (2004). Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. American Journal of Psychiatry, 161, 1581–1587.
Hettema J. M. , Prescott C. A. , Myers J. M. , Neale M. C. , & Kendler K. S. (2005). The structure of genetic and environmental risk ractors for anxiety disorders in men and women. Archives of General Psychiatry, 62, 182–189.
Hettema J. M. , Neale M. C. , Myers J. M. , Prescott C. A. , & Kendler K. S. (2006a). A population-based twin study of the relationship between neuroticism and internalizing disorders. American Journal of Psychiatry, 163, 857–864.
Hettema J. M. , An S. S. , Neale M. C. , et al. (2006b). Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Molecular Psychiatry, 11, 794.
Hodges L. , Weissman M. , Haghighi F. , et al. (2009). Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 150B, 65–73.
Horwath E. , Wolk S. , Goldstein R. , et al. (1995). Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors. Archives of General Psychiatry, 52, 574–582.
Hu X. Z. , Lipsky R. , Zhu G. , et al. (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. American Journal of Human Genetics, 78, 815–826.
Hunnerkopf R. , Strobel A. , Gutknecht L. , Brocke B. , & Lesch K. P. (2007). Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology, 32, 2552–2560.
Inada Y. , Yoneda H. , Koh J. , et al. (2003). Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Research, 118, 25–31.
Ishiguro H. , Arinami T. , Yamada K. , et al. (1997). An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry and Clinical Neurosciences, 51, 333–335.
Jang K. L. , Stein M. B. , Taylor S. , & Livesley W. J. (1999). Gender differences in the etiology of anxiety sensitivity: a twin study. Journal of Gender Specific Medicine, 2, 39–44.
Jardine R. , Martin N. , & Henderson A. (1984). Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genetic Epidemiology, 1, 89–107.
Johnson J. , Cohen P. , Kasen S. , & Brook J. (2008). Parental concordance and offspring risk for anxiety, conduct, depressive, and substance use disorders. Psychopathology, 41, 124–128.
Jorm A. , Prior M. , Sanson A. , et al. (2000). Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: A longitudinal study from infancy to the mid-teens. Molecular Psychiatry, 5, 542–547.
Kagan J. , Reznick J. , & Gibbons J. (1989). Inhibited and uninhibited types of children. Child Development, 60, 838–845.
Karayiorgou M. , Alternus M. , Galke B. , et al. (1997). Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive–compulsive disorder. Proceedings of the National Academy of Sciences of the USA, 94, 4572–4575.
Karayiorgou M. , Sobin C. , Blundell M. , et al. (1999). Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive–compulsive disorder. Biological Psychiatry, 45, 1178–1189.
Kendler K. , Neale M. , Kessler R. , Heath A. , & Eaves L. (1993). Panic disorder in women: A population-based twin study. Psychological Medicine, 23, 397–406.
Kendler K. , Walters E. , Truett K. R. , et al. (1995). A twin family study of self-report symptoms of panic, phobia, and somatization. Behavior Genetics, 25, 499–515.
Kendler K. S. , Karkowski L. M. , & Prescott C. A. (1999). Fears and phobias: reliability and heritability. Psychological Medicine, 29, 539–553.
Kendler K. S. , Gardner C. O. , & Prescott C. A. (2001a). Panic syndromes in a population-based sample of male and female twins. Psychological Medicine, 31, 989–1000.
Kendler K. S. , Myers J. , Prescott C. A. , & Neale M. C. (2001b). The genetic epidemiology of irrational fears and phobias in men. Archives of General Psychiatry, 58, 257–265.
Kendler K. , Gardner C. O. , Annas P. , et al. (2008). A longitudinal twin study of fears from middle childhood to early adulthood: evidence for a developmentally dynamic genome. Archives of General Psychiatry, 65, 421–429.
Kennedy J. L. , Neves-Pereira M. , King N. , et al. (2001). Dopamine system genes not linked to social phobia. Psychiatric Genetics, 11, 213–217.
Kessler R. , Chiu W. , Demler O. , Merikangas K. , & Walters E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 25, 617–627.
Kilpatrick D. G. , Koenen K. C. , Ruggiero K. J. , et al. (2007). The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. American Journal of Psychiatry, 164, 1693–1699.
Kim S. , Lee H. , & Kim C. (2005). Obsessive–compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology, 52, 176–182.
Kinnear C. , Niehaus D. , Moolman-Smook J. , et al. (2000). Obsessive–compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. International Journal of Neuropsychopharmacology, 3, 327–331.
Kirk K. , Birley A. , Statham D. , Haddon B. , et al. (2000). Anxiety and depression in twin and sib pairs extremely discordant and concordant for neuroticism: prodromus to a linkage study. Twin Research and Human Genetics, 3, 299–309.
Knowles J. , Fyer A. , Vieland V. , et al. (1998). Results of a genome-wide genetic screen for panic disorder. American Journal of Medical Genetics, 81, 139–147.
Koenen K. C. (2007). Genetics of posttraumatic stress disorder: review and recommendations for future studies. Journal of Traumatic Stress Studies, 20, 737–750.
Koenen K. C. , Nugent N. R. , & Amstadter A. B. (2008). Gene–environment interaction in posttraumatic stress disorder: review, strategy and new directions for future research. European Archives of Psychiatry and Clinical Neuroscience, 258, 82–96.
Koenen K. C. , Amstadter A. B. , Ruggiero K. J. , et al. (2009). RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depression and Anxiety, 26, 309–315.
Lee H. J. , Lee M. S. , Kang R. H. , et al. (2005). Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depression and Anxiety, 21, 135–139.
Lenane M. C. , Swedo S. E. , Leonard H. , et al. (1990). Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 407–412.
Leygraf A. , Hohoff C. , Freitag C. , et al. (2006). Rgs 2 gene polymorphisms as modulators of anxiety in humans? Journal of Neural Transmission, 113, 1921–1925.
Lichtenstein P. , & Annas P. (2000). Heritability and prevalence of specific fears and phobias in childhood. Journal of Child Psychology and Psychiatry and Allied Disciplines, 41, 927–937.
Lochner C. , Hemmings S. , Seedat S. , et al. (2007). Genetics and personality traits in patients with social anxiety disorder: a case–control study in South Africa. European Neuropsychopharmacology, 17, 321–327.
Logue M. , Vieland V. , Goedken R. , & Crowe R. R. (2003). Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 121B, 95–99.
Low N. C. P. , Cui L. , & Merikangas K. R. (2008). Community versus clinic sampling: Effect on the familial aggregation of anxiety disorders. Biological Psychiatry, 63, 884–890.
Maier W. , Lichtermann D. , Minges J. , Oehrlein A. , & Franke P. (1993). A controlled family study in panic disorder. Journal of Psychiatric Research, 27, 79–87.
Mannasis K. , Bradley S , Goldberg S , Hood J , Swinson R. (1995). Behavioural inhibition, attachment and anxiety in children of mothers with anxiety disorders. Canadian Journal of Psychiatry, 40, 87–92.
Maron E. , Nikopensius T. , Koks S. , et al. (2005). Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatric Genetics, 15, 17–24.
Matheny A. (1989). Children's behavioral inhibition over age and across situations: genetic similarity for a trait during change. Journal of Personality, 57, 215–235.
Matsushita S. , Muramatsu T. , Kimura M. , et al. (1997). Serotonin transporter gene regulatory region polymorphism and panic disorder. Molecular Psychiatry, 2, 390–392.
McDougle C. J. , Epperson C. N. , Price L. H. , & Gelernter J. (1998). Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Molecular Psychiatry, 3, 270–273.
McGrath M. , Kawachi I. , Ascherio A. , et al. (2004). Association between catechol-O-methyltransferase and phobic anxiety. American Journal of Psychiatry, 161, 1703–1705.
Meira-Lima I. , Shavitt R. , Miguita K. , et al. (2004). Association analysis of the catechol-omethyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive–compulsive disorder. Genes, Brain, and Behavior, 3, 75–79.
Mendlewicz J. , Papadimitriou G. , & Wilmotte J. (1993). Family study of panic disorder: comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatric Genetics, 3, 73–78.
Middledorp C. , Birley A. , Cath D. G. , et al. (2005). Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Research and Human Genetics, 8, 609–615.
Millet B. , Chabane N. , Delorme R. , et al. (2003). Association between the dopamine receptor D4(DRD4) gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 116B, 55–59.
Munafo M. , Clark T. , & Flint J. (2005). Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Molecular Psychiatry, 10, 415–419.
Nestadt G. , Samuels J. , Riddle M. , et al. (2000). A family study of obsessive–compulsive disorder. Archives of General Psychiatry, 57, 358–363.
Newman S. , & Bland R. (2006). A population-based family study of DSM-III generalized anxiety disorder. Psychological Medicine, 36, 1275–1281.
Nicolini H. , Cruz C. , Camarena B. , et al. (1996). DRD2, DRD3, and 5HT2A receptor genes polymorphisms in obsessive–compulsive disorder. Molecular Psychiatry, 1, 461–465.
Niehaus D. , Kinnear C. , Corfield V. , et al. (2001). Association between a catechol-o-methyltransferase polymorphism and obsessive–compulsive disorder in the Afrikaner population. Journal of Affect Disorders, 65, 61–65.
Noyes R. , Crowe R. R. , Harris E. , et al. (1986). Relationship between panic disorder and agoraphobia: a family study. Archives of General Psychiatry, 43, 227–232.
Noyes R. , Clarkson C. , Crowe R. , Yates W. , & McChesney C. (1987). A family study of generalized anxiety disorder. American Journal of Psychiatry, 144, 1019–1024.
Nugent N. R. , Amstadter A. B. , & Koenen K. C. (2008). Genetics of post-traumatic stress disorder: informing clinical conceptualizations and promoting future research. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 127–132.
Ohara K. , Nagai M. , Suzuki Y. , Ochiai M. , & Ohara K. (1998). No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Research, 80, 145–148.
Ohara K. , Suzuki Y. , Ochiai M. , et al. (1999). A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 23, 55–65.
Pauls D. (2008). The genetics of obsessive–compulsive disorder: a review of the evidence. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 133–139.
Pauls D. , Alsobrook J. P. , Goodman W. , Rasmussen S. , & Leckman J. F. (1995). A family study of obsessive–compulsive disorder. American Journal of Psychiatry, 152, 76–84.
Perna G. , Caldirola D. , Arancio C. , & Bellodi L. (1997). Panic attacks: a twin study. Psychiatry Research, 66, 69–71.
Plomin R. , Emde R. , Bruaungart J. , et al. (1993). Genetic change and continuity from fourteen to twenty months: the MacArthur Longitudinal Twin Study. Child Development, 64, 1354–1376.
Plomin R. , DeFries J. C. , McClearn G. E. , & McGuffin P. (2001). Behavioral Genetics. New York, NY: Worth.
Poulton R. , Andrews G. , & Millichamp J. (2008). Gene–environment interaction and the anxiety disorders. European Archives of Psychiatry and Clinical Neuroscience, 258, 65–68.
Risch N. J. , & Merikangas K. (1996). The future of genetic studies of complex human diseases. Science, 273, 1516–1517.
Robinson J. , Kagan J. , Reznick J. , & Corley P. A. (1992). The heritability of inhibited and uninhibited behavior: a twin study. Development and Psychopathology, 28, 1030–1037.
Rosenbaum J. , Biederman J. , Hirshfeld-Becker D. R. , et al. (2000). A controlled study of behavioral inhibition in children of parents with panic disorder and depression. American Journal of Psychiatry, 157, 2002–2010.
Rowe D. , Stever C. , Gard J. , et al. (1998). The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behavior Genetics, 28, 215–225.
Sack W. H. , Clarke G. N. , & Seeley J. (1995). Posttraumatic stress disorder across two generations of Cambodian refugees. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1160–1166.
Saiz P. A. , Garcia-Portilla M. P. , Arango C. , et al. (2008). Association study between obsessive–compulsive disorder and serotonergic candidate genes. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 765–770.
Samochowiec J. , Hajduk A. , Samochowiec A. , et al. (2004). Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research, 128, 21–26.
Schindler K. , Richter M. A. , Kennedy J. L. , Pato M. , & Pato C. (2000). Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. American Journal of Medical Genetics, 96, 721–724.
Schinka J. A. (2005). Measurement scale does moderate the association between the serotonin transporter gene and trait anxiety: comments on Munafo et al. Molecular Psychiatry, 10, 892–893.
Schwartz C. , Snidman N. , & Kagan J. (1999). Adolescent social anxiety as an outcome of inhibited temperament in childhood. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1008–1015.
Seckl J. , & Meaney M. (2006). Glucocorticoid “programming” and PTSD risk. Annals of the New York Academy of Sciences, 1071, 351–378.
Segman R. H. , Cooper-Kazaz R. , Macciardi F. , et al. (2002). Association between the dopamine transporter gene and posttraumatic stress disorder. Molecular Psychiatry, 7, 903–907.
Shifman S. , Bhomra A. , & Smiley S. (2008). A whole genome association study of neuroticism using DNA pooling. Molecular Psychiatry, 13, 302–312.
Shugart Y. , Samuels J. , Willour V. , et al. (2006). Genomewide linkage scan for obsessive–compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Molecular Psychiatry, 11, 763–770.
Skinner M. , Anway M. D. , Savenkova M. I. , Gore A. C. , & Crews D. (2008). Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PloS ONE, 3 (11), e3745.
Skre I. , Onstad S. , Torgesen S. , Lygren S. , & Kringlen E. (1993). A twin study of DSM-III-R anxiety disorders. Acta Psychiatrica Scandinavica, 88, 85–92.
Smoller J. W. (2008). Genetics of mood and anxiety disorders. In J. W. Smoller , B. R. Sheidley , & M. T. Tsuang , eds., Psychiatric Genetics: Applications in Clinical Practice. Washington, DC: American Psychiatric Publishing, pp. 131–176.
Smoller J. , Acerno J. , Rosenbaum J. , et al. (2001a). Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. American Journal of Medical Genetics, 105, 195–206.
Smoller J. , Rosenbaum J. F. , Biederman J. , et al. (2001b). Genetic association analysis of behavioral inhibition using candidate loci from mouse models. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 105B, 226–235.
Smoller J. , Rosenbaum J. F. , Biederman J. , et al. (2003). Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biological Psychiatry, 54, 1376–1381.
Smoller J. , Yamaki L. H. , Fagerness J. A. , et al. (2005). The corticotropin releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biological Psychiatry, 57, 1485–1492.
Smoller J. , Paulus M. P. , Fagerness J. A. , et al. (2008a). Influence of RGS2 on anxiety-related temperament, personality, and brain function. Archives of General Psychiatry, 65, 298–308.
Smoller J. , Gardner-Schuster E. , & Covino J. (2008b). The genetic basis of panic and phobic anxiety disorders. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 118–126.
Stein M. , Chartier M. , Hazen A. , et al. (1998a). A direct-interview family study of generalized social phobia. American Journal of Psychiatry, 155, 90–97.
Stein M. B. , Chartier M. J. , Kozak M. V. , King N. , & Kennedy J. L. (1998b). Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Research, 81, 283–291.
Stein M. B. , Jang K. J. , & Livesley J. (1999). Heritability of anxiety sensitivity: a twin study. American Journal of Psychiatry, 156, 246–251.
Stein M. B. , Jang K. J. , Taylor S. , Vernon P. A. , & Livesley W. J. (2002). Genetic and environmental influences on trauma exposure and posttraumatic stress disorder: a twin study. American Journal of Psychiatry, 159, 1675–1681.
Stein M. , Fallin M. , Schork N. J , & Gelernter J. (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology, 30, 2092–2102.
Stein M. B. , Seedat S. , & Gelernter J. (2006). Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology, 187, 68–72.
Stein M. B. , Schork N. J. , & Gelernter J. (2008). Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology, 33, 312–319.
Stewart S. , Fagerness J. A. , Platko J. , et al. (2007). Association of the SLCA1 glutamate transporter gene and obsessive–compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 1027–1033.
Strug L. , Suresh R. , Fyer A. , et al. (2010). Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Molecular Psychiatry, 15, 166–176.
Tadic A. , Rujescu D. , Szegedi A. , et al. (2003). Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 117, 1–6.
Talati A. , Ponniah K. , Strug L. , et al. (2008). Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biological Psychiatry, 63, 594–601.
Taylor S. , Jang K. L. , Stewart S. H. , & Stein M. B. (2008). Etiology of the dimensions of anxiety sensitivity: a behavioral-genetic analysis. Journal of Anxiety Disorders, 22, 899–914.
Thorgeirsson T. E. , Oskarsson H. , Desnica N. , et al. (2003). Anxiety with panic disorder linked to chromosome 9q in Iceland. American Journal of Human Genetics, 72, 1221–1230.
Tochigi M. , Hibino H. , Otowa T. , et al. (2006). Association between dopamine D4 receptor (DRD4) exon III polymorphism and neuroticism in the Japanese population. Neuroscience Letters, 398, 333–336.
Torgersen S. (1983). Genetic factors in anxiety disorders. Archives of General Psychiatry, 40, 1085–1089.
Tot S. , Erdal M. , Yazici K. , Yazici A. , & Metin O. (2003). T102C and-1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive–compulsive disorder. European Psychiatry, 18, 249–254.
True W. J. , Rice J. , Eisen S. A. , et al. (1993). A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Archives of General Psychiatry, 50, 257–264.
Turner S. , Bieidel D. , & Wolff P. (1996). Is behavioral inhibition related to the anxiety disorders? Clinical Psychology Review, 16, 157–172.
van Beek N. , & Griez E. (2003). Anxiety sensitivity in first-degree relatives of patients with panic disorder. Behavior Research and Therapy, 41, 949–957.
van Grootheest D. , Bartels M. , Cath D. , et al. (2007). Genetic and environmental contributions underlying stability in childhood obsessive–compulsive behavior. Biological Psychiatry, 61, 308–315.
van Grootheest D. , Cath D. , Beekman A. , & Boomsma D. (2005). Twin studies on obsessive–compulsive disorder: A review. Twin Research Human Genetics, 8, 450–458.
Wacker J. , Reuter M. , Hennig J. , & Stemmler G. (2006). Sexually dimorphic link between dopamine D2 receptor gene and neuroticism–anxiety. Neuroreport, 16, 611–614.
Walitza S. , Wewetzer C. , Warnke A. , et al. (2002). 5-HT2A promoter polymorphism-1438G/A in children and adolescents with obsessive–compulsive disorders. Molecular Psychiatry, 7, 1054–1057.
Walitza S. , Wewetzer C. , Gerlach M. , et al. (2004). Transmission disequilibrium studies in children and adolescents with obsessive–compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. Journal of Neural Transmission, 111, 817–825.
Weissman M. , Fyer A. , Haghighi F. , et al. (2000). Potential panic disorder syndrome: Clinical and genetic linkage evidence. American Journal of Medical Genetics, 96, 24–35.
Weissman M. , Gross R. , Fyer A. , et al. (2004). Interstitial cystitis and panic disorder: a potential genetic syndrome. Archives of General Psychiatry, 61, 273–279.
Willis-Owen S. A. G. , Fullerton J. , Surtees P. G. , et al. (2005). The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biological Psychiatry, 58, 738–742.
Willour V. , Yao Shugart Y. , Samuels J. , et al. (2004). Replication study supports evidence for linkage to 9p24 in obsessive–compulsive disorder. American Journal of Human Genetics, 75, 508–513.
Yehuda R. , Halligan S. L. , & Bierer L. M. (2001). Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. Journal of Psychiatric Research, 35, 261–270.
Yehuda R. , Bell A. , Bierer L. , & Schmeidler J. (2008). Maternal, not paternal, PTSD is related to increased risk for PTSD in offspring of Holocaust survivors. Journal of Psychiatric Research, 42, 1104–1111.
You J.-S. , Hu S.-Y. , Chen B. , & Zhang H. G. (2005). Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatric Genetics, 15, 7–11.
Young B. R. , Lawford B. R. , Noble E. P. , et al. (2002). Harmful drinking in military veterans with posttraumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol & Alcoholism, 37, 451–456.

Reference Title: References

Reference Type: bibliography

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Andreatini R. , Blanchard C. , Blanchard R. , et al. (2001). The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. Brazilian Journal of Medical and Biological Research, 34, 145–154.
Arguello P. A. , & Gogos J. A. (2006). Modeling madness in mice: one piece at a time. Neuron, 52, 179–196.
Belin D. , Mar A. C. , Dalley J. W. , Robbins T. W. , & Everitt B. J. (2008). High impulsivity predicts the switch to compulsive cocaine-taking. Science, 320, 1352–1355.
Belzung C. , Misslin R. , Vogel E. , Dodd R. H. , & Chapouthier G. (1987). Anxiogenic effects of methylbeta-carboline-3-carboxylate in a light/dark choice situation. Pharmacology, Biochemistry, and Behavior, 28, 29–33.
Blanchard D. C. , Hynd A. L. , Minke K. A. , Minemoto T. , & Blanchard R. J. (2001a). Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neuroscience and Biobehavioral Reviews, 25, 761–770.
Blanchard D. C. , Griebel G. , & Blanchard R. J. (2001b). Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews, 25, 205–218.
Blier P. , Pineyro G. , el Mansari M. , Bergeron R. , & de Montigny C. (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Annals of the New York Academy of Sciences, 861, 204–216.
Bloom F. E. & Kupfer D. J. , eds. (1995). Psychopharmacology: the Fourth Generation of Progress. New York, NY: Raven Press.
Bodnoff S. R. , Suranyi-Cadotte B. , Quirion R. , & Meaney M. J. (1989). A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berlin), 97, 277–279.
Borsini F. , Podhorna J. , & Marazziti D. (2002). Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berlin), 163, 121–141.
Drevets W. C. , Thase M. E. , Moses-Kolko E. L. , et al. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology, 34, 865–877.
Drugan R. C. , Ryan S. M. , Minor T. R. , & Maier S. F. (1984). Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. Pharmacology Biochemistry and Behavior, 21, 749–754.
Dulawa S. C. , & Hen R. (2005). Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neuroscience and Biobehavioral Reviews, 29, 771–783.
Fava M. , Rush A. J. , Alpert J. E. , et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry, 165, 342–351.
File S. E. (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods, 2, 219–238.
Frazer A. , & Morilak D. A. (2005). What should animal models of depression model? Neuroscience and Biobehavioral Reviews, 29, 515–523.
Gambarana C. , Scheggi S. , Tagliamonte A. , Tolu P. , & De Montis M. G. (2001). Animal models for the study of antidepressant activity. Brain Research. Brain Research Protocols, 7, 11–20.
Gardier A. M. , Malagie I. , Trillat A. C. , Jacquot C. , & Artigas F. (1996). Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental and Clinical Pharmacology, 10, 16–27.
Gordon J. W. , Scangos G. A. , Plotkin D. J. , Barbosa J. A. , & Ruddle F. H. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA. Proceedingss of the National Academy of Sciences of the USA, 77, 7380–7384.
Gossen M. , & Bujard H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the USA, 89, 5547–5551.
Gottesman I. I. , & Gould T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–645.
Gross C. , Zhuang X. , Stark K. , et al. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature, 416, 396–400.
Haller J. , Halasz J. , & Majercsik E. (2004). Psychosocial conditions and the efficacy of clinically available anxiolytics. Current Drug Targets, 5, 655–664.
Heisler L. K. , Chu H. M. , Brennan T. J. , et al. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the USA, 95, 15049–15054.
Hickman-Davis J. M. , & Davis I. C. (2006). Transgenic mice. Paediatric Respiratory Reviews, 7, 49–53.
Jacob H. J. , & Kwitek A. E. (2002). Rat genetics: attaching physiology and pharmacology to the genome. Nature Reviews Genetics, 3, 33–42.
Kalueff A. V. , & Murphy D. L. (2007). The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plasticity, 2007, 52087.
Klemenhagen K. C. , Gordon J. A. , David D. J. , Hen R. , & Gross C. T. (2006). Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology, 31, 101–111.
Koponen E. , Voikar V. , Riekki R. , et al. (2004). Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Molecular and Cellular Neuroscience, 26, 166–181.
Lapiz-Bluhm M. D. , Bondi C. O. , Doyen J. , et al. (2008). Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. Journal of Neuroendocrinology, 20, 1115–1137.
Le Francois B. , Czesak M. , Steubl D. , & Albert P. R. (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology, 55, 977–85.
Leonardo E. D. , & Hen R. (2008). Anxiety as a developmental disorder. Neuropsychopharmacology, 33, 134–140.
Lister R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin), 92, 180–185.
Lo Iacono L. , & Gross C. (2008). Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. Journal of Neuroscience, 28, 6250–6257.
Lucki I. (1997). The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology, 8, 523–532.
Maren S. (2001). Neurobiology of Pavlovian fear conditioning. Annual Review of Neuroscience, 24, 897–931.
McKinney W. T. (1984). Animal models of depression: an overview. Psychiatric Development, 2, 77–96.
Melton D. W. (1994). Gene targeting in the mouse. Bioessays, 16, 633–638.
Millan M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
Moret C. , & Briley M. (2000). The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. European Journal of Pharmacology, 404, 1–12.
Nemeroff C. B. (2002). Comorbidity of mood and anxiety disorders: the rule, not the exception? American Journal of Psychiatry, 159, 3–4.
Nemeroff C. B. (2003). Anxiolytics: past, present, and future agents. Journal of Clinical Psychiatry, 64(Suppl. 3), 3–6.
Nesse R. M. (1999). Proximate and evolutionary studies of anxiety, stress and depression: synergy at the interface. Neuroscience and Biobehavioral Reviews, 23, 895–903.
Ohl F. , Toschi N. , Wigger A. , Henniger M. S. , & Landgraf R. (2001). Dimensions of emotionality in a rat model of innate anxiety. Behavioral Neuroscience, 115, 429–436.
Parks C. L. , Robinson P. S. , Sibille E. , Shenk T. , & Toth M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the USA, 95, 10734–10739.
Perry J. L. , & Carroll M. E. (2008). The role of impulsive behavior in drug abuse. Psychopharmacology (Berlin), 200, 1–26.
Porter R. , Bock G. , Clark S. , & Ciba Foundation (1986). Antidepressants and Receptor Function. Chichester; New York, NY: Wiley.
Ramboz S. , Oosting R. , Amara D. A. , et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the USA, 95, 14476–14481.
Ressler K. J. , & Nemeroff C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12(Suppl. 1), 2–19.
Robbins T. W. (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berlin), 163, 362–380.
Rodgers R. J. (1997). Animal models of “anxiety”: where next? Behavioural Pharmacology, 8, 477–496; discussion 497–504.
Santarelli L. , Saxe M. , Gross C. , et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805–809.
Serretti A. , Calati R. , Mandelli L. , & De Ronchi D. (2006). Serotonin transporter gene variants and behavior: a comprehensive review. Current Drug Targets, 7, 1659–1669.
Sramek J. J. , Zarotsky V. , & Cutler N. R. (2002). Generalised anxiety disorder: treatment options. Drugs, 62, 1635–1648.
Stark K. L. , Gross C. , Richardson-Jones J. , Zhuang X. , & Hen R. (2007). A novel conditional knockout strategy applied to serotonin receptors. Handbook of Experimental Pharmacology, 178, 347–363.
van der Staay F. J. (2006). Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Research Reviews, 52, 131–159.
Weiss J. M. , Goodman P. A. , Losito B. G. , et al. (1981). Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Research Reviews, 3, 167–205.
Willner P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin), 134, 319–329.
Willner P. , & Mitchell P. J. (2002). The validity of animal models of predisposition to depression. Behavioural Pharmacology, 13, 169–188.
Zohar J. , Kennedy J. L. , Hollander E. , & Koran L. M. (2004). Serotonin-1D hypothesis of obsessive–compulsive disorder: an update. Journal of Clinical Psychiatry, 65(Suppl. 14), 18–21.

Reference Title: References

Reference Type: bibliography

Amargos-Bosch M. , Bortolozzi A. , Puig M. V. , et al. (2004). Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex, 14, 281–299.
Amargos-Bosch M. , Artigas F. , & Adell A. (2005). Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. European Journal of Pharmacology, 516, 235–238.
Amat J. , Baratta M. V. , Paul E. , et al. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience, 8, 365–371.
Amat J. , Paul E. , Zarza C. , Watkins L. R. , & Maier S. F. (2006). Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. Journal of Neuroscience, 26, 13264–13272.
Amat J. , Paul E. , Watkins L. R. , & Maier S. F. (2008). Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience, 154, 1178–1186.
Ansorge M. S. , Zhou M. , Lira A. , Hen R. , & Gingrich J. A. (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science, 306, 879–881.
Ansorge M. S. , Hen R. , & Gingrich J. A. (2007). Neurodevelopmental origins of depressive disorders. Current Opinion in Pharmacology, 7, 8–17.
Araneda R. , & Andrade R. (1991). 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience, 40, 399–412.
Arango V. , Underwood M. D. , & Mann J. J. (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences, 836, 269–287.
Arce E. , Simmons A. N. , Lovero K. L. , Stein M. B. , & Paulus M. P. (2008). Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berlin), 196, 661–672.
Azmitia E. C. , Gannon P. J. , Kheck N. M. , & Whitaker-Azmitia P. M. (1996). Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology, 14, 35–46.
Baratta M. V. , Christianson J. P. , Gomez D. M. , et al. (2007). Controllable versus uncontrollable stressors bi-directionally modulate conditioned but not innate fear. Neuroscience, 146, 1495–1503.
Beique J. C. , Imad M. , Mladenovic L. , Gingrich J. A. , & Andrade R. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proceedingss of the National Academy of Sciences of the USA, 104, 9870–9875.
Bennett A. J. , Lesch K. P. , Heils A. , et al. (2002). Early experience and serotonin transporter gene variation interact to influence primate CNS function. Molecular Psychiatry, 7, 118–122.
Bevilaqua L. R. , Bonini J. S. , Rossato J. I. , et al. (2006). The entorhinal cortex plays a role in extinction. Neurobiology of Learning and Memory, 85, 192–197.
Bhagwagar Z. , Hinz R. , Taylor M. , et al. (2006). Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907. American Journal of Psychiatry, 163, 1580–1587.
Bishop S. , Duncan J. , Brett M. , & Lawrence A. D. (2004). Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nature Neuroscience, 7, 184–188.
Bortolozzi A. , Amargos-Bosch M. , et al. (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. European Journal of Neuroscience, 18, 1235–1246.
Bortolozzi A. , Diaz-Mataix L. , Scorza M. C. , Celada P. , & Artigas F. (2005). The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry, 95, 1597–1607.
Bruening S. , Oh E. , Hetzenauer A. , et al. (2006). The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system. Journal of Neurochemistry, 99, 892–899.
Burgos-Robles A. , Vidal-Gonzalez I. , Santini E. , & Quirk G. J. (2007). Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron, 53, 871–880.
Cai X. , Gu Z. , Zhong P. , Ren Y. , & Yan Z. (2002). Serotonin 5-HT1A receptors regulate AMPA receptor channels through inhibiting Ca2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. Journal of Biological Chemistry, 277, 36553–36562.
Cameron O. G. , Huang G. C. , Nichols T. , et al. (2007) Reduced gamma-aminobutyric acidA-benzodiazepine binding sites in insular cortex of individuals with panic disorder. Archives of General Psychiatry, 64, 793–800.
Carroll J. C. , Boyce-Rustay J. M. , Millstein R. , et al. (2007). Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behavior Genetics, 37, 214–222.
Caspi A. , Sugden K ,. Moffitt T. E. , et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389.
Celada P. , Puig M. V. , Casanovas J. M. , Guillazo G. , & Artigas F. (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA, and glutamate receptors. Journal of Neuroscience, 21, 9917–9929.
Celada P. , Puig M. , Amargos-Bosch M. , Adell A. , & Artigas F. (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry and Neuroscience, 29, 252–265.
Celada P. , Puig M. V. , Diaz-Mataix L. , & Artigas F. (2008). The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biological Psychiatry, 64, 392–400.
Champoux M. , Bennett A. , Shannon C. , et al. (2002). Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Molecular Psychiatry, 7, 1058–1063.
Cheng L. L. , Wang S. J. , & Gean P. W. (1998). Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. European Journal of Neuroscience, 10, 2163–2172.
Corcoran K. A. , & Quirk G. J. (2007). Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. Journal of Neuroscience, 27, 840–844.
Cornea-Hebert V. , Riad M. , Wu C. , Singh S. K. , & Descarries L. (1999). Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. Journal of Computational Neurology, 409, 187–209.
Crayton J. W. , Joshi I. , Gulati A. , Arora R. C. , & Wolf W. A. (1996). Effect of corticosterone on serotonin and catecholamine receptors and uptake sites in rat frontal cortex. Brain Research, 728, 260–262.
Critchley H. D. , Wiens S. , Rotshtein P. , Ohman A. , & Dolan R. J. (2004). Neural systems supporting interoceptive awareness. Nature Neuroscience, 7, 189–195.
Davis M. (2004). Functional neuroanatomy of anxiety and fear. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Davis M. (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. American Psychologist, 61, 741–756.
Egner T. (2008). Multiple conflict-driven control mechanisms in the human brain. Trends in Cognitive Science, 12, 374–380.
Etkin A. , Egner T. , Peraza D. M. , Kandel E. R. , & Hirsch J. (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron, 51, 871–882.
Forster G. L. , Feng N. , Watt M. J. , et al. (2006). Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience, 141, 1047–1055.
Fox M. A. , Andrews A. M. , Wendland J. R. , et al. (2007). A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berlin), 195, 147–166.
Frokjaer V. G. , Mortensen E. L. , Nielsen F. Å. , et al. (2008). Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry, 63, 569–576.
Fuchs E. , & Flugge G. (2004). Animal models of anxiety disorders. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Gilmartin M. R. , & McEchron M. D. (2005). Single neurons in the medial prefrontal cortex of the rat exhibit tonic and phasic coding during trace fear conditioning. Behavioral Neuroscience, 119, 1496–1510.
Golimbet V. E. , Alfimova M. V. , & Mitiushina N. G. (2004) [Polymorphism of the serotonin 2A receptor gene (5HTR2A) and personality traits]. Molecular Biology (Mosk), 38, 404–412.
Grahn R. E. , Will M. J. , Hammack S. E. , et al. (1999). Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Research, 826, 35–43.
Griebel G. , Perrault G. , & Sanger D. J. (1997). A comparative study of the effects of selective and nonselective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology, 36, 793–802.
Gross C. , Santarelli L. , Brunner D. , Zhuang X. , & Hen R. (2000). Altered fear circuits in 5-HT1A receptor KO mice. Biological Psychiatry, 48, 1157–1163.
Hariri A. R. , Mattay V. S. , Tessitore A. , et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297, 400–403.
Hariri A. R. , Mattay V. S. , Tessitore A. , Fera F. , & Weinberger D. R. (2003). Neocortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry, 53, 494–501.
Higley J. D. , Suomi S. J. , & Linnoila M. (1991). CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berlin), 103, 551–556.
Holmes A. (2008). Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neuroscience and Biobehavioral Reviews, 32, 1293–1314.
Holmes A. , Yang R. J. , Murphy D. L. , & Crawley J. N. (2002). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology, 27, 914–923.
Holmes A. , Lit Q. , Murphy D. L. , Gold E. , & Crawley J. N. (2003a). Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes, Brain, and Behavior, 2, 365–380.
Holmes A. , Murphy D. L. , & Crawley J. N. (2003b). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry, 54, 953–959.
Hoyer D. , & Martin G. R. (1996). Classification and nomenclature of 5-HT receptors: a comment on current issues. Behavioural Brain Research, 73, 263–268.
Hoyer D. , Clarke D. E. , Fozard J. R. , et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews, 46, 157–203.
Humphrey P. P. , Hartig P. , & Hoyer D. (1993). A proposed new nomenclature for 5-HT receptors. Trends in Pharmacological Sciences, 14, 233–236.
Jacobs B. L. , & Azmitia E. C. (1992). Structure and function of the brain serotonin system. Physiological Reviews, 72, 165–229.
Jakab R. L. , & Goldman-Rakic P. S. (1998). 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proceedings of the National Academy of Sciences of the USA, 95, 735–740.
Kalueff A. V. , Fox M. A. , Gallagher P. S. , & Murphy D. L. (2007). Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior, 6, 389–400.
Klemenhagen K. C. , Gordon J. A. , David D. J. , Hen R. , & Gross C. T. (2006). Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology, 31, 101–111.
Koyama S. , Kubo C. , Rhee J. S. , & Akaike N. (1999). Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. Journal of Physiology, 518, 525–538.
Koyama S. , Matsumoto N. , Murakami N. , et al. (2002). Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sciences, 72, 375–387.
Krysiak R. , Obuchowicz E. , & Herman Z. S. (2000) Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides, 34, 148–157.
Lambe E. K. , & Aghajanian G. K. (2006). Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology, 31, 1682–1689.
Laviolette S. R. , Lipski W. J. , & Grace A. A. (2005). A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. Journal of Neuroscience, 25, 6066–6075.
Lesch K. P. , Zeng Y. , Reif A. , & Gutknecht L. (2003). Anxiety-related traits in mice with modified genes of the serotonergic pathway. European Journal of Pharmacology, 480, 185–204.
Li X. , Inoue T. , Abekawa T. , Weng S. , et al. (2006). 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. European Journal of Pharmacology, 532, 74–80.
Lira A ,. Zhou M. , Castanon N. , et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry, 54, 960–971.
Maier S. F. , & Watkins L. R. (2005). Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews, 29, 829–841.
Marek G. J. , & Aghajanian G. K. (1998). 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience, 86, 485–497.
Marek G. J. , & Aghajanian G. K. (1999). 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. European Journal of Pharmacology, 367, 197–206.
Marek G. J. , Wright R. A. , Gewirtz J. C. , & Schoepp D. D. (2001). A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience, 105, 379–392.
Marschner A. , Kalisch R. , Vervliet B. , Vansteenwegen D. , & Buchel C. (2008). Dissociable roles for the hippocampus and the amygdala in human cued versus context fear conditioning. Journal of Neuroscience, 28, 9030–9036.
Martin-Ruiz R. , Puig M. V. , Celada P. , et al. (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience, 21, 9856–9866.
Mathew S. J. , Price R. B. , & Charney D. S. (2008). Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. American Journal of Medical Genetics C: Seminars in Medical Genetics, 148C, 89–98.
Meyer J. H. , McMain S. , Kennedy S. H. , et al. (2003). Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. American Journal of Psychiatry, 160, 90–99.
Milad M. R. , Wright C. I. , Orr S. P. , et al. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 62, 446–454.
Millan M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83–244.
Miller E. K. , & Cohen J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202.
Miner L. A. , Backstrom J. R. , Sanders-Bush E. , & Sesack S. R. (2003). Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience, 116, 107–117.
Monk C. S. , Telzer E. H. , Mogg K. , et al. (2008). Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Archives of General Psychiatry, 65, 568–576.
Murphy D. L. , Li Q. , Engel S. , et al. (2001). Genetic perspectives on the serotonin transporter. Brain Research Bulletin, 56, 487–494.
Nash J. R. , Sargent P. A. , Rabiner E. A. , et al. (2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. British Journal of Psychiatry, 193, 229–234.
Nitschke J. B. , Sarinopoulos I. , Mackiewicz K. L. , Schaefer H. S. , & Davidson R. J. (2006). Functional neuroanatomy of aversion and its anticipation. Neuroimage, 29, 106–116.
Norton N. , & Owen M. J. (2005). HTR2A: association and expression studies in neuropsychiatric genetics. Annals of Medicine, 37, 121–129.
Papez J. W. (1995). A proposed mechanism of emotion. 1937. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 103–112.
Parks C. L. , Robinson P. S. , Sibille E. , Shenk T. , & Toth M. (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the USA, 95, 10734–10739.
Paulus M. P. , & Stein M. B. (2006). An insular view of anxiety. Biological Psychiatry, 60, 383–387.
Pehek E. A. , McFarlane H. G. , Maguschak K. , Price B. , & Pluto C. P. (2001). M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Research, 888, 51–59.
Pezawas L. , Meyer-Lindenberg A. , Drabant E. M. , et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828–834.
Phelps E. A. , Delgado M. R. , Nearing K. I. , & LeDoux J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron, 43, 897–905.
Pompeiano M. , Palacios J. M. , & Mengod G. (1992). Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. Journal of Neuroscience, 12, 440–453.
Puig M. V. , Celada P. , Diaz-Mataix L. , & Artigas F. (2003). In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex, 13, 870–882.
Quirk G. J. , & Mueller D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology, 33, 56–72.
Quirk G. J. , Russo G. K. , Barron J. L. , & Lebron K. (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. Journal of Neuroscience, 20, 6225–6231.
Quirk G. J. , Likhtik E. , Pelletier J. G. , & Pare D. (2003). Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. Journal of Neuroscience, 23, 8800–8807.
Ramboz S. , Oosting R. , Amara D. A. , et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the USA, 95, 14476–14481.
Rauch S. L. , Shin L. M. , & Phelps E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research: past, present, and future. Biological Psychiatry, 60, 376–382.
Remijnse P. L. , Nielen M. M. , van Balkom A. J. , et al. (2006). Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive–compulsive disorder. Archives of General Psychiatry, 63, 1225–1236.
Ressler K. J. , & Mayberg H. S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience, 10, 1116–1124.
Risch N. , Herrell R. , Lehner T. , et al. (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA, 301, 2462–2471.
Rosenkranz J. A. , & Grace A. A. (2002). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. Journal of Neuroscience, 22, 324–337.
Santana N. , Bortolozzi A. , Serrats J. , Mengod G. , & Artigas F. (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex, 14, 1100–1109.
Sarinopoulos I. , Dixon G. E. , Short S. J. , Davidson R. J. , & Nitschke J. B. (2006). Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain, Behavior, and Immunity, 20, 120–132.
Serretti A. , Drago A. , & De Ronchi D. (2007). HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Current Medicinal Chemistry, 14, 2053–2069.
Stein C. , Davidowa H. , & Albrecht D. (2000). 5-HT1A receptor-mediated inhibition and 5-HT2 as well as 5-HT3 receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse, 38, 328–337.
Stein M. & Bienvenu J. (2004). Diagnostic classification of anxiety disorders: DSM-5 and beyond. In D. S. Charney & E. J. Nestler , eds., Neurobiology of Mental Illness. Oxford: Oxford University Press.
Tipples J. , & Sharma D. (2000). Orienting to exogenous cues and attentional bias to affective pictures reflect separate processes. British Journal of Psychology, 91, 87–97.
Tochigi M. , Umekage T. , Kato C. , et al. (2005). Serotonin 2A receptor gene polymorphism and personality traits: no evidence for significant association. Psychiatric Genetics, 15, 67–69.
Tork I. (1990), Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 600, 9–34.
Torres G. E. , & Amara S. G. (2007). Glutamate and monoamine transporters: new visions of form and function. Current Opinion in Neurobiology, 17, 304–312.
Tsetsenis T. , Ma X. H. , Lo Iacono L. , Beck S. G. , & Gross C. (2007). Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus. Nature Neuroscience, 10, 896–902.
Unschuld P. G. , Ising M. , Erhardt A. , et al. (2007). Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 424–429.
Vollenweider F. X. , Vontobel P. , Hell D. , & Leenders K. L. (1999). 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man: a PET study with 11 Craclopride. Neuropsychopharmacology, 20, 424–433.
Vuilleumier P. (2005). How brains beware: neural mechanisms of emotional attention. Trends in Cognitive Science, 9, 585–594.
Weisstaub N. V. , Zhou M. , Lira A. , et al. (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science, 313, 536–540.
Wright C. I. , Martis B. , McMullin K. , Shin L. M. , & Rauch S. L. (2003). Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biological Psychiatry, 54, 1067–1076.
Zhao S. , Edwards J. , Carroll J. , Wiedholz L. , et al. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience, 140, 321–334.

Reference Title: References

Reference Type: bibliography

Adhikari A. , Topiwala M.A. , Gordon J.A. (2010). Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron, 65, 257–269.
Aguilar R. , Gil L. , Flint J. , et al. (2002). Learned fear, emotional reactivity and fear of heights: a factor analytic map from a large F2 intercross of Roman rat strains. Brain Research Bulletin, 57, 17–26.
Alheid G. F. , de Olmos J. S. , & Beltramino C. A. (1995). Amygdala and extended amygdala. In G. Paxinos , ed., The Rat Nervous System. New York, NY: Academic Press.
Bagdy G. , Graf M. , Anheuer Z. E. , Modos E. A. , & Kantor S. (2001). Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. International Journal of Neuropsychopharmacology, 4, 399–408.
Bannerman D. M. , Rawlins J. N. , McHugh S. B. , et al. (2004). Regional dissociations within the hippocampus: memory and anxiety. Neuroscience and Biobehavioral Review, 28, 273–283.
Belzung C. , & Griebel G. (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behavioral Brain Research, 125, 141–149.
Berkowitz R. L. , Coplan J. D. , Reddy D. P. , & Gorman J. M. (2007). The human dimension: how the prefrontal cortex modulates the subcortical fear response. Reviews in the Neurosciences, 18, 191–207.
Bourin M. , & Hascoet M. (2003). The mouse light/dark box test. European Journal of Pharmacology, 463, 55–65.
Britton D. R. , & Britton K. T. (1981). A sensitive open field measure of anxiolytic drug activity. Pharmacology, Biochemistry, and Behavior, 15, 577–582.
Burgos-Robles A. , Vidal-Gonzalez I. , Santini E. , & Quirk G. J. (2007). Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron, 53, 871–880.
Burwell R. D. , & Witter M. P. (2002). Basic anatomy of the parahippocampal region in monkeys and rats. In M. P. Witter & F. G. Wouterlood , eds., The Parahippocampal Region: Organization and Role in Cognitive Function. Oxford: Oxford University Press.
Burwell R. D. , Witter M. P. , & Amaral D. G. (1995). Perirhinal and postrhinal cortices of the rat: a review of the neuroanatomical literature and comparison with findings from the monkey brain. Hippocampus, 5, 390–408.
Campeau S. , & Davis M. (1995). Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. Journal of Neuroscience, 15, 2301–2311.
Crawley J. N. (1985). Exploratory behavior models of anxiety in mice. Neuroscience and Biobehavioral Reviews, 9, 37–44.
Cruz A. P. , Frei F. , & Graeff F. G. (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology, Biochemistry, and Behavior, 49, 171–176.
Davis M. (1992). The role of the amygdala in fear and anxiety. Annual Review of Neuroscience, 15, 353–375.
Davis M. (1997). Neurobiology of fear responses: the role of the amygdala. Journal of Neuropsychiatry and Clinical Neuroscience, 9, 382–402.
de Angelis L. , & File S. E. (1979). Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology (Berlin), 64, 127–129.
Dekeyne A. , Brocco M. , Adhumeau A. , Gobert A. , & Millan M. J. (2000). The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats: a comparison with other anxiolytic agents. Psychopharmacology (Berlin), 152, 55–66.
Drapier D. , Bentue-Ferrer D. , Laviolle B. , et al. (2007). Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behavioral Brain Research, 176, 202–209.
Dulawa S. C. , Holick K. A. , Gundersen B. , & Hen R. (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology, 29, 1321–1330.
Durand M. , Berton O. , Aguerre S. , et al. (1999). Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology, 38, 893–907.
Etkin A. , & Wager T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Falls W. A. , Miserendino M. J. , & Davis M. (1992). Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. Journal of Neuroscience, 12, 854–863.
Fanselow M. S. , & Kim J. J. (1994). Acquisition of contextual pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behavioral Neuroscience, 108(1), 210–212.
File S. E. , & Hyde J. R. (1979). A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacology, Biochemistry, and Behavior, 11, 65–69.
File S. E. , & Seth P. (2003). A review of 25 years of the social interaction test. European Journal of Pharmacology, 463, 35–53.
Garakani A. , Mathew S. J. , & Charney D. S. (2006). Neurobiology of anxiety disorders and implications for treatment. Mount Sinai Journal of Medicine, 73, 941–949.
Gewirtz J. C. , & Davis M. (1998). Application of Pavlovian higher-order conditioning to the analysis of the neural substrates of fear conditioning. Neuropharmacology, 37, 453–459.
Gonzalez L. E. , Rujano M. , Tucci S. , et al. (2000). Medial prefrontal transection enhances social interaction. I: Behavioral studies. Brain Research, 887, 7–15.
Gordon J. A. , & Hen R. (2004). The serotonergic system and anxiety. Neuromolecular Medicine, 5, 27–40.
Gorman J. M. , Kent J. M. , & Coplan J. D. (2002). Current and emerging therapeutics of anxiety and stress disorders. In K. L. Davis , D. S. Charney , J. T. Coyle , & C. Nemeroff , eds., Neuropsychopharmacology: the Fifth Generation of Progress. Philadelphia, PA: Lippincott Williams & Wilkins.
Green S. , & Vale A. L. (1992). Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behavioral Pharmacology, 3, 261–264.
Griebel G. , Moreau J. L. , Jenck F. , Misslin R. , & Martin J. R. (1994). Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berlin), 113, 463–470.
Griebel G. , Blanchard D. C. , & Blanchard R. J. (1996). Evidence that the behaviors in the mouse defense test battery relate to different emotional states: a factor analytic study. Physiology and Behavior, 60, 1255–1260.
Griebel G. , Cohen C. , Perrault G. , & Sanger D. J. (1999). Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiology and Behavior, 67, 315–320.
Grillon C. , Levenson J. , & Pine D. S. (2007). A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology, 32, 225–231.
Guastella A. J. , Dadds M. R. , Lovibond P. F. , Mitchell P. , & Richardson R. (2007). A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research, 41, 466–471.
Guastella A. J. , Richardson R. , Lovibond P. F. , et al. (2008). A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biological Psychiatry, 63, 544–549.
Hitchcock J. M. , & Davis M. (1991). Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behavioral Neuroscience, 105, 826–842.
Hofmann S. G. , Meuret A. E. , Smits J. A. , et al. (2006). Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298–304.
Hoover W. B. , & Vertes R. P. (2007). Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Structure and Function, 212, 149–179.
Kantor S. , Graf M. , Anheuer Z. E. , & Bagdy G. (2001). Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment. European Neuropsychopharmacology, 11, 15–24.
Kjelstrup K. G. , Tuvnes F. A. , Steffenach H. A. , et al. (2002). Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Sciences of the USA, 99, 10825–10830.
Kondo Y. , & Sakuma Y. (2005). The medial amygdala controls the coital access of female rats: a possible involvement of emotional responsiveness. Japanese Journal of Physiology, 55, 345–353.
Kurt M. , Arik A. C. , & Celik S. (2000). The effects of sertraline and fluoxetine on anxiety in the elevated plusmaze test in mice. Journal of Basic Clinical Physiology and Pharmacology, 11, 173–180.
Kushner M. G. , Kim S. W. , Donahue C. , et al. (2007). D-cycloserine augmented exposure therapy for obsessive–compulsive disorder. Biological Psychiatry, 62, 835–838.
Lacroix L. , Spinelli S. , Heidbreder C. A. , & Feldon J. (2000). Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behavioral Neuroscience, 114, 1119–1130.
LeDoux J. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155–184.
LeDoux J. (2003). The emotional brain, fear, and the amygdala. Cellular and Molecular Neurobiology, 23, 727–738.
McNamara R. K. , & Skeleton R. W. (1993). Effects of intracranial infusions of chlordiazepoxide on spatial learning in the Morris water maze. I. Neuroanatomical specificity. Behavioral Brain Research, 59, 175–191.
Miserendino M. J. , Sananes C. B. , Melia K. R. , & Davis M. (1990). Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature, 345, 716–718.
Moller C. , Wiklund L. , Sommer W. , Thorsell A. , & Heilig M. (1997). Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Research, 760, 94–101.
Montgomery K. C. (1955). The relation between fear induced by novel stimulation and exploratory behavior. Journal of Computational Physiology and Psychology, 48, 254–260.
Norberg M. M. , Krystal J. H. , & Tolin D. F. (2008). A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118–1126.
Pellow S. , & File S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plusmaze: a novel test of anxiety in the rat. Pharmacology, Biochemistry and Behavior, 24, 525–529.
Pellow S. , Chopin P. , File S. E. , & Briley M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149–167.
Pesold C. , & Treit D. (1995). The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Research, 671, 213–221.
Prut L. , & Belzung C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology, 463, 3–33.
Quirk G. J. , & Beer J. S. (2006). Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Current Opinion in Neurobiology, 16, 723–727.
Quirk G. J. , & Mueller D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology, 33, 56–72.
Ramos A. , Berton O. , Mormede P. , & Chaouloff F. (1997). A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioural Brain Research, 85, 57–69.
Rauch S. L. , Shin L. M. , & Phelps E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research: past, present, and future. Biological Psychiatry, 60, 376–382.
Ressler K. J. , Rothbaum B. O. , Tannenbaum L. , et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives General Psychiatry, 61, 1136–1144.
Rodgers R. J. (1997). Animal models of “anxiety”: where next? Behavioral Pharmacology, 8, 477–496; discussion 497–504.
Roffman J. L. , Marci C. D. , Glick D. M. , Dougherty D. D. , & Rauch S. L. (2005). Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine, 35, 1385–1398.
Sanders S. K. , & Shekhar A. (1995). Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biological Psychiatry, 37, 473–476.
Schienle A. , Schafer A. , Walter B. , Stark R. , & Vaitl D. (2005). Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neuroscience Letters, 388, 1–6.
Schmitt U. , & Hiemke C. (1998). Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior. Progress in Neuropsychopharmacology and Biological Psychiatry, 22, 1197–1215.
Seidenbecher T. , Laxmi T. R. , Stork O. , & Pape H. C. (2003). Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval. Science, 301, 846–850.
Shah A. A. , & Treit D. (2003). Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests. Brain Research, 969, 183–194.
Siemiatkowski M. , Sienkiewicz-Jarosz H. , Czlonkowska A. I. , Bidzinski A. , & Plaznik A. (2000). Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H] muscimol binding after buspirone pretreatment. Pharmacology, Biochemistry and Behavior, 66, 645–651.
Silva R. C. , & Brandao M. L. (2000). Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacology, Biochemistry and Behavior, 65, 209–216.
Storch E. A. , Merlo L. J. , Bengtson M. , et al. (2007). D-cycloserine does not enhance exposure-response prevention therapy in obsessive–compulsive disorder. International Clinical Psychopharmacology, 22, 230–237.
Straube T. , Mentzel H. J. , & Miltner W. H. (2007). Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage, 37, 1427–1436.
To C. T. , & Bagdy G. (1999). Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. Neuropharmacology, 38, 279–282.
Treit D. , Aujla H. , & Menard J. (1998). Does the bed nucleus of the stria terminalis mediate fear behaviors? Behavioral Neuroscience, 112, 379–386.
Veening J. G. , Swanson L. W. , & Sawchenko P. E. (1984). The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Research, 303, 337–357.
Vertes R. P. (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse, 51, 32–58.
Walker D. L. , & Davis M. (1997a). Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biological Psychiatry, 42, 461–471.
Walker D. L. , & Davis M. (1997b). Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. Journal of Neuroscience, 17, 9375–9383.
Walker D. L. , & Davis M. (2002). The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacology, Biochemistry and Behavior, 71, 379–392.
Walker D. L. , Ressler K. J. , Lu K. T. , & Davis M. (2002). Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience, 22, 2343–2351.
Whishaw I. Q. , Gharbawie O. A. , Clark B. J. , & Lehmann H. (2006). The exploratory behavior of rats in an open environment optimizes security. Behavioral Brain Research, 171, 230–239.
Wilhelm S. , Buhlmann U. , Tolin D. F. , et al. (2008). Augmentation of behavior therapy with d-cycloserine for obsessive–compulsive disorder. American Journal of Psychiatry, 165, 335–341; quiz 409.
Zangrossi Junior H. , & Graeff F. G. (1994). Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze. Brazilian Journal of Medical and Biological Research, 27, 2453–2456.

Reference Title: References

Reference Type: bibliography

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Bandler R. , & Shipley M. T. (1994). Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends in Neuroscience, 17, 379–389.
Baxter L. R. , Schwartz J. M. , Bergman K. S. , et al. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive–compulsive disorder. Archives of General Psychiatry, 49, 681–689.
Behbehani M. M. (1995). Functional characteristics of the midbrain periaqueductal gray. Progress in Neurobiology, 46, 575–605.
Bishop S. J. , Duncan J. , & Lawrence A. D. (2004). State anxiety modulation of the amygdala response to unattended threat-related stimuli. Journal of Neuroscience, 24, 10364–10368.
Botvinick M. , Nystrom L. E. , Fissell K. , Carter C. S. , & Cohen J. D. (1999). Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature, 402, 179–181.
Bryant R. A. , Kemp A. H. , Felmingham K. L. , et al. (2008a). Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: an fMRI study. Human Brain Mapping, 29, 517–523.
Bryant R. A. , Felmingham K. , Kemp A. , et al. (2008b). Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychology and Medicine, 38, 555–561.
Buchel C. , & Dolan R. J. (2000). Classical fear conditioning in functional neuroimaging. Current Opinions in Neurobiology, 10, 219–223.
Buckner R. L. , & Carroll D. C. (2007). Self-projection and the brain. Trends in Cognitive Sciences, 11, 49–57.
Corcoran K. A. , Desmond T. J. , Frey K. A. , & Maren S. (2005). Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. Journal of Neuroscience, 25, 8978–8987.
Courtney S. M. , Ungerleider L. G. , Keil K. , & Haxby J. V. (1997). Transient and sustained activity in a distributed neural system for human working memory. Nature, 386, 608–611.
Critchley H. D. , Wiens S. , Rotshtein P. , Ohman A. , & Dolan R. J. (2004). Neural systems supporting interoceptive awareness. Nature Neuroscience, 7, 189–195.
Delgado M. R. , Nearing K. I. , Ledoux J. E. , & Phelps E. A. (2008). Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron, 59, 829–838.
D'Esposito M. , Postle B. R. , & Rypma B. (2000). Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Experimental Brain Research, 133, 3–11.
Egner T. , & Hirsch J. (2005a). Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information. Nature Neuroscience, 8, 1784–1790.
Egner T. , & Hirsch J. (2005b). The neural correlates and functional integration of cognitive control in a Stroop task. Neuroimage, 24, 539–547.
Egner T. , Etkin A. , Gale S. , & Hirsch J. (2008). Dissociable neural systems resolve conflict from emotional versus nonemotional distracters. Cerebral Cortex, 18, 1475–1484.
Eisenberg M. , Kobilo T. , Berman D. E. , & Dudai Y. (2003). Stability of retrieved memory: inverse correlation with trace dominance. Science, 301, 1102–1104.
Etkin A. , & Wager T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Etkin A. , Klemenhagen K. C. , Dudman J. T. , et al. (2004). Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron, 44, 1043–1055.
Etkin A. , Pittenger C. , Polan H. J. , & Kandel E. R. (2005). Toward a neurobiology of psychotherapy: basic science and clinical applications. Journal of Neuropsychiatry and Clinical Neuroscience, 17, 145–158.
Etkin A. , Egner T. , Peraza D. M. , Kandel E. R. , & Hirsch J. (2006). Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron, 51, 871–882.
Furmark T. , Tillfors M. , Marteinsdottir I. , et al. (2002). Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive–behavioral therapy. Archives of General Psychiatry, 59, 425–433.
Gabbott P. L. , Warner T. A. , Jays P. R. , Salway P. , & Busby S. J. (2005). Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. Journal of Computational Neurology, 492, 145–177.
Gratton G. , Coles M. G. , & Donchin E. (1992). Optimizing the use of information: strategic control of activation of responses. Journal of Experimental Psychology: General, 121, 480–506.
Gross J. J. (1998). The emerging field of emotion regulation: an integrative review. Review of General Psychology, 2, 271–299.
Gusnard D. A. , & Raichle M. E. (2001). Searching for a baseline: functional imaging and the resting human brain. Nature Reviews Neuroscience, 2, 685–694.
Kalisch R. , Korenfeld E. , Stephan K. E. , et al. (2006). Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. Journal of Neuroscience, 26, 9503–9511.
Karl A. , Schaefer M. , Malta L. S. , et al. (2006). A meta-analysis of structural brain abnormalities in PTSD. Neuroscience and Biobehavioral Review, 30, 1004–1031.
Kasai K. , Yamasue H. , Gilbertson M. W. , et al. (2008). Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biological Psychiatry, 63, 550–556.
Kerns J. G. , Cohen J. D. , MacDonald A. W. , et al. (2004). Anterior cingulate conflict monitoring and adjustments in control. Science, 303, 1023–1026.
Kim J. J. , Rison R. A. , & Fanselow M. S. (1993). Effects of amygdala, hippocampus, and periaqueductal gray lesions on short-and long-term contextual fear. Behavioral Neuroscience, 107, 1093–1098.
Kober H. , Barrett L. F. , Joseph J. , et al. (2008). Functional grouping and cortical-subcortical interactions in emotion: A meta-analysis of neuroimaging studies. Neuroimage, 42, 998–1031.
Kringelbach M. L. , & Rolls E. T. (2004). The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress in Neurobiology, 72, 341–372.
LaBar K. S. , Gatenby J. C. , Gore J. C. , LeDoux J. E. , & Phelps E. A. (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron, 20, 937–945.
Lanius R. A. , Williamson P. C. , Hopper J. , et al. (2003). Recall of emotional states in posttraumatic stress disorder: an fMRI investigation. Biological Psychiatry, 53, 204–210.
Maren S. , Aharonov G. , & Fanselow M. S. (1997). Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behavioral Brain Research, 88, 261–274.
Milad M. R. , & Quirk G. J. (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature, 420, 70–74.
Milad M. R. , Vidal-Gonzalez I. , & Quirk G. J. (2004). Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behavioral Neuroscience, 118, 389–394.
Milad M. R. , Wright C. I. , Orr S. P. , et al. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 62, 446–454.
Nee D. E. , Wager T. D. , & Jonides J. (2007). Interference resolution: Insights from a meta-analysis of neuroimaging tasks. Cognitive, Affective, and Behavioral Neuroscience, 7, 1–17.
Northoff G. , Heinzel A. , de Greck M. , et al. (2006). Self-referential processing in our brain: a meta-analysis of imaging studies on the self. Neuroimage, 31, 440–457.
Ochsner K. N. , & Gross J. J. (2005). The cognitive control of emotion. Trends in Cognitive Sciences, 9, 242–249.
Ochsner K. N. , & Gross J. J. (2008). Cognitive emotion regulation: Insights from social cognitive and affective neuroscience. Current Directions in Psychological Science, 17, 153–158.
Paxinos G. (2003). The Human Nervous System, 2nd edn. San Diego, CA: Academic Press.
Phan K. L. , Wager T. , Taylor S. F. , & Liberzon I. (2002). Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage, 16, 331–348.
Phan K. L. , Britton J. C. , Taylor S. F. , Fig L. M. , & Liberzon I. (2006). Corticolimbic blood flow during nontraumatic emotional processing in posttraumatic stress disorder. Archives of General Psychiatry, 63, 184–192.
Phelps E. A. , Delgado M. R. , Nearing K. I. , & LeDoux J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron, 43, 897–905.
Quirk G. J. , Russo G. K. , Barron J. L. , & Lebron K. (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. Journal of Neuroscience, 20, 62256231.
Raichle M. E. , MacLeod A. M. , Snyder A. Z. , et al. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences of the USA, 98, 676–682.
Rauch S. L. , Whalen P. J. , Shin L. M. , et al. (2000). Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biological Psychiatry, 47, 769–776.
Schienle A. , Schafer A. , Hermann A. , Rohrmann S. , & Vaitl D. (2007). Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. European Archives of Psychiatry and Clinical Neuroscience, 257, 486–493.
Shin L. M. , Whalen P. J. , Pitman R. K. , et al. (2001). An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biological Psychiatry, 50, 932–942.
Shin L. M. , Wright C. I. , Cannistraro P. A. , et al. (2005). A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Archives of General Psychiatry, 62, 273–281.
Simmons A. , Stein M. B. , Matthews S. C. , Feinstein J. S. , & Paulus M. P. (2006). Affective ambiguity for a group recruits ventromedial prefrontal cortex. Neuroimage, 29, 655–661.
Straube T. , Glauer M. , Dilger S. , Mentzel H. J. , & Miltner W. H. (2006). Effects of cognitive–behavioral therapy on brain activation in specific phobia. Neuroimage, 29, 125–135.
Tillfors M. , Furmark T. , Marteinsdottir I. , et al. (2001). Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. American Journal of Psychiatry, 158, 1220–1226.
Vertes R. P. (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse, 51, 32–58.
Wager T. D. , & Smith E. E. (2003). Neuroimaging studies of working memory: a metaanalysis. Cognitive, Affective, and Behavioral Neuroscience, 3, 255–274.
Wager T. D. , Barrett L. F. , Bliss-Moreau E. , et al. (2008a). The neuroimaging of emotion. In M. Lewis , J. M. Haviland-Jones , & L. F. Barrett , eds., Handbook of Emotions, 3rd edn. New York, NY: Guilford Press.
Wager T. D. , Hughes B. , Davidson M. , Lindquist M. L. , & Ochsner K. N. (2008b). Prefrontal–subcortical pathways mediating successful emotion regulation. Neuron, 59, 1037–1050.
Whalen P. J. , Kagan J. , Cook R. G. , et al. (2004). Human amygdala responsivity to masked fearful eye whites. Science, 306, 2061.
Whalen P. J. , Johnstone T. , Somerville L. H. , et al. (2008). A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biological Psychiatry, 63, 858–863.
Williams L. M. , Kemp A. H. , Felmingham K. , et al. (2006). Trauma modulates amygdala and medial prefrontal responses to consciously attended fear. Neuroimage, 29, 347–357.
Wright C. I. , Martis B. , McMullin K. , Shin L. M. , & Rauch S. L. (2003). Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biological Psychiatry, 54, 1067–1076.
Yamasue H. , Kasai K. , Iwanami A. , et al. (2003). Voxel-based analysis of MRI reveals anterior cingulate graymatter volume reduction in posttraumatic stress disorder due to terrorism. Proceedings of the National Academy of Sciences of the USA, 100, 9039–9043.

Reference Title: References

Reference Type: bibliography

Abramowitz J. S. , Foa E. B. , & Franklin M. E. (2003). Exposure and ritual prevention for obsessive–compulsive disorder: effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology, 71, 394–398.
Achenbach T. M. , Krukowski R. A. , Dumenci L. , & Ivanova M. Y. (2005). Assessment of adult psychopathology: meta-analyses and implications of cross-informant correlations. Psychological Bulletin, 131, 361–382.
Albano A. M. , & Silverman W. K. (1996). The Anxiety Disorders Interview Schedule for Children for DSM-IV: (Child and Parent Versions): Clinician's Manual. New York, NY: Oxford University Press.
Albano A. M. , Chorpita B. F. , & Barlow D. H. (2003). Anxiety disorders. In E.J. Mash & R.A. Barkley , eds., Child Psychopathology, 2nd edn. New York, NY: Guilford Press.
Barlow D. H. (1988). Anxiety and its Disorders. New York, NY: Guilford Press.
Barlow D. H. , ed. (2001). Clinical Handbook of Psychological Disorders, 3rd edn. New York, NY: Guilford Press.
Barlow D. H. (2002). Anxiety and its Disorders, 2nd edn. New York, NY: Guilford Press.
Barrios B. A. , & Hartmann D. (1984). Fears and anxieties. In E. J. Mash & L. G. Terdal , eds., Behavioral Assessment of Childhood Disorders. New York, NY: Guilford Press.
Beck A. T. (1967). Depression: causes and treatment. Philadelphia, PA: University of Pennsylvania Press.
Bitran S. , Morissette S. B. , Spiegel D. A. , & Barlow D. H. (2008). A pilot study of sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia: preliminary outcome and benchmarking data. Behavior Modification, 32, 196–214.
Borkovec T. D. (1994). The nature, functions, and origins of worry. In G. Davey & F. Tallis , eds., Worrying: Perspectives on Theory, Assessment, and Treatment. New York, NY: Wiley.
Borkovec T. D. , & Inz J. (1990). The nature of worry in generalized anxiety disorder: a preponderance of thought activity. Behaviour Research and Therapy, 28, 153–158.
Bouton M. E. (1993). Context, time and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin, 114, 90–99.
Bouton M. E. (2007). Learning and Behaviour: a Contemporary Synthesis. Sunderland, MA: Sinauer Associates.
Brewin C. R. , Dalgleish T. , & Joseph S. (1996). A dual representation theory of posttraumatic stress disorder. Psychological Review, 103, 670–686.
Brown T. A. , O'Leary T. , & Barlow D. H. (2001). Generalized anxiety disorder. In D.H. Barlow , ed., Clinical Handbook of Psychological Disorders, 3rd edn. New York, NY: Guilford Press.
Chorpita B. F. , & Barlow D. H. (1998). The development of anxiety: the role of control in the early environment. Psychological Bulletin, 124, 3–21.
Choudhury M. S. , Pimentel S. S. , & Kendall P. C. (2003). Childhood anxiety disorders: parent–child (dis) agreement using a structured interview for the DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 957–964.
Clark D. M. , Ehlers A. , Hackman A. , et al. (2006). Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. Journal of Consulting and Clinical Psychology, 75, 568–578.
Comer J. S. , & Kendall P. C. (2004). A symptom-level examination of parent–child agreement in the diagnosis of anxious youths. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 878–886.
Craske M. G. , Kircanski K. , Zelikowsky M. , et al. (2008). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy, 46, 5–27.
Davis M. , Montgomery I. , & Wilson G. (2002). Worry and heart rate variables: autonomic rigidity under challenge. Journal of Anxiety Disorders, 16, 639–659.
Deacon B. J. , & Abramowitz J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. Journal of Clinical Psychology, 60, 429–441.
De Los Reyes A. , & Kazdin A. E. (2005). Informant discrepancies in the assessment of childhood psychopathology: a critical review, theoretical framework, and recommendations for further study. Psychological Bulletin, 131, 483–509.
De Los Reyes A. , & Kazdin A. E. (2006). Conceptualizing changes in behavior in intervention research: the range of possible changes model. Psychological Review, 113, 554–583.
Eelen P. , & Vervliet B. (2006). Fear conditioning and clinical implications: what can we learn from the past? In M. G. Craske , D. Hermans , & D. Vansteenwegen , eds., Fear and Learning. Washington, DC, American Psychological Association, pp. 17–35.
Ellis A. (1962). Reason and Emotion in Psychotherapy. Secaucus, NJ: Citadel.
Eysenck H. J. (1952). The effects of psychotherapy: an evaluation. Journal of Consulting Psychology, 16, 319–324.
Gohm C. L. (2003). Mood regulation and emotional intelligence: individual differences. Journal of Personality and Social Psychology, 84, 594–607.
Gohm C. L. , & Clore G. L. (2002). Four latent traits of emotional experience and their involvement in wellbeing, coping, and attributional state. Cognition and Emotion, 16, 495–518.
Gray J. A. , & McNaughton N. (1996). The neuropsychology of anxiety: reprise. In D. A. Hope , ed., Perspectives on Anxiety, Panic and Fear. Lincoln, NE: University of Nebraska Press.
Horvath A. O. , & Symonds B. S. (1991). Relation between working alliance and outcome in psychotherapy: a metaanalysis. Journal of Counseling Psychology, 38, 139–149.
Jones M. C. (1924). A laboratory study of fear: the case of Peter. Pedagogical Seminary, 31, 308–315.
Kazdin A. E. (2006). Arbitrary metrics: implications for identifying evidence-based treatments. American Psychologist, 61, 42–49.
Kendall P. C. , ed. (2005). Child and Adolescent Therapy: Cognitive Behavioral Procedures, 3rd edn. New York, NY: Guilford Press.
Kendall P. C. , & Hollon S. D. , eds. (1979). Cognitive–behavioral Interventions: theory, research, and procedures. New York, NY: Academic Press.
Kendall P. C. , Comer J. S. , Marker C. D. , et al. (2009). In-session exposure tasks and therapeutic alliance across the treatment of childhood anxiety disorders. Journal of Consulting and Clinical Psychology, 77, 517–525.
Larsen R. J. , & Diener E. (1987). Affect intensity as an individual difference characteristic: a review. Journal of Research in Personality, 21, 1–39.
Mahoney M. J. (1974). Cognition and Behavior Modification. Cambridge, MA: Ballinger.
Martin D. J. , Garske J. P. , & Davis M. K. (2000). Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consulting and Clinical Psychology, 68, 438–450.
Meichenbaum D. (1977). Cognitive–Behavior Modification: an Integrative Approach. New York, NY: Plenum.
Mennin D. S. (2004). Emotion regulation therapy for generalized anxiety disorder. Clinical Psychology and Psychotherapy, 11, 17–29.
Mennin D. S. , Heimberg R. G. , Turk C. L. , & Fresco D. M. (2002). Applying an emotion regulation framework to integrative approaches to generalized anxiety disorder. Clinical Psychology: Science and Practice, 9, 85–90.
Mennin D. S. , Heimberg R. G. , Turk C. L. , & Fresco D. M. (2005). Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behaviour Research and Therapy, 43, 1281–1310.
Mogg K. , Bradley B. , Williams R. , & Mathews A. (1993). Subliminal processing of emotional information in anxiety and depression. Journal of Abnormal Psychology, 102, 304–311.
Mowrer O. H. (1947). On the dual nature of learning: A reinterpretation of “conditioning” and “problem solving”. Harvard Educational Review, 17, 102–148.
Myers K. M. , & Davis M. (2007). Mechanisms of fear extinction. Molecular Psychiatry, 12, 120–150.
O'Donohue W. , & Krasner L. (1995). Theories of Behavior Therapy: Exploring Behavior Change. Washington, DC: American Psychological Association Press.
Pine D. S. , Helfinstein S. M. , Bar-Haim Y. , Nelson E. , & Fox N. A. (2008). Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety. Neuropsychopharmacology Reviews, 1–16.
Roth A. , & Fonagy P. (2004). What Works for Whom? A Critical Review of Psychotherapy Research, 2nd edn. New York, NY: Guilford Press.
Rowe M. K. , & Craske M. G. (1998). Effects of an expanding-spaced vs. massed exposure on fear reduction and return of fear. Behaviour Research and Therapy, 36, 701–717.
Storch E. A. , Merlo L. J. , Lehmkuhl H. , et al. (2008). Cognitive–behavioral therapy for obsessive–compulsive disorder: a non-randomized comparison of intensive and weekly approaches. Journal of Anxiety Disorders, 22, 1146–1158.
Tsao J. C. I. , & Craske M. G. (2000). Timing of treatment and return of fear: effects of massed, uniform-, and expanding-spaced exposure schedules. Behavior Therapy, 31, 479–497.
Turk C. L. , Heimberg R.G. , Luterek J.A. , Mennin D.S. , & Fresco D.M. (2005). Delineating emotion regulation deficits in generalized anxiety disorder: a comparison with social anxiety disorder. Cognitive Therapy and Research, 29, 89–106.
Watson J. , & Raynor R. (1920). Conditioned emotional reactions. Journal of Genetic Psychology, 37, 394–419.

Reference Title: References

Reference Type: bibliography

American Psychiatric Association (1952). Diagnostic and Statistical Manual of Mental Disorders (DSM-I). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders, 2nd edn (DSM-II). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (DSM-III). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised (DSM-III-R). Washington, DC: American Psychiatric Association.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
Bodkin J. A. , Pope H. G. , Detke M. J. , & Hudson J. I. (2007). Is PTSD caused by traumatic stress? Journal of Anxiety Disorders, 21, 176–182.
Breslau N. (2002). Epidemiologic studies of trauma, posttraumatic stress disorder, and psychiatric disorders. Canadian Journal of Psychiatry, 47, 923–929.
Breslau N. , & Davis G. C. , (1987). Posttraumatic stress disorder: The stressor criterion. Journal of Nervous and Mental Disease, 175, 255–264.
Breslau N. , & Kessler R. C. (2001). The stressor criterion in DSM-IV posttraumatic stress disorder: An empirical investigation. Biological Psychiatry, 50, 699–704.
Breslau N. , Davis G. C. , Andreski P. , & Peterson E. (1991). Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of General Psychiatry, 48, 216–222.
Dohrenwend B. P. (1979). Stressful life events and psychopathology: some issues of theory and method. In J. F. Barrett , R. M. Rose , & G. L. Klerman , eds., Stress and Mental Disorder. New York, NY: Raven Press.
Dohrenwend B. P. (1998). Theoretical integration. In B. P. Dohrenwend , ed., Adversity, Stress and Psychopathology. New York, NY: Oxford University Press.
Dohrenwend B. P. (2000). The role of adversity and stress in psychopathology: some evidence and its implications for theory and research. Journal of Health and Social Behavior, 41, 1–19.
Dohrenwend B. P. (2006). Inventorying stressful life events as risk factors for psychopathology: toward resolution of the problem of intracategory variability. Psychological Bulletin, 132, 477–495.
Dohrenwend B.P. , Turner J.B. , Turse N.A. , et al. (2006). The psychological risks of Vietnam for U.S. veterans: a revisit with new data and methods. Science, 313, 979–982.
Engdahl B. Dikel M. A , Eberly R. , & Blank A. (1997). Posttraumatic stress disorder in a community group of former prisoners of war: a normative response to severe stress. American Journal of Psychiatry, 154, 1576–1581.
Erwin B. A. , Heimberg R. G. , Marx B. P. , Franklin M. E. (2006). Traumatic and socially stressful life events among persons with social anxiety disorder. Journal of Anxiety Disorders, 20, 896–914.
First M. B. , Spitzer R. L. , Gibbon M. , & Williams J. B. W. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: New York State Psychiatric Institute.
Foa E. B. , Cashman L. , Jaycox L. , & Perry K. (1997). The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological Assessment, 9, 445–451.
Friedman M. J. (2005). Veterans' mental health in the wake of war. New England Journal of Medicine, 352, 1287–1290.
Friedman M. J. , Resick P. A. , & Keane T. M. (2007a). PTSD twenty-five years of progress and challenges. In M. J. Friedman , T. M. Keane , & P. A. Resick , eds., Handbook of PTSD: Science and Practice. New York, NY: Guilford Press.
Friedman M. J. , Resick P. A. , & Keane T. M. (2007b). Key questions and an agenda for future research. In M. J. Friedman , T. M. Keane , & P. A. Resick , eds., Handbook of PTSD: Science and Practice. New York, NY: Guilford Press.
Gold S. D. , Marx B. P. , Soler-Baillo J. M. , & Loan D. M. (2005). Is life stress more traumatic than traumatic stress? Journal of Anxiety Disorders, 19, 687–698.
Goodman L. A. , Corcoran C. , Turner K. , Yuan N. , & Green B. (1998). Assessing traumatic event exposure: general issues and preliminary findings for the Stressful Life Events Screening Questionnaire. Journal of Traumatic Stress, 11, 521–542.
Hammen C. (1991). Generation of stress in the course of unipolar depression. Journal of Abnormal Psychology, 100, 555–561.
Helzer J. E. , Robins L. N. , & McEvoy L. (1987). Post-traumatic stress disorder in the general populaton: findings of the Epidemiologic Catchment Area Survey. New England Journal of Medicine, 417, 1630–1634.
Horowitz M. J. (1978). Stress Response Syndromes. Northvale, NJ: Jason Aronson.
Horowitz M. J. (1986). Stress Response Syndromes, 2nd edn. Northvale, NJ: Jason Aronson.
Horowitz M. J. , Winer N. , & Alvarez W. (1979). Impact of Event Scale: a measure of subjective stress. Psychosomatic Medicine, 41, 209–218.
Hovens J. E. , & van der Ploeg H. M. (1993). Post-traumatic stress disorder in Dutch psychiatric inpatients. Journal of Traumatic Stress, 6, 91–101.
Keane T. M. , Malloy P. F. , & Fairbank J. A. (1984). Empirical development of an MMPI subscale for the assessment of combat-related posttraumatic stress disorder. Journal of Clinical and Consulting Psychology, 52, 888–891.
Keane T. M. , Caddel J. M. , & Taylor K. L. (1988). Mississippi scale for combat-related posttraumatic stress disorder: three studies in reliability and validity. Journal of Clinical and Consulting Psychology, 56, 85–90.
Kendler K. S. , & Baker J. H. (2007). Genetic influences on measures of the environment. Psychological Medicine, 37, 615–626.
Kessler R. C. , Sonnega A. , Bromet E. , & Nelson C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048–60.
Kilpatrick D. G. , Resnick H. S. , Freedy J. R. , et al. (1998). Posttraumatic stress disorder field trial: evaluation of the PTSD construct. Criteria A through E. In T. Widiger , A. J. Frances , H. A. Pincus , et al., eds., DSM Sourcebook, Volume 4. Washington, DC: American Psychiatric Association.
Long M. E. , Elhai J. D. , Schweinle A. , et al. (2008). Differences in posttraumatic stress disorder diagnostic rates and symptom severity between Criterion A1 and non-Criterion A1 stressors. Journal of Anxiety Disorders, 22, 1255–1263.
Maier T. (2007). Weathers' and Keane's “The Criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma”. Journal of Traumatic Stress, 20, 915–916.
Maslow A. H. (1954). Motivation and Personality. New York, NY: Harper.
McNally R. J. (2003). Progress and controversy in the study of posttraumatic stress disorder. Annual Review of Psychology, 54, 229–252.
Mol S. S. L. , Arntz A. , Metsemakers J. F. M. , et al. (2005). Symptoms of post-traumatic stress disorder after non-traumatic events: evidence from an open population study. British Journal of Psychiatry, 186, 494–499.
Olff M. , Koeter M. W. J. , Van Haaften E. H. , Kersten P. H. , & Gersons B. P. R. (2005). Impact of foot and mouth disease crisis on post-traumatic stress symptoms in farmers. British Journal of Psychiatry, 186, 165–166.
Rahe R. H. (1988). Acute versus chronic reactions to combat. Military Medicine, 153, 365–372.
Robins L. N. , Helzer J. E. , Croughan J. , & Ratcliff K. S. (1981). The Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry, 38, 318–389.
Rona R. J. , Fear N. T. , Hull L. , Greenberg N. , et al. (2007). Mental health consequences of overstretch in UK armed forces: first phase of a cohort study. BMJ, 335, 604–609.
Rubin D. C. , Berntsen D. , & Bohni M. K. (2008). A memory-based model of posttraumatic stress disorder: evaluating basic assumptions underlying the PTSD diagnosis. Psychological Review, 115, 985–1011.
Sarason I. , Johnson J. , & Siegel J. (1978). Assessing the impact of life changes: development of the life experiences survey. Journal of Consulting and Clinical Psychology, 46, 932–946.
Schlenger W. E. , Caddell J. M. , Ebert L. , et al. (2002). Psychological reactions to terrorist attacks: findings from the National Study of Americans' Reactions to September 11. JAMA, 288, 581–588.
Seidler G. H. , & Wagner F. E. (2006). The stressor criterion in PTSD: notes on the genealogy of a problematic construct. American Journal of Psychotherapy, 60, 261–270.
Solomon S. D. , & Canino G. J. (1990) Appropriateness of DSM-III-R criteria for posttraumatic stress disorder. Comprehensive Psychiatry, 312, 227–237.
Spitzer C. , Abrahamson G. , Reschke K. , et al. (2000). Posttraumatic stress disorder following high- and low-magnitude stressors in psychotherapeutic inpatients. Clinical Psychology and Psychotherapy, 7, 379–384.
Spitzer R. , Williams J. , & Gibbon M. (1987). Structured Clinical Interview for DSM-III-R, Version NP-V. New York, NY: New York State Psychiatric Institute, Biometrics Research Department.
Suvak M. , Maguen S. , Litz B. T. , Silver R. C. , & Holman E. A. (2008). Indirect exposure to the September 11 terrorist attacks: Does symptom structure resemble PTSD? Journal of Traumatic Stress, 21, 30–39.
Van Hooff M. , McFarlane A. C. , Baur J. , Abraham M. , & Barnes D. J. (2009). The stressor criterion-A1 and PTSD: a matter of opinion? Journal of Anxiety Disorders, 232, 77–86.
Weathers F. W. , & Keane T. M. (2007). The Criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma. Journal of Traumatic Stress, 20, 107–121.
Weathers F. W. , Litz B. T. , Herman D. S. , & Keane T. M. (1993). The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Paper presented at the annual meeting of the International Society for Traumatic Stress Studies, San Antonio, Texas.
Weiss D. S. , & Marmar C. R. (1997). The Impact of Event Scale-Revised. In J. P. Wilson & T. M. Keane , eds., Assessing Psychological Trauma and PTSD. New York, NY: Guilford Press.
Wessely S. (2005). Risk, psychiatry and the military. British Journal of Psychiatry, 186, 459–566.
World Health Organization (1990). Composite International Diagnostic Interview (CIDI). Geneva: World Health Organization.
World Health Organization (1997). Composite International Diagnostic Interview (CIDI), Version 2.1. Geneva: World Health Organization.
Yehuda R. , & McFarlane A. C. (1995). Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. American Journal of Psychiatry, 152, 1705–1713.

Reference Title: References

Reference Type: bibliography

Ainsworth M. (1969). Object relations, dependency and attachment: a theoretical review of the infant–mother relationship. Child Development, 40, 969–1025.
Ainsworth M. (1991). An ethological approach to personality development. American Psychologist, 46, 333–341.
Ainsworth M. , Blehar M. C. , Waters E. , & Wall S. (1978). Patterns of Attachment: a Psychological Study of the Strange Situation. Hillsdale, NJ: Lawrence Erlbaum.
Armsden G. C. , & Greenberg M. T. (1987). The inventory of parent and peer attachment: Individual differences and their relationship to psychological well-being in adolescence. Journal of Youth and Adolescence, 16, 427–454.
Armstrong S. , & Roth D. (1989). Attachment and separation difficulties in eating disorders: A preliminary investigation. International Journal of Eating Disorders, 8, 141–155.
Aschenbrand S. G. , Kendall P. C. , Webb A. , Safford S. M. , & Flannery-Schroeder E. (2003). Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1478–1485.
Bartholomew K. , & Horowitz L. M. (1991). Attachment styles among young adults: a test of a four-category model. Journal of Personality and Social Psychology, 61, 226–244.
Beck A. T. (1985). Cognitive Therapy and the Emotional Disorders. New York, NY: International Universities Press.
Bifulco A. , Kwon J. , Jacobs C. , et al. (2006). Adult attachment styles as mediator between childhood neglect/abuse and adult depression and anxiety. Social Psychiatry and Psychiatric Epidemiology, 41, 796–805.
Birmaher B. , Axelson D. A. , Monk K. , et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 415–423.
Blanchard E. B. , Jones-Alexander J. , Buckley T. C. , & Forneris C. A. (1996). Psychometric properties of the PTSD Checklist (PCL). Behavior Research and Therapy, 34, 669–673.
Bowlby J. (1969). Attachment and Loss, Vol. 1: Attachment. New York, NY: Basic Books.
Bowlby J. (1973). Attachment and Loss, Vol. 2: Separation: Anxiety and Anger. New York, NY: Basic Books.
Bowlby J. (1977). The making and breaking of affectional bonds. British Journal of Psychiatry, 130, 201–210.
Bowlby J. (1980). Attachment and Loss. Vol. 3: Loss, Sadness and Depression. New York, NY: Basic Books.
Bowlby J. (1988). A Secure Base. New York, NY: Basic Books.
Briere J. , & Runtz M. G. (1989). The Trauma Symptom Checklist (TSC-33): early data on a new scale. Journal of Interpersonal Violence, 4, 151–163.
Cantwell D. P. , & Baker L. (1989). Stability and natural history of DSM-III childhood diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 691–700.
Collins N. L. (1996). Working models of attachment: Implications for explanation, emotion, and behavior. Journal of Personality and Social Psychology, 71, 810–832.
Collins N. L. , & Read S. J. (1990). Adult attachment, working models, and relationship quality in dating couples. Journal of Personality and Social Psychology, 58, 644–663.
Cronk N. J. , Slutske W. S. , Madden P. A. , Bucholz K. K. , & Heath A. C. (2004). Risk for separation anxiety disorder among girls: paternal absence, socioeconomic disadvantage, and genetic vulnerability. Journal of Abnormal Psychology, 113, 237–247.
Cyranowski J. M. , Shear M. K. , Rucci P. , et al. (2002). Adult separation anxiety: psychometric properties of a new structured clinical interview. Journal of Psychiatric Research, 36, 77–86.
Dallaire D. H. , & Weinraub M. (2005). Predicting children's separation anxiety at age 6: the contributions of infant–mother attachment security, maternal sensitivity, and maternal separation anxiety. Attachment and Human Development, 7, 393–408.
Declercq F. , & Palmans V. (2006). Two subjective factors as moderators between critical incidents and the occurrence of post traumatic stress disorders: adult attachment and perception of social support. Psychology and Psychotherapy, 79, 323–337.
Dieperink M. , Leskela J. , Thuras P. , & Engdahl B. (2001). Attachment style classification and posttraumatic stress disorder in former prisoners of war. American Journal of Orthopsychiatry, 71, 374–378.
Ellis A. (1962). Reason and Emotion in Psychotherapy. Secaucus, NJ: Citadel Press.
Fagiolini A. , Shear M. K. , Cassano G. B. , & Frank E. (1998). Is lifetime separation anxiety a manifestation of panic spectrum? CNS Spectrums, 3, 63–72.
Foley D. L. , Pickles A. , Maes H. M. , Silberg J. L. , & Eaves L. J. (2004). Course and short-term outcomes of separation anxiety disorder in a community sample of twins. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1107–1114.
Fonagy P , & Target M. (2005). Bridging the transmission gap: an end to an important mystery of attachment research? Attachment and Human Development, 7, 333–343.
George C. , Kaplan N. , & Main M. (1985). The Berkeley Adult Attachment Interview. Berkeley, CA: University of California.
Hamilton C. E. (2000). Continuity and discontinuity of attachment from infancy through adolescence. Child Development, 71, 690–694.
Hazan C. , & Shaver P. (1987). Romantic love conceptualized as an attachment process. Journal of Personality and Social Psychology, 52, 511–524.
Hock E. , McBride S , & Gnezda M. (1989). Maternal separation anxiety: mother–infant separation from the maternal perspective. Child Development, 60, 79–802.
Hock E. , Eberly M. , Bartle-Haring S. , Ellwanger P. , & Widaman K. F. (2001). Separation anxiety in parents of adolescents: theoretical significance and scale development. Child Development, 72, 284–298.
Hofer M. (1984). Relationships as regulators: a psychobiologic perspective on bereavement. Psychosomatic Medicine, 46, 183–197.
Kendall P. C. (1994). Treating anxiety disorders in children: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62, 100–110.
Klerman G. , Weissman M. , Rounseville B. , & Chevron E. S. (1984). Interpersonal Psychotherapy for Depression. New York, NY: Basic Books.
Kobak R. R. , & Sceery A. (1988). Attachment in late adolescence: working models, affect regulation, and representations of self and others. Child Development, 59, 135–146.
Last C. G. , Perrin S. , Hersen M. , & Kazdin A. E. (1996). A prospective study of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1502–1510.
Maller R G , & Reiss S. (1992). Anxiety sensitivity in 1984 and panic attacks in 1987. Journal of Anxiety Disorders, 6, 241–247.
Manicavasagar V. , & Silove D. (1997). Is there an adult form of separation anxiety disorder? A brief clinical report. Australian and New Zealand Journal of Psychiatry, 31, 299–303.
Manicavasagar V. , Silove D. , & Curtis J. (1997). Separation anxiety in adulthood: a phenomenological investigation. Comprehensive Psychiatry, 38, 274–282.
Manicavasagar V. , Silove D. , Curtis J. , & Wagner R. (2000). Continuities of separation anxiety from early life into adulthood. Journal of Anxiety Disorders, 14, 1–18.
Manicavasagar V. , Silove D. , Rapee R. , Waters F. , & Momartin S. (2001). Parent–child concordance for separation anxiety: a clinical study. Journal of Affective Disorders, 65, 81–84.
Marcaurelle R. , Belanger C. , Marchand A. , Katerelos T. E. , & Mainguy N. (2005). Marital predictors of symptom severity in panic disorder with agoraphobia. Journal of Anxiety Disorders, 19, 211–232.
Masi G. , Mucci M. , & Millepiedi S. (2001). Separation anxiety disorder in children and adolescents: Epidemiology, diagnosis and management. CNS Drugs, 15, 93–104.
Mickelson K. D. , Kessler R. C. , & Shaver P. (1997). Adult attachment in a nationally representative sample. Journal of Personality and Social Psychology, 73, 1092–1106.
Mikulincer M. , & Shaver P. R. (2007). Attachment in Adulthood: Structure, Dynamics, and Change. New York, NY: Guilford Press.
Mikulincer M. , & Shaver P. (2003). The attachment behavioral system in adulthood: activation, psychodynamics, and interpersonal processes. In M. P. Zanna , ed., Advances in Experimental Social Psychology, Vol. 35. New York, NY: Academic Press, pp. 53–152.
Mikulincer M. , Birnbaum G. , Woddis D. , & Nachmias O. (2000). Stress and accessibility of proximity-related thoughts: exploring the normative and intraindividual components of attachment theory. Journal of Personality and Social Psychology, 78, 509–523.
Mikulincer M. , Shaver P. , & Pereg D. (2003). Attachment theory and affect regulation: The dynamics, development, and cognitive consequences of attachment-related strategies. Motivation and Emotion, 27, 77–102.
Neria Y. , Guttman-Steinmetz S. , Koenen K. , et al. (2001). Do attachment and hardiness relate to each other and to mental health in real life stress? Journal of Social and Personal Relationships, 18, 844–858.
O'Connor M. , & Elklit A. (2008). Attachment styles, traumatic events, and PTSD: a cross-sectional investigation of adult attachment and trauma. Attachment and Human Development, 10, 59–71.
Ollendick T. H. , Lease C. , & Cooper C. (1993). Separation anxiety in young adults: a preliminary examination. Journal of Anxiety Disorders, 7, 293–305.
Panksepp J. (2005). Why does separation distress hurt? Comment on MacDonald and Leary (2005). Psychological Bulletin, 131, 224–230; author reply 237–240.
Rector N. A. , Szacun-Shimizu K. , & Leybman M. (2007). Anxiety sensitivity within the anxiety disorders: disorder-specific sensitivities and depression comorbidity. Behaviour Research and Therapy, 45, 197–1975.
Reiss S. (1991). Expectancy model of fear, anxiety, and panic. Clinical Psychology Review, 11, 141–153.
Research Unit on Pediatric Psychopharmacology Anxiety Study Group (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279–1285.
Sable P. (2008). What is adult attachment? Clinical Social Work Journal, 36, 21–30.
Scher C. D. , & Stein M. B. (2003). Developmental antecedents of anxiety sensitivity. Anxiety Disorders, 17, 253–269.
Schmidt N. B. , Lerew D. R. , & Jackson R. J. (1997). The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. Journal of Abnormal Psychology, 106, 355–364.
Schmidt N. B. , Lerew D. R. , & Jackson R. J. (1999). Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: replication and extension. Journal of Abnormal Psychology, 108, 532–537.
Schore A. N. (1996). The experience-dependent maturation of a regulatory system in the orbital prefrontal cortex and the origin of developmental psychopathology. Development and Psychopathology, 8, 59–87.
Schore A. N. (2000). Attachment and the regulation of the right brain. Attachment and Human Development, 2, 23–47.
Schore A. N. (2001). The effects of a secure attachment relationship on right brain development, affect regulation, and infant mental health. Infant Mental Health Journal, 22, 7–66.
Schore A. N. (2002). Advances in neuropsychoanalysis, attachment theory, and trauma research: implications for self psychology. Psychoanalytic Inquiry, 22, 433–484.
Schore J. , & Schore A. (2008). Modern attachment theory: the central role of affect regulation in development and treatment. Clinical Social Work Journal, 36, 9–20.
Shear K. , Jin R. , Ruscio A. M. , Walters E. E. , & Kessler R. C. (2006). Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 1074–1083.
Silove D. , Manicavasagar V. , Curtis J. , & Blaszczynski A. (1996). Is early separation anxiety a risk factor for adult panic disorder? A critical review. Comprehensive Psychiatry, 37, 167–179.
Silverman W. K. , Kurtines W. M. , Ginsburg G. S. , et al. (1999). Treating anxiety disorders in children with group cognitive–behaviorial therapy: a randomized clinical trial. Journal of Consulting and Clinical Psychology, 67, 995–1003.
Solomon Z. , Ginzburg K. , Mikulincer M. , Neria Y. , & Ohry A. (1998). Coping with war captivity: the role of attachment style. European Journal of Personality, 12, 271–285.
Stein M. B. , Jang K. L. , & Livesley W. J. (1999). Heritability of anxiety sensitivity: a twin study. American Journal of Psychiatry, 156, 246–251.
Stewart S. H. , & Watt M. C. (2008). Introduction to the special issue on interoceptive exposure in the treatment of anxiety and related disorders: novel applications and mechanisms of action. Journal of Cognitive Psychotherapy, 22, 291–302.
Taylor S. , Koch W. J. , & McNally R. J. (1992). How does anxiety sensitivity vary across the anxiety disorders? Journal of Anxiety Disorders, 6, 249–259.
Viana A. G. , & Rabian B. (2008). Perceived attachment: relations to anxiety sensitivity, worry, and GAD symptoms. Behaviour Research and Therapy, 46, 737–747.
Walkup J. T. , Albano A. M. , Piacentini J. , et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
Warren S. L. , Huston L. , Egeland B. , & Sroufe L. A. (1997). Child and adolescent anxiety disorders and early attachment. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 637–644.
Waters E. , Weinfield N. S. , & Hamilton C. E. (2000). The stability of attachment security from infancy to adolescence and early adulthood: general discussion. Child Development, 71, 703–706.
Watt M. C. , Stewart S. H. , & Cox B. J. (1998). A retrospective study of the learning history origins of anxiety sensitivity. Behaviour Research and Therapy, 36, 505–525.
Watt M. C. , McWilliams L. A. , & Campbell A. G. (2005). Relations between anxiety sensitivity and attachment style dimensions. Journal of Psychopathology and Behavioral Assessment, 27, 191–200.
Weems C. , & Carrion V. (2003). The treatment of separation anxiety disorder employing attachment theory and cognitive behavior therapy techniques. Clinical Case Studies, 2, 188–198.
Weems C. , Berman S. , Silverman W. , & Saavedra L. (2001). Cognitive errors in youth with anxiety disorders: the linkages between negative cognitive errors and anxious symptoms. Cognitive Therapy and Research, 25, 559–575.
Weems C. , Berman S. , Silverman W. , & Rodriquez E. (2002). The relation between anxiety sensitivity and attachment style in adolescence and early adulthood. Journal of Psychopathology and Behavioral Assessment, 24, 159–168.
Wijeratne C. , & Manicavasagar V. (2003). Separation anxiety in the elderly. Journal of Anxiety Disorders, 17, 695–702.

Reference Title: References

Reference Type: bibliography

Amaral D. G. , & Price J. L. (1984). Amygdalo-cortical projections in the monkey (Macaca fascicularis). Journal of Computational Neurology, 230, 465–496.
AyanlarBatuman O. , Ferrero A. P. , Diaz A. , & Jimenez S. A. (1991). Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. Journal of Clinical Investigation, 88, 1574–1580.
Barros M. , & Tomaz C. (2002). Non-human primate models for investigating fear and anxiety. Neuroscience and Biobehavioral Review, 26, 187–201.
Cirulli F. , Francia N. , Branchi I. , et al. (2009). Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques. Psychoneuroendocrinology, 34, 172–180.
Coplan J. D. , Rosenblum L. A. , Friedman S. , Bassoff T. B. , & Gorman J. M. (1992). Behavioral effects of oral yohimbine in differentially reared nonhuman primates. Neuropsychopharmacology, 6, 31–37.
Coplan J. D. , Andrews M. W. , Rosenblum L. A. , et al. (1996). Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proceedings of the National Academy of Sciences of the USA, 93, 1619–1623.
Coplan J. D. , Trost R. C. , Owens M. J. , et al. (1998). Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. Archives of General Psychiatry, 55, 473–477.
Coplan J. D. , Smith E. L. , Trost R. C. , et al. (2000). Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations. Psychiatry Research, 95, 93–102.
Coplan J. D. , Mathew S. J. , Smith E. L. , et al. (2001). Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function. CNS Spectrums, 6, 607–612, 617.
Davidson R. J. , Lewis D. A. , Alloy L. B. , et al. (2002). Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry, 52, 478–502.
De Bellis M. D. , Keshavan M. S. , Spencer S. , & Hall J. (2000). N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. American Journal of Psychiatry, 157, 1175–1177.
Drevets W. C. (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research, 126, 413–431.
Etkin A. , & Wager T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Fergus S. , & Zimmerman M. A. (2005). Adolescent resilience: a framework for understanding healthy development in the face of risk. Annual Review of Public Health, 26, 399–419.
Glaser D. (2000). Child abuse and neglect and the brain: a review. Journal of Child Psychology and Psychiatry, 41, 97–116.
Goldberg S. , Muir R. , & Kerr J. (1995). Attachment Theory: Social, Developmental, and Clinical Perspectives. Hillsdale, NJ: Analytic Press.
Gorman J. M. , Kent J. M. , Sullivan G. M. , & Coplan J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157, 493–505.
Gould E. , Tanapat P. , McEwen B. S. , Flugge G. , & Fuchs E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proceedings of the National Academy of Sciences of the USA, 95, 3168–3171.
Greenberg B. D. , Askland K. D. , & Carpenter L. L. (2008). The evolution of deep brain stimulation for neuropsychiatric disorders. Frontiers in Bioscience, 13, 4638–4648.
Gunnar M. R. , Brodersen L. , Nachmias M. , Buss K. , & Rigatuso J. (1996). Stress reactivity and attachment security. Developmental Psychobiology, 29, 191–204.
Hajek T. , Kopecek M. , Kozeny J. , et al. (2009). Amygdala volumes in mood disorders: meta-analysis of magnetic resonance volumetry studies. Journal of Affective Disorders, 115, 395–410.
Harlow H. F. , & Suomi S. J. (1974). Induced depression in monkeys. Behavioral Biology, 12, 273–296.
Heinrichs M. , Baumgartner T. , Kirschbaum C. , & Ehlert U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54, 1389–1398.
Herman J. P. , Figueiredo H. , Mueller N. K. , et al. (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness. Frontiers in Neuroendocrinology, 24, 151–180.
Holmes A. , Murphy D. L. , & Crawley J. N. (2003). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry, 54, 953–959.
Izquierdo A. , Suda R. K. , & Murray E. A. (2004). Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. Journal of Neuroscience, 24, 7540–7548.
Kalin N. H. (2004). Studying non-human primates: a gateway to understanding anxiety disorders. Psychopharmacological Bulletin, 38(Suppl. 1), 8–13.
Kalin N. H. , & Shelton S. E. (2003). Nonhuman primate models to study anxiety, emotion regulation, and psychopathology. Annals of the New York Academy of Sciences, 1008, 189–200.
Kalin N. H. , Shelton S. E. , & Takahashi L. K. (1991). Defensive behaviors in infant rhesus monkeys: ontogeny and context-dependent selective expression. Child Development, 62, 1175–1183.
Kalin N. H. , Shelton S. E. , & Davidson R. J. (2004). The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. Journal of Neuroscience, 24, 5506–5515.
Kalin N. H. , Shelton S. E. , & Davidson R. J. (2007). Role of the primate orbitofrontal cortex in mediating anxious temperament. Biological Psychiatry, 62, 1134–1139.
Kaufman J. , Plotsky P. M. , Nemeroff C. B. , & Charney D. S. (2000). Effects of early adverse experiences on brain structure and function: clinical implications. Biological Psychiatry, 48, 778–790.
Kaufman D. , Banerji M. A. , Shorman I. , et al. (2007). Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes, 56, 1382–1386.
Krabbe K. S. , Nielsen A. R. , Krogh-Madsen R. , et al. (2007). Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia, 50, 431–438.
Lyons D. M. , Yang C. , Sawyer-Glover A. M. , Moseley M. E. , & Schatzberg A. F. (2001). Early life stress and inherited variation in monkey hippocampal volumes. Archives of General Psychiatry, 58, 1145–1151.
Lyons D. M. , Afarian H. , Schatzberg A. F. , Sawyer-Glover A. , & Moseley M. E. (2002). Experience-dependent asymmetric variation in primate prefrontal morphology. Behavioral Brain Research, 136, 51–59.
Maestripieri D. , McCormack K. , Lindell S. G. , Higley J. D. , & Sanchez M. M. (2006). Influence of parenting style on the offspring's behaviour and CSF monoamine metabolite levels in crossfostered and noncrossfostered female rhesus macaques. Behavioral Brain Research, 175, 90–95.
Mathew S. J. , Coplan J. D. , Schoepp D. D. , et al. (2001). Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disorders. CNS Spectrums, 6, 555–556, 561–554.
Mathew S. J. , Shungu D. C. , Mao X. , et al. (2003). A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. Biological Psychiatry, 54, 727–735.
Meaney M. J. , & Szyf M. (2005). Maternal care as a model for experience-dependent chromatin plasticity? Trends in Neuroscience, 28, 456–463.
Mirescu C. , & Gould E. (2006). Stress and adult neurogenesis. Hippocampus, 16, 233–238.
Nelson E. E. , & Winslow J. T. (2009). Non-human primates: model animals for developmental psychopathology. Neuropsychopharmacology, 34, 90–105.
Nemeroff C. B. , & Vale W. W. (2005). The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry, 66(Suppl. 7), 5–13.
Ochsner K. N. , & Gross J. J. (2005). The cognitive control of emotion. Trends in Cognitive Science, 9, 242–249.
Onen Sertoz O. , Tolga Binbay I. , Koylu E. , et al. (2008). The role of BDNF and HPA axis in the neurobiology of burnout syndrome. Progress in Neuropsychopharmacology and Biological Psychiatry, 32, 1459–1465.
Parker K. J. , Buckmaster C. L. , Schatzberg A. F. , & Lyons D. M. (2004). Prospective investigation of stress inoculation in young monkeys. Archives of General Psychiatry, 61, 933–941.
Parker K. J. , Buckmaster C. L. , Justus K. R. , Schatzberg A. F. , & Lyons D. M. (2005a). Mild early life stress enhances prefrontal-dependent response inhibition in monkeys. Biological Psychiatry, 57, 848–855.
Parker K. J. , Buckmaster C. L. , Schatzberg A. F. , & Lyons D. M. (2005b). Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology, 30, 924–929.
Parker K. J. , Buckmaster C. L. , Sundlass K. , Schatzberg A. F. , & Lyons D. M. (2006). Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates. Proceedings of the National Academy of Sciences of the USA, 103, 3000–3005.
Parker K. J. , Rainwater K. L. , Buckmaster C. L. , et al. (2007). Early life stress and novelty seeking behavior in adolescent monkeys. Psychoneuroendocrinology, 32, 785–792.
Perlis R. H. , Mischoulon D. , Smoller J. W. , et al. (2003). Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biological Psychiatry, 54, 879–883.
Perna G. , Favaron E. , Di Bella D. , Bussi R. , & Bellodi L. (2005). Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology, 30, 2230–2235.
Price J. L. , & Amaral D. G. (1981). An autoradiographic study of the projections of the central nucleus of the monkey amygdala. Journal of Neuroscience, 1, 1242–1259.
Prost R. W. , Mark L. , Mewissen M. , & Li S. J. (1997). Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 tesla. Magnetic Resonance in Medicine, 37, 615–618.
Rolls E. T. (2004). The functions of the orbitofrontal cortex. Brain and Cognition, 55, 11–29.
Rosenblum L. A. , & Paully G. S. (1984). The effects of varying environmental demands on maternal and infant behavior. Child Development, 55, 305–314.
Rosenblum L. A. , & Paully G. S. (1987). Primate models of separation-induced depression. Psychiatric Clinics of North America, 10, 437–447.
Rosenblum L. A. , Coplan J. D. , Friedman S. , et al. (1994). Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biological Psychiatry, 35, 221–227.
Rosenblum L. A. , Forger C. , Noland S. , Trost R. C. , & Coplan J. D. (2001). Response of adolescent bonnet macaques to an acute fear stimulus as a function of early rearing conditions. Developmental Psychobiology, 39, 40–45.
Sanchez M. M. (2006). The impact of early adverse care on HPA axis development: nonhuman primate models. Hormones and Behavior, 50(4), 623–631.
Sanchez M. M. , Ladd C. O. , & Plotsky P. M. (2001). Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Developmental Psychopathology, 13, 419–449.
Sanchez M. M. , Noble P. M. , Lyon C. K. , et al. (2005). Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biological Psychiatry, 57, 373–381.
Schuff N. , Neylan T. C. , Lenoci M. A. , et al. (2001). Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biological Psychiatry, 50, 952–959.
Serretti A. , Calati R. , Mandelli L. , & De Ronchi D. (2006). Serotonin transporter gene variants and behavior: a comprehensive review. Current Drug Targets, 7, 1659–1669.
Smith E. L. , Batuman O. A. , Coplan J. D. , & Rosenblum L. A. (2001). Stress, peer affiliation, and transforming growth factor-β1 in differentially reared primates. CNS Spectrums, 6, 573–578.
Smith E. L. , Batuman O. A. , Trost R. C. , Coplan J. D. , & Rosenblum L. A. (2002). Transforming growth factor-beta 1 and cortisol in differentially reared primates. Brain Behavioral Immunology, 16, 140–149.
Sternberg E. M. (1997). Neural-immune interactions in health and disease. Journal of Clinical Investigation, 100, 2641–2647.
Suomi S. J. (1997). Early determinants of behaviour: evidence from primate studies. British Medical Bulletin, 53, 170–184.
Suomi S. J. (2006). Risk, resilience, and gene × environment interactions in rhesus monkeys. Annals of the New York Academy of Sciences, 1094, 52–62.
Taylor S. E. , Eisenberger N. I. , Saxbe D. , Lehman B. J. , & Lieberman M. D. (2006). Neural responses to emotional stimuli are associated with childhood family stress. Biological Psychiatry, 60, 296–301.

Reference Title: References

Reference Type: bibliography

Abramowitz J. S. , Franklin M. E. , Zoellner L. A. , & DiBernardo C. L. (2002). Treatment compliance and outcome in obsessive–compulsive disorder. Behavior Modification, 26, 447–463.
Ackerman D. L. , & Greenland S. (2002). Multivariate meta-analysis of controlled drug studies for obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 22, 309–317.
Albert U. , Aguglia E. , Maina G. , & Bogetto F. (2002). Venlafaxine versus clomipramine in the treatment of obsessive–compulsive disorder: a preliminary single-blind, 12-week, controlled study. Journal of Clinical Psychiatry, 63, 1004–1009.
Baer L. , Greist J. , & Marks I. M. (2007). Computeraided cognitive behaviour therapy. Psychotherapy and Psychosomatics, 76, 193–195.
Baer R. (2004). Mindfulness training as a clinical intervention: a conceptual and empirical review. Clinical Psychology: Science and Practice, 10, 125–143.
Bishop S. R. (2002). What do we really know about mindfulness-based stress reduction? Psychosomatic Medicine, 64, 71–84.
Bloch M. H. , Landeros-Weisenberger A. , Kelmendi B. , et al. (2006). A systematic review: antipsychotic augmentation with treatment refractory obsessive–compulsive disorder. Molecular Psychiatry, 11, 622–632.
Bystritsky A. , Ackerman D. L. , Rosen R. M. , et al. (2004). Augmentation of serotonin reuptake inhibitors in refractory obsessive–compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. Journal of Clinical Psychiatry, 65, 565–568.
Carey P. D. , Vythilingum B. , Seedat S. , Muller J. E. , Van Ameringen M. , & Stein D. J. (2005). Quetiapine augmentation of SRIs in treatment refractory obsessive–compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry, 5, 5.
Cordioli A. V. , Basso de Sousa M. , & Bochi D. B. (2003). Intravenous clomipramine in severe and refractory obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 23, 665–666.
Coric V. , Taskiran S. , Pittenger C. , Wasylink S. , et al. (2005). Riluzole augmentation in treatment-resistant obsessive–compulsive disorder: an open-label trial. Biological Psychiatry, 58, 424–428.
Cottraux J. , Mollard E. , Bouvard M. , et al. (1990). A controlled study of fluvoxamine and exposure in obsessive–compulsive disorder. International Clinical Psychopharmacology, 5, 17–30.
Cottraux J. , Note I. , Yao S. N. , et al. (2001). A randomized controlled trial of cognitive therapy in obsessive–compulsive disorder. Psychotherapy and Psychosomatics, 70, 288–297.
Davis M. , Myers K. M. , Chhatwal J. , & Ressler K. J. (2006). Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. NeuroRx, 3, 82–96.
Dell'osso B. , Mundo E. , Marazziti D. , & Altamura A. C. (2008). Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series. Journal of Psychopharmacology, 22, 210–213.
Denys D. , van der Wee N. , van Megen H. J. , & Westenberg H. G. (2003). A double blind comparison of venlafaxine and paroxetine in obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 23, 568–575.
Denys D. , van Megen H. J. , van der Wee N. , & Westenberg H. G. (2004a). A double-blind switch study of paroxetine and venlafaxine in obsessive–compulsive disorder. Journal of Clinical Psychiatry, 65, 37–43.
Denys D. , de Geus F. , van Megen H. J. , & Westenberg H. G. (2004b). A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive–compulsive disorder refractory to serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 65, 1040–1048.
Eddy K. T. , Dutra L. , Bradley R. , & Westen D. (2004). A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive–compulsive disorder. Clinical Psychology Review, 24, 1011–1030.
El Mansari M. , & Blier P. (2006). Mechanisms of action of current and potential pharmacotherapies of obsessive–compulsive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 362–373.
Emmelkamp P. M. , & Beens H. (1991). Cognitive therapy with obsessive–compulsive disorder: a comparative evaluation. Behaviour Research and Therapy, 29, 293–300.
Emmelkamp P. M. , Visser S. , & Hoekstra R. J. (1988). Cognitive therapy vs exposure in vivo in the treatment of obsessive–compulsives. Cognitive Therapy and Research, 12, 103–114.
Fals-Stewart W. , Marks A. P. , & Schafer J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive–compulsive disorder. Journal of Nervous and Mental Disease, 181, 189–193.
Foa E. B. , & Kozak M. J. (1996). Psychological treatment for obsessive–compulsive disorder. In M. R. Mavissakalian & R. F. Prien , eds., Long-Term Treatments of Anxiety Disorders. Washington, DC: American Psychiatric Press.
Foa E. B. , Grayson J. B. , Steketee G. S. , et al. (1983). Success and failure in the behavioral treatment of obsessive–compulsives. Journal of Consulting and Clinical Psychology, 51, 287–297.
Foa E. B. , Dancu C. V. , Hembree E. A. , et al. (1999). A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. Journal of Consulting and Clinical Psychology, 67, 194–200.
Foa E. B. , Liebowitz M. R. , Kozak M. J. , et al. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder. American Journal of Psychiatry, 162, 151–161.
Franklin M. E. (2005). Combining serotonergic medication with cognitive–behavior therapy: is it necessary for all OCD patients? In J. S. Abramowitz and A. C. Houts , eds., Concepts and Controversies in Obsessive–Compulsive Disorder. New York, NY: Springer, pp. 377–389.